{
 "retrieved": "2026-11-15",
 "roles": [
  {
   "role": "main",
   "label": "About 340B"
  },
  {
   "role": "part",
   "label": "Has a part on 340B"
  },
  {
   "role": "mention",
   "label": "Mentions 340B"
  }
 ],
 "kinds": [
  "contract-pharmacy",
  "payer-nondiscrimination",
  "reporting",
  "medicaid",
  "use-of-savings",
  "study",
  "other"
 ],
 "bills": [
  {
   "bill_id": "us-119-hr1",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 1",
   "title": "An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.",
   "official_title": "An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.",
   "role": "part",
   "kinds": [
    "medicaid",
    "reporting"
   ],
   "summary": "Earlier versions carried Medicaid pharmacy payment rules for 340B drugs and a pharmacy benefit manager report that named 340B. The text that became law does not name the program.",
   "names_program_in": [
    "earlier text"
   ],
   "text_mentions": 0,
   "quote": "… the actual acquisition cost (as defined in 447.502 of title 42, Code of Federal Regulations) for such drug if— (aa) such drug was subject to an agreement under section 340B of the Public Health Service Act; (bb) such payment for the ingredient cost of such drug does not exceed the maximum payment that would have been made by the entity or …",
   "introduced_date": "2025-05-20",
   "sponsor": "Rep. Arrington, Jodey C. [R-TX-19]",
   "cosponsors": 0,
   "committees": "House Budget Committee",
   "stage": "Became law",
   "stage_date": "2025-07-04",
   "failed_vote": "",
   "latest_action_date": "2025-07-04",
   "latest_action": "Became Public Law No: 119-21.",
   "law": "Public Law 119-21",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/1",
   "text_version": "Enrolled Bill",
   "text_date": "",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr1enr/html/BILLS-119hr1enr.htm",
   "status_updated": "2026-05-08",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr44",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 44",
   "title": "Rural 340B Access Act of 2025",
   "official_title": "To amend title III of the Public Health Service Act to include rural emergency hospitals in the definition of a covered entity for purposes of the 340B drug discount program.",
   "role": "main",
   "kinds": [
    "other"
   ],
   "summary": "Would add rural emergency hospitals to the providers that can take part in 340B.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 5,
   "quote": "… and Commerce A BILL To amend title III of the Public Health Service Act to include rural emergency hospitals in the definition of a covered entity for purposes of the 340B drug discount program. 1. Short title This Act may be cited as the Rural 340B Access Act of 2025 . 2. Including rural emergency hospitals as covered entities for …",
   "introduced_date": "2025-01-03",
   "sponsor": "Rep. Bergman, Jack [R-MI-1]",
   "cosponsors": 6,
   "committees": "House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2025-01-03",
   "failed_vote": "",
   "latest_action_date": "2025-01-03",
   "latest_action": "Referred to the House Committee on Energy and Commerce.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/44",
   "text_version": "Introduced in House",
   "text_date": "2025-01-03",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr44ih/html/BILLS-119hr44ih.htm",
   "status_updated": "2026-04-14",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr950",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 950",
   "title": "Saving Seniors Money on Prescriptions Act",
   "official_title": "To amend title XVIII of the Social Security Act to establish pharmacy benefit manager reporting requirements with respect to prescription drug plans and MA-PD plans under Medicare part D.",
   "role": "part",
   "kinds": [
    "reporting"
   ],
   "summary": "Among the things a Medicare Part D pharmacy benefit manager would have to report is a list of the drugs for which it, or an affiliate, had an arrangement with a 340B covered entity.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… drugs for which the pharmacy benefit manager or an affiliate of the pharmacy benefit manager had a contract or other arrangement with a covered entity under section 340B of the Public Health Service Act in the service area of such plan. (III) Where a drug approved under section 505(c) of the Federal Food, Drug, and Cosmetic Act …",
   "introduced_date": "2025-02-04",
   "sponsor": "Rep. Landsman, Greg [D-OH-1]",
   "cosponsors": 2,
   "committees": "House Ways and Means Committee; House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2025-02-04",
   "failed_vote": "",
   "latest_action_date": "2025-02-04",
   "latest_action": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/950",
   "text_version": "Introduced in House",
   "text_date": "2025-02-04",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr950ih/html/BILLS-119hr950ih.htm",
   "status_updated": "2026-02-05",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr1195",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 1195",
   "title": "Protect Medicaid Act",
   "official_title": "To amend title XIX of the Social Security Act to prohibit Federal Medicaid funding for the administrative costs of providing health benefits to individuals who are unauthorized immigrants.",
   "role": "mention",
   "kinds": [],
   "summary": "Would order an analysis that includes how far certain noncitizens receive drugs bought under 340B.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… under— (i) the Medicaid Drug Rebate Program under section 1927 of the Social Security Act ( 42 U.S.C. 1396r–8 ); or (ii) the drug discount program under section 340B of the Public Health Service Act ( 42 U.S.C. 256b ); and (B) the effect that the provision to such noncitizens of covered outpatient drugs purchased under the programs …",
   "introduced_date": "2025-02-11",
   "sponsor": "Rep. Hudson, Richard [R-NC-9]",
   "cosponsors": 16,
   "committees": "House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2025-02-11",
   "failed_vote": "",
   "latest_action_date": "2025-02-11",
   "latest_action": "Referred to the House Committee on Energy and Commerce.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/1195",
   "text_version": "Introduced in House",
   "text_date": "2025-02-11",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr1195ih/html/BILLS-119hr1195ih.htm",
   "status_updated": "2025-12-05",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr1768",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 1768",
   "title": "Lower Costs for Everyday Americans Act",
   "official_title": "To provide for lower costs for everyday Americans, and for other purposes.",
   "role": "part",
   "kinds": [
    "medicaid",
    "reporting"
   ],
   "summary": "In its Medicaid pharmacy payment rules, would let a plan or pharmacy benefit manager pay a covered entity more than its cost for a 340B drug, up to what it would pay had the drug been bought outside the program, if the covered entity reports to the Secretary; what is reported would be published by state and by type of covered entity. It would also have Medicare Part D pharmacy benefit managers list the 340B drugs for which they had an arrangement with a covered entity.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… (as defined in 447.502 of title 42, Code of Federal Regulations, or any successor regulation) for such drug if— (aa) such drug was subject to an agreement under section 340B of the Public Health Service Act; (bb) such payment for the ingredient cost of such drug does not exceed the maximum payment that would have been made by the entity or …",
   "introduced_date": "2025-03-03",
   "sponsor": "Rep. Pallone, Frank [D-NJ-6]",
   "cosponsors": 0,
   "committees": "House Education and Workforce Committee; House Judiciary Committee; House Budget Committee; House Ways and Means Committee; House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2025-03-03",
   "failed_vote": "",
   "latest_action_date": "2025-03-03",
   "latest_action": "Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, the Budget, the Judiciary, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/1768",
   "text_version": "Introduced in House",
   "text_date": "2025-03-03",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr1768ih/html/BILLS-119hr1768ih.htm",
   "status_updated": "2026-10-19",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr2197",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 2197",
   "title": "No 340B Savings for Transgender Care Act",
   "official_title": "To prevent 340B covered entities from using savings derived for sex reassignment surgeries, hormonal therapies, and for other purposes.",
   "role": "main",
   "kinds": [
    "use-of-savings"
   ],
   "summary": "Would bar a covered entity from using what it earns through 340B to pay for sex reassignment surgeries or hormone treatments for transgender individuals.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 7,
   "quote": "… Ezell , Mrs. Bice , Mr. Moore of Alabama , and Mr. Rose ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To prevent 340B covered entities from using savings derived for sex reassignment surgeries, hormonal therapies, and for other purposes. 1. Short title This Act may be cited as the No …",
   "introduced_date": "2025-03-18",
   "sponsor": "Rep. Johnson, Dusty [R-SD-At Large]",
   "cosponsors": 10,
   "committees": "House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2025-03-18",
   "failed_vote": "",
   "latest_action_date": "2025-03-18",
   "latest_action": "Referred to the House Committee on Energy and Commerce.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/2197",
   "text_version": "Introduced in House",
   "text_date": "2025-03-18",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr2197ih/html/BILLS-119hr2197ih.htm",
   "status_updated": "2025-10-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr2542",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 2542",
   "title": "Old Drugs, New Cures Act",
   "official_title": "To amend titles XVIII and XIX of the Social Security Act to provide that priority research drugs shall not be treated as line extensions of existing drugs for purposes of calculating manufacturer rebates under the Medicare and Medicaid programs, and for other purposes.",
   "role": "mention",
   "kinds": [],
   "summary": "Names 340B among the programs whose claims count toward a test for what the bill calls a priority research drug.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… title XXI; (BB) part D of title XVIII with respect to an individual who is eligible for subsidies under section 1860D–14; (CC) the drug discount program under section 340B of the Public Health Service Act ( 42 U.S.C. 256b ; or (DD) a health care program administered by the Department of Veterans Affairs. . (b) Exclusion of priority …",
   "introduced_date": "2025-04-01",
   "sponsor": "Rep. Davis, Donald G. [D-NC-1]",
   "cosponsors": 1,
   "committees": "House Ways and Means Committee; House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2025-04-01",
   "failed_vote": "",
   "latest_action_date": "2025-04-01",
   "latest_action": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/2542",
   "text_version": "Introduced in House",
   "text_date": "2025-04-01",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr2542ih/html/BILLS-119hr2542ih.htm",
   "status_updated": "2026-05-04",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr2554",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 2554",
   "title": "Lower Drug Costs for Families Act",
   "official_title": "To amend title XVIII of the Social Security Act to apply prescription drug inflation rebates to drugs furnished in the commercial market and to change the base year for rebate calculations.",
   "role": "mention",
   "kinds": [],
   "summary": "Names 340B in a list of drug units that are counted apart when Medicare drug inflation rebates are worked out.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… with plan year 2026, units of each dosage form and strength of such part D rebatable drug for which the manufacturer provides a discount under the program under section 340B of the Public Health Service Act. ; and (ii) in paragraph (6), by striking information .—The Secretary and all that follows through rebatable covered part D drug …",
   "introduced_date": "2025-04-01",
   "sponsor": "Rep. Horsford, Steven [D-NV-4]",
   "cosponsors": 2,
   "committees": "House Ways and Means Committee; House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2025-04-01",
   "failed_vote": "",
   "latest_action_date": "2025-04-01",
   "latest_action": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/2554",
   "text_version": "Introduced in House",
   "text_date": "2025-04-01",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr2554ih/html/BILLS-119hr2554ih.htm",
   "status_updated": "2026-01-10",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr3222",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 3222",
   "title": "SMART Health Care Act",
   "official_title": "To amend title XVIII of the Social Security Act to improve risk adjustment under Medicare Advantage, and for other purposes.",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "One section would require a covered entity to give each patient a 340B drug at no more than the price the entity paid for it, and have the Secretary publish what is paid and received for those drugs.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… health services furnished by the entity are furnished to individuals residing in such a rural area. . 5. Making drugs more affordable for medicare patients Section 340B(a)(5) of the Public Health Service Act ( 42 U.S.C. 256b(a)(5) ) is amended— (1) in subparagraph (C), by striking subparagraphs (A) or (B) and inserting subparagraph …",
   "introduced_date": "2025-05-06",
   "sponsor": "Rep. Spartz, Victoria [R-IN-5]",
   "cosponsors": 0,
   "committees": "House Ways and Means Committee; House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2025-05-06",
   "failed_vote": "",
   "latest_action_date": "2025-05-06",
   "latest_action": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/3222",
   "text_version": "Introduced in House",
   "text_date": "2025-05-06",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr3222ih/html/BILLS-119hr3222ih.htm",
   "status_updated": "2025-05-21",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr3527",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 3527",
   "title": "Real Education and Access for Healthy Youth Act of 2025",
   "official_title": "To provide for the overall health and well-being of young people, including the promotion and attainment of lifelong sexual health and healthy relationships, and for other purposes.",
   "role": "mention",
   "kinds": [],
   "summary": "Would let 340B covered entities apply for grants to provide sexual health services to young people.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… (c) Eligible entity In this section, the term eligible entity means— (1) a public or private youth-serving organization; or (2) a covered entity, as defined in section 340B of the Public Health Service Act ( 42 U.S.C. 256b ). (d) Applications An eligible entity desiring a grant under this section shall submit an application to the …",
   "introduced_date": "2025-05-21",
   "sponsor": "Rep. Adams, Alma S. [D-NC-12]",
   "cosponsors": 24,
   "committees": "House Energy and Commerce Committee; House Education and Workforce Committee",
   "stage": "Introduced",
   "stage_date": "2025-05-21",
   "failed_vote": "",
   "latest_action_date": "2025-05-21",
   "latest_action": "Referred to the Committee on Education and Workforce, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/3527",
   "text_version": "Introduced in House",
   "text_date": "2025-05-21",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr3527ih/html/BILLS-119hr3527ih.htm",
   "status_updated": "2026-09-19",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr4317",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 4317",
   "title": "PBM Reform Act of 2025",
   "official_title": "To assure pharmacy access and choice for Medicare beneficiaries, and for other purposes.",
   "role": "part",
   "kinds": [
    "medicaid",
    "reporting"
   ],
   "summary": "In its Medicaid pharmacy payment rules, would let a plan or pharmacy benefit manager pay a covered entity more than its cost for a 340B drug, up to what it would pay had the drug been bought outside the program, if the covered entity reports to the Secretary; what is reported would be published by state and by type of covered entity. It would also have Medicare Part D pharmacy benefit managers list the 340B drugs for which they had an arrangement with a covered entity.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… inclusive of the brand name, generic or non-proprietary name, and National Drug Code of covered part D drugs subject to an agreement with a covered entity under section 340B of the Public Health Service Act for which the pharmacy benefit manager or an affiliate of the pharmacy benefit manager had a contract or other arrangement with such a …",
   "introduced_date": "2025-07-10",
   "sponsor": "Rep. Carter, Earl L. \"Buddy\" [R-GA-1]",
   "cosponsors": 71,
   "committees": "House Ways and Means Committee; House Education and Workforce Committee; House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2025-07-10",
   "failed_vote": "",
   "latest_action_date": "2025-07-10",
   "latest_action": "Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/4317",
   "text_version": "Introduced in House",
   "text_date": "2025-07-10",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr4317ih/html/BILLS-119hr4317ih.htm",
   "status_updated": "2026-09-29",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr4581",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 4581",
   "title": "340B PATIENTS Act of 2025",
   "official_title": "To ensure the accessibility of drugs furnished through the drug discount program under section 340B of the Public Health Service Act.",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar a drug maker from putting conditions on a covered entity's purchase of 340B drugs, such as limits on where the drugs are delivered or dispensed or a demand for claims data, and adds a paragraph on contract pharmacies.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 20,
   "quote": "… bill; which was referred to the Committee on Energy and Commerce A BILL To ensure the accessibility of drugs furnished through the drug discount program under section 340B of the Public Health Service Act. 1. Short title This Act may be cited as the 340B Pharmaceutical Access To Invest in Essential, Needed Treatments &amp; Support Act of …",
   "introduced_date": "2025-07-22",
   "sponsor": "Rep. Matsui, Doris O. [D-CA-7]",
   "cosponsors": 21,
   "committees": "House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2025-07-22",
   "failed_vote": "",
   "latest_action_date": "2025-07-22",
   "latest_action": "Referred to the House Committee on Energy and Commerce.",
   "law": "",
   "same_as": "S. 2372",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/4581",
   "text_version": "Introduced in House",
   "text_date": "2025-07-22",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr4581ih/html/BILLS-119hr4581ih.htm",
   "status_updated": "2026-09-19",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr5256",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 5256",
   "title": "340B ACCESS Act",
   "official_title": "To amend the Public Health Service Act to reform the 340B drug pricing program, and for other purposes.",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination",
    "reporting",
    "medicaid",
    "other"
   ],
   "summary": "A broad rewrite of the program. Its sections cover contract pharmacies, hospital eligibility and child sites, what patients pay, Medicaid duplicate discounts, reporting by covered entities, a claims data clearinghouse, fees, and equal treatment of covered entities by payers.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 124,
   "quote": "… in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend the Public Health Service Act to reform the 340B drug pricing program, and for other purposes. 1. Short title; table of contents (a) Short title This Act may be cited as the 340B Affording Care for Communities and …",
   "introduced_date": "2025-09-10",
   "sponsor": "Rep. Carter, Earl L. \"Buddy\" [R-GA-1]",
   "cosponsors": 1,
   "committees": "House Ways and Means Committee; House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2025-09-10",
   "failed_vote": "",
   "latest_action_date": "2025-09-10",
   "latest_action": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/5256",
   "text_version": "Introduced in House",
   "text_date": "2025-09-10",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr5256ih/html/BILLS-119hr5256ih.htm",
   "status_updated": "2025-09-24",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr6166",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 6166",
   "title": "Lowering Drug Costs for American Families Act",
   "official_title": "To expand the drug price negotiation program under title XI of the Social Security Act and repeal certain changes to the program made by Public Law 119-21, to apply prescription drug inflation rebates under the Medicare program to drugs furnished in the commercial market, and to establish out-of-pocket limits on expenditures for prescription drugs under private health insurance.",
   "role": "mention",
   "kinds": [],
   "summary": "Names 340B in a list of drug units that are counted apart when Medicare drug inflation rebates are worked out.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… with plan year 2026, units of each dosage form and strength of such part D rebatable drug for which the manufacturer provides a discount under the program under section 340B of the Public Health Service Act. ; and (ii) in paragraph (6), by striking information and all that follows through rebatable covered part D drug dispensed and …",
   "introduced_date": "2025-11-20",
   "sponsor": "Rep. Pallone, Frank [D-NJ-6]",
   "cosponsors": 60,
   "committees": "House Education and Workforce Committee; House Ways and Means Committee; House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2025-11-20",
   "failed_vote": "",
   "latest_action_date": "2025-11-20",
   "latest_action": "Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/6166",
   "text_version": "Introduced in House",
   "text_date": "2025-11-20",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr6166ih/html/BILLS-119hr6166ih.htm",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr6501",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 6501",
   "title": "Bipartisan Health Insurance Affordability Act",
   "official_title": "To amend the Internal Revenue Code of 1986 to extend and modify the enhanced premium tax credit, to amend the Patient Protection and Affordable Care Act to make certain adjustments to the operation of the Exchanges established under such Act, and for other purposes.",
   "role": "part",
   "kinds": [
    "reporting"
   ],
   "summary": "Among the things a Medicare Part D pharmacy benefit manager would have to report is a list of the drugs under 340B for which it, or an affiliate, had an arrangement with a covered entity.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… inclusive of the brand name, generic or non-proprietary name, and National Drug Code of covered part D drugs subject to an agreement with a covered entity under section 340B of the Public Health Service Act for which the pharmacy benefit manager or an affiliate of the pharmacy benefit manager had a contract or other arrangement with such a …",
   "introduced_date": "2025-12-09",
   "sponsor": "Rep. Fitzpatrick, Brian K. [R-PA-1]",
   "cosponsors": 22,
   "committees": "House Education and Workforce Committee; House Ways and Means Committee; House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2025-12-09",
   "failed_vote": "",
   "latest_action_date": "2025-12-09",
   "latest_action": "Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/6501",
   "text_version": "Introduced in House",
   "text_date": "2025-12-09",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr6501ih/html/BILLS-119hr6501ih.htm",
   "status_updated": "2026-01-07",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr6575",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 6575",
   "title": "CommonGround for Affordable Health Care Act",
   "official_title": "To amend the Internal Revenue Code of 1986 to extend and modify the enhanced premium tax credit, to amend the Patient Protection and Affordable Care Act to make certain adjustments to the operation of the Exchanges established under such Act, and for other purposes.",
   "role": "part",
   "kinds": [
    "reporting"
   ],
   "summary": "Among the things a Medicare Part D pharmacy benefit manager would have to report is a list of the drugs under 340B for which it, or an affiliate, had an arrangement with a covered entity.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… inclusive of the brand name, generic or non-proprietary name, and National Drug Code of covered part D drugs subject to an agreement with a covered entity under section 340B of the Public Health Service Act for which the pharmacy benefit manager or an affiliate of the pharmacy benefit manager had a contract or other arrangement with such a …",
   "introduced_date": "2025-12-10",
   "sponsor": "Rep. Kiggans, Jennifer A. [R-VA-2]",
   "cosponsors": 38,
   "committees": "House Rules Committee; House Ways and Means Committee; House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2025-12-10",
   "failed_vote": "",
   "latest_action_date": "2025-12-10",
   "latest_action": "Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/6575",
   "text_version": "Introduced in House",
   "text_date": "2025-12-10",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr6575ih/html/BILLS-119hr6575ih.htm",
   "status_updated": "2026-04-22",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr7148",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 7148",
   "title": "Consolidated Appropriations Act, 2026",
   "official_title": "Making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes.",
   "role": "part",
   "kinds": [
    "reporting"
   ],
   "summary": "Among the things a Medicare Part D pharmacy benefit manager has to report is a list of the drugs under 340B for which it, or an affiliate, had an arrangement with a covered entity.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… inclusive of the brand name, generic or non-proprietary name, and National Drug Code of covered part D drugs subject to an agreement with a covered entity under section 340B of the Public Health Service Act for which the pharmacy benefit manager or an affiliate of the pharmacy benefit manager had a contract or other arrangement with such a …",
   "introduced_date": "2026-01-20",
   "sponsor": "Rep. Cole, Tom [R-OK-4]",
   "cosponsors": 0,
   "committees": "House Ways and Means Committee; House Budget Committee; House Appropriations Committee",
   "stage": "Became law",
   "stage_date": "2026-02-03",
   "failed_vote": "",
   "latest_action_date": "2026-02-03",
   "latest_action": "Became Public Law No: 119-75.",
   "law": "Public Law 119-75",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/7148",
   "text_version": "Enrolled Bill",
   "text_date": "",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr7148enr/uslm/BILLS-119hr7148enr.htm",
   "status_updated": "2026-09-08",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr7391",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 7391",
   "title": "Community Health Center Drug Pricing Protection Act",
   "official_title": "To amend title III of the Public Health Service Act to ensure that Federally-qualified health centers are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase.",
   "role": "main",
   "kinds": [
    "other"
   ],
   "summary": "Would bar agreements under which a federally qualified health center pays more than the 340B ceiling price when it buys a drug and is paid back later by rebate.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 8,
   "quote": "… Energy and Commerce A BILL To amend title III of the Public Health Service Act to ensure that Federally-qualified health centers are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase. 1. Short title This Act may be cited as the Community Health Center Drug Pricing Protection Act . 2. …",
   "introduced_date": "2026-02-05",
   "sponsor": "Rep. Bergman, Jack [R-MI-1]",
   "cosponsors": 58,
   "committees": "House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2026-02-05",
   "failed_vote": "",
   "latest_action_date": "2026-02-05",
   "latest_action": "Referred to the House Committee on Energy and Commerce.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/7391",
   "text_version": "Introduced in House",
   "text_date": "2026-02-05",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr7391ih/html/BILLS-119hr7391ih.htm",
   "status_updated": "2026-09-22",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr7871",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 7871",
   "title": "MVP Act",
   "official_title": "To amend title XIX of the Social Security Act to codify value-based purchasing arrangements under the Medicaid program and reforms related to price reporting under such arrangements, and for other purposes.",
   "role": "mention",
   "kinds": [],
   "summary": "Names 340B among the programs that a review of value-based purchasing arrangements in Medicaid would look at.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… are available in the commercial market for such drugs; (C) the Medicaid drug rebate program under section 1927 of the Social Security Act ( 42 U.S.C. 1396r–8 ), the 340B drug pricing program under section 340B of the Public Health Service Act ( 42 U.S.C. 256b ), and part B of title XVIII of the Social Security Act ( 42 U.S.C. 1395j et …",
   "introduced_date": "2026-03-09",
   "sponsor": "Rep. Guthrie, Brett [R-KY-2]",
   "cosponsors": 18,
   "committees": "House Ways and Means Committee; House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2026-03-09",
   "failed_vote": "",
   "latest_action_date": "2026-03-09",
   "latest_action": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
   "law": "",
   "same_as": "S. 1637",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/7871",
   "text_version": "Introduced in House",
   "text_date": "2026-03-09",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr7871ih/html/BILLS-119hr7871ih.htm",
   "status_updated": "2026-11-12",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr8840",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 8840",
   "title": "Fair Care Act of 2026",
   "official_title": "To address the high costs of health care services, prescription drugs, and health insurance coverage in the United States, and for other purposes.",
   "role": "part",
   "kinds": [
    "reporting"
   ],
   "summary": "Two sections would add reporting for hospitals in 340B: yearly data on how they provide care for patients, to be published by the Department of Health and Human Services, and reports by disproportionate share hospitals on their low-income utilization rate.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 11,
   "quote": "… information. Sec. 323. Advisory group on reducing burden of hospital administrative requirements. Sec. 324. Data reporting to improve the transparency regarding how 340 B hospital covered entities provide care for patients. Sec. 325. Requiring 340 B drug discount program reports by DSH hospital covered entities on low-income utilization …",
   "introduced_date": "2026-05-14",
   "sponsor": "Rep. Westerman, Bruce [R-AR-4]",
   "cosponsors": 0,
   "committees": "House Committee on House Administration; House Armed Services Committee; House Budget Committee; House Rules Committee; House Oversight and Government Reform Committee; House Judiciary Committee; House Education and Workforce Committee; House Ways and Means Committee; House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2026-05-14",
   "failed_vote": "",
   "latest_action_date": "2026-05-14",
   "latest_action": "Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Workforce, the Judiciary, Oversight and Government Reform, Rules, the Budget, Armed Services, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/8840",
   "text_version": "Introduced in House",
   "text_date": "2026-05-14",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr8840ih/html/BILLS-119hr8840ih.htm",
   "status_updated": "2026-09-19",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr9504",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 9504",
   "title": "Tax Exempt Hospital Transparency Act",
   "official_title": "To amend the Internal Revenue Code of 1986 to establish additional reporting requirements for hospital organizations, and for other purposes.",
   "role": "part",
   "kinds": [
    "reporting"
   ],
   "summary": "Would have high-revenue tax-exempt hospital organizations that are covered entities report 340B figures on their tax return: the people given 340B drugs by type of insurance, what was paid for those drugs above the ceiling price, and what it cost to take part.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 11,
   "quote": "… advertising information, (B) the specified health service line information, and (C) in the case of an organization which is a covered entity described in section 340B(a)(4) of the Public Health Service Act, the specified Federal 340B drug discount program information. (2) Specified advertising information For purposes of this …",
   "introduced_date": "2026-06-29",
   "sponsor": "Rep. Murphy, Gregory F. [R-NC-3]",
   "cosponsors": 1,
   "committees": "House Ways and Means Committee",
   "stage": "Introduced",
   "stage_date": "2026-06-29",
   "failed_vote": "",
   "latest_action_date": "2026-07-01",
   "latest_action": "Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 25 - 15.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/9504",
   "text_version": "Introduced in House",
   "text_date": "2026-06-29",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr9504ih/html/BILLS-119hr9504ih.htm",
   "status_updated": "2026-10-07",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr9599",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 9599",
   "title": "SECURE 340B Act",
   "official_title": "To strengthen the 340B drug discount program.",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination",
    "reporting",
    "study",
    "other"
   ],
   "summary": "A broad rewrite of the program. Its sections cover a definition of patient, contract pharmacies, child sites, what patients pay, data reporting, program integrity, a data clearinghouse, a bar on discrimination by payers, and studies.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 135,
   "quote": "… determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To strengthen the 340B drug discount program. 1. Short title; table of contents (a) Short title This Act may be cited as the Strengthening the Exercise of Controls and Upgrading Requirements …",
   "introduced_date": "2026-07-06",
   "sponsor": "Rep. Peters, Scott H. [D-CA-50]",
   "cosponsors": 8,
   "committees": "House Education and Workforce Committee; House Ways and Means Committee; House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2026-07-06",
   "failed_vote": "",
   "latest_action_date": "2026-07-06",
   "latest_action": "Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/9599",
   "text_version": "Introduced in House",
   "text_date": "2026-07-06",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr9599ih/html/BILLS-119hr9599ih.htm",
   "status_updated": "2026-10-06",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr9682",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 9682",
   "title": "Cure Hepatitis C Act of 2026",
   "official_title": "To require the Secretary of Health and Human Services to carry out activities to eliminate hepatitis C virus in the United States.",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "Would set up a federal program to buy hepatitis C treatments, and bar providers and pharmacies from using 340B for treatments obtained through it.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 9,
   "quote": "… Health care providers, pharmacies, and sites of dispensing shall not utilize any other Federal drug discount program, including the drug discount program under section 340B of the Public Health Service Act ( 42 U.S.C. 256b ), with respect to hepatitis C treatments obtained through the program. (ii) Enforcement To ensure compliance with …",
   "introduced_date": "2026-07-14",
   "sponsor": "Rep. Miller-Meeks, Mariannette [R-IA-1]",
   "cosponsors": 6,
   "committees": "House Ways and Means Committee; House Natural Resources Committee; House Judiciary Committee; House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2026-07-14",
   "failed_vote": "",
   "latest_action_date": "2026-07-14",
   "latest_action": "Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Natural Resources, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/9682",
   "text_version": "Introduced in House",
   "text_date": "2026-07-14",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr9682ih/html/BILLS-119hr9682ih.htm",
   "status_updated": "2026-10-06",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr9877",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 9877",
   "title": "Health Equity and Accountability Act of 2026",
   "official_title": "To improve the health of minority individuals, and for other purposes.",
   "role": "mention",
   "kinds": [],
   "summary": "Would let 340B covered entities apply for grants to provide sexual health services to young people.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… (3) Eligible entity In this section, the term eligible entity means— (A) a public or private youth-serving organization; or (B) a covered entity, as defined in section 340B of the Public Health Service Act ( 42 U.S.C. 256b ). (4) Applications An eligible entity desiring a grant under this section shall submit an application to the …",
   "introduced_date": "2026-07-22",
   "sponsor": "Rep. Ruiz, Raul [D-CA-25]",
   "cosponsors": 27,
   "committees": "House Veterans' Affairs Committee; House Foreign Affairs Committee; House Transportation and Infrastructure Committee; House Financial Services Committee; House Homeland Security Committee; House Armed Services Committee; House Natural Resources Committee; House Budget Committee; House Judiciary Committee; House Education and Workforce Committee; House Oversight and Government Reform Committee; House Agriculture Committee; House Ways and Means Committee; House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2026-07-22",
   "failed_vote": "",
   "latest_action_date": "2026-09-29",
   "latest_action": "Referred to the Subcommittee on Health.",
   "law": "",
   "same_as": "S. 5066",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/9877",
   "text_version": "Introduced in House",
   "text_date": "2026-07-22",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr9877ih/html/BILLS-119hr9877ih.htm",
   "status_updated": "2026-11-06",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr10134",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 10134",
   "title": "Local Health Care Protection Act of 2026",
   "official_title": "To establish an eligibility exception for the drug discount program due to cuts to the Medicaid program.",
   "role": "main",
   "kinds": [
    "study",
    "other"
   ],
   "summary": "Would let a hospital that was in 340B on 3 July 2025 stay in it, for cost reporting periods ending by 30 September 2030, even if it no longer meets the disproportionate share percentage the program requires. It also orders a study.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 7,
   "quote": "… described in subsection (c), but otherwise meets the requirements for being a covered entity under subparagraph (L), (M), or (O) of subsection (a)(4) of section 340B of the Public Health Service Act ( 42 U.S.C. 256b ) and is in compliance with all other requirements of the program under such section, shall be deemed a covered entity …",
   "introduced_date": "2026-08-20",
   "sponsor": "Rep. Scholten, Hillary J. [D-MI-3]",
   "cosponsors": 0,
   "committees": "House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2026-08-20",
   "failed_vote": "",
   "latest_action_date": "2026-08-20",
   "latest_action": "Referred to the House Committee on Energy and Commerce.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/10134",
   "text_version": "Introduced in House",
   "text_date": "2026-08-20",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr10134ih/html/BILLS-119hr10134ih.htm",
   "status_updated": "2026-08-24",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr10770",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 10770",
   "title": "340B Rebate Model Delay Act",
   "official_title": "To amend title III of the Public Health Service Act to temporarily limit the use of rebates under the 340B Program.",
   "role": "main",
   "kinds": [
    "other"
   ],
   "summary": "Would bar, through 31 December 2028, agreements under which a covered entity pays more than the ceiling price when it buys a drug, and hold back the 340B Rebate Model Pilot Program for the same period.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 8,
   "quote": "… which was referred to the Committee on Energy and Commerce A BILL To amend title III of the Public Health Service Act to temporarily limit the use of rebates under the 340B Program. 1. Short title This Act may be cited as the 340B Rebate Model Delay Act . 2. Limiting use of rebates under the 340B Program (a) In general Section 340B(a) of …",
   "introduced_date": "2026-10-09",
   "sponsor": "Rep. Bresnahan, Robert P. [R-PA-8]",
   "cosponsors": 34,
   "committees": "House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2026-10-09",
   "failed_vote": "",
   "latest_action_date": "2026-10-09",
   "latest_action": "Referred to the House Committee on Energy and Commerce.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/10770",
   "text_version": "Introduced in House",
   "text_date": "2026-10-09",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr10770ih/html/BILLS-119hr10770ih.htm",
   "status_updated": "2026-11-13",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr10919",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 10919",
   "title": "Safety Net Provider Drug Pricing Protection Act",
   "official_title": "To amend title III of the Public Health Service Act to ensure that certain safety net providers are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase.",
   "role": "main",
   "kinds": [
    "other"
   ],
   "summary": "Would bar agreements under which certain covered entities, which the bill calls safety net providers, pay more than the ceiling price when they buy a drug and are paid back later by rebate.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 8,
   "quote": "… on Energy and Commerce A BILL To amend title III of the Public Health Service Act to ensure that certain safety net providers are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase. 1. Short title This Act may be cited as the Safety Net Provider Drug Pricing Protection Act . 2. …",
   "introduced_date": "2026-10-29",
   "sponsor": "Rep. Bergman, Jack [R-MI-1]",
   "cosponsors": 13,
   "committees": "House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2026-10-29",
   "failed_vote": "",
   "latest_action_date": "2026-10-29",
   "latest_action": "Referred to the House Committee on Energy and Commerce.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/10919",
   "text_version": "Introduced in House",
   "text_date": "2026-10-29",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr10919ih/html/BILLS-119hr10919ih.htm",
   "status_updated": "2026-11-02",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-hr10937",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "H.R. 10937",
   "title": "PROTECT 340B Act of 2026",
   "official_title": "To amend title XXVII of the Public Health Service Act to ensure the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program, and for other purposes.",
   "role": "main",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "Would bar health plans, insurers and pharmacy benefit managers from treating a covered entity or its pharmacy differently because it dispenses 340B drugs, for example by paying less for a 340B drug.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 51,
   "quote": "… concerned A BILL To amend title XXVII of the Public Health Service Act to ensure the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program, and for other purposes. 1. Short title This Act may be cited as the Preserving Rules Ordered for The Entities Covered Through 340B Act of 2026 or …",
   "introduced_date": "2026-10-29",
   "sponsor": "Rep. Matsui, Doris O. [D-CA-7]",
   "cosponsors": 15,
   "committees": "House Ways and Means Committee; House Energy and Commerce Committee",
   "stage": "Introduced",
   "stage_date": "2026-10-29",
   "failed_vote": "",
   "latest_action_date": "2026-10-29",
   "latest_action": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/house-bill/10937",
   "text_version": "Introduced in House",
   "text_date": "2026-10-29",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119hr10937ih/html/BILLS-119hr10937ih.htm",
   "status_updated": "2026-11-14",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-s523",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "S. 523",
   "title": "Protect Medicaid Act",
   "official_title": "A bill to amend title XIX of the Social Security Act to prohibit Federal Medicaid funding for the administrative costs of providing health benefits to individuals who are unauthorized immigrants.",
   "role": "mention",
   "kinds": [],
   "summary": "Would order an analysis that includes how far certain noncitizens receive drugs bought under 340B.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… under— (i) the Medicaid Drug Rebate Program under section 1927 of the Social Security Act ( 42 U.S.C. 1396r–8 ); or (ii) the drug discount program under section 340B of the Public Health Service Act ( 42 U.S.C. 256b ); and (B) the effect that the provision to such noncitizens of covered outpatient drugs purchased under the programs …",
   "introduced_date": "2025-02-11",
   "sponsor": "Sen. Cassidy, Bill [R-LA]",
   "cosponsors": 3,
   "committees": "Senate Finance Committee",
   "stage": "Introduced",
   "stage_date": "2025-02-11",
   "failed_vote": "",
   "latest_action_date": "2025-02-11",
   "latest_action": "Read twice and referred to the Committee on Finance.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/senate-bill/523",
   "text_version": "Introduced in Senate",
   "text_date": "2025-02-11",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119s523is/html/BILLS-119s523is.htm",
   "status_updated": "2025-12-05",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-s882",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "S. 882",
   "title": "Patients Before Middlemen Act",
   "official_title": "A bill to amend title XVIII of the Social Security Act to assure pharmacy access and choice for beneficiaries under prescription drug plans and MA-PD plans and to establish requirements of pharmacy benefit managers under Medicare part D.",
   "role": "part",
   "kinds": [
    "reporting"
   ],
   "summary": "Among the things a Medicare Part D pharmacy benefit manager would have to report is a list of the drugs under 340B for which it, or an affiliate, had an arrangement with a covered entity.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… inclusive of the brand name, generic or non-proprietary name, and National Drug Code of covered part D drugs subject to an agreement with a covered entity under section 340B of the Public Health Service Act for which the pharmacy benefit manager or an affiliate of the pharmacy benefit manager had a contract or other arrangement with such a …",
   "introduced_date": "2025-03-06",
   "sponsor": "Sen. Blackburn, Marsha [R-TN]",
   "cosponsors": 7,
   "committees": "Senate Finance Committee",
   "stage": "Introduced",
   "stage_date": "2025-03-06",
   "failed_vote": "",
   "latest_action_date": "2025-03-06",
   "latest_action": "Read twice and referred to the Committee on Finance.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/senate-bill/882",
   "text_version": "Introduced in Senate",
   "text_date": "2025-03-06",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119s882is/html/BILLS-119s882is.htm",
   "status_updated": "2026-02-19",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-s891",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "S. 891",
   "title": "Bipartisan Health Care Act",
   "official_title": "A bill to extend expiring health provisions and improve health care delivery.",
   "role": "part",
   "kinds": [
    "medicaid",
    "reporting"
   ],
   "summary": "In its Medicaid pharmacy payment rules, would let a plan or pharmacy benefit manager pay a covered entity more than its cost for a 340B drug, up to what it would pay had the drug been bought outside the program, if the covered entity reports to the Secretary; what is reported would be published by state and by type of covered entity. It would also have Medicare Part D pharmacy benefit managers list the 340B drugs for which they had an arrangement with a covered entity.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… (as defined in 447.502 of title 42, Code of Federal Regulations, or any successor regulation) for such drug if— (aa) such drug was subject to an agreement under section 340B of the Public Health Service Act; (bb) such payment for the ingredient cost of such drug does not exceed the maximum payment that would have been made by the entity or …",
   "introduced_date": "2025-03-06",
   "sponsor": "Sen. Wyden, Ron [D-OR]",
   "cosponsors": 1,
   "committees": "Senate Finance Committee",
   "stage": "Introduced",
   "stage_date": "2025-03-06",
   "failed_vote": "",
   "latest_action_date": "2025-03-06",
   "latest_action": "Read twice and referred to the Committee on Finance.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/senate-bill/891",
   "text_version": "Introduced in Senate",
   "text_date": "2025-03-06",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119s891is/html/BILLS-119s891is.htm",
   "status_updated": "2026-08-12",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-s927",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "S. 927",
   "title": "Protecting Pharmacies in Medicaid Act",
   "official_title": "A bill to amend title XIX of the Social Security Act to ensure accurate payments to pharmacies under Medicaid and to prevent the use of abusive spread pricing practices under Medicaid.",
   "role": "part",
   "kinds": [
    "medicaid",
    "reporting"
   ],
   "summary": "In its Medicaid pharmacy payment rules, would let a plan or pharmacy benefit manager pay a covered entity more than its cost for a 340B drug, up to what it would pay had the drug been bought outside the program, if the covered entity reports to the Secretary; what is reported would be published by state and by type of covered entity.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… (as defined in 447.502 of title 42, Code of Federal Regulations, or any successor regulation) for such drug if— (aa) such drug was subject to an agreement under section 340B of the Public Health Service Act; (bb) such payment for the ingredient cost of such drug does not exceed the maximum payment that would have been made by the entity or …",
   "introduced_date": "2025-03-11",
   "sponsor": "Sen. Welch, Peter [D-VT]",
   "cosponsors": 3,
   "committees": "Senate Finance Committee",
   "stage": "Introduced",
   "stage_date": "2025-03-11",
   "failed_vote": "",
   "latest_action_date": "2025-03-11",
   "latest_action": "Read twice and referred to the Committee on Finance.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/senate-bill/927",
   "text_version": "Introduced in Senate",
   "text_date": "2025-03-11",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119s927is/html/BILLS-119s927is.htm",
   "status_updated": "2026-03-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-s1186",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "S. 1186",
   "title": "Lower Drug Costs for Families Act",
   "official_title": "A bill to amend title XVIII of the Social Security Act to apply prescription drug inflation rebates to drugs furnished in the commercial market and to change the base year for rebate calculations.",
   "role": "mention",
   "kinds": [],
   "summary": "Names 340B in a list of drug units that are counted apart when Medicare drug inflation rebates are worked out.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… with plan year 2026, units of each dosage form and strength of such part D rebatable drug for which the manufacturer provides a discount under the program under section 340B of the Public Health Service Act. ; and (ii) in paragraph (6), by striking information .—The Secretary and all that follows through rebatable covered part D drug …",
   "introduced_date": "2025-03-27",
   "sponsor": "Sen. Cortez Masto, Catherine [D-NV]",
   "cosponsors": 13,
   "committees": "Senate Finance Committee",
   "stage": "Introduced",
   "stage_date": "2025-03-27",
   "failed_vote": "",
   "latest_action_date": "2025-03-27",
   "latest_action": "Read twice and referred to the Committee on Finance.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/senate-bill/1186",
   "text_version": "Introduced in Senate",
   "text_date": "2025-03-27",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119s1186is/html/BILLS-119s1186is.htm",
   "status_updated": "2026-06-03",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-s1637",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "S. 1637",
   "title": "MVP Act",
   "official_title": "A bill to amend title XIX of the Social Security Act to codify value-based purchasing arrangements under the Medicaid program and reforms related to price reporting under such arrangements, and for other purposes.",
   "role": "mention",
   "kinds": [],
   "summary": "Names 340B among the programs that a review of value-based purchasing arrangements in Medicaid would look at.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… are available in the commercial market for such drugs; (C) the Medicaid drug rebate program under section 1927 of the Social Security Act ( 42 U.S.C. 1396r–8 ), the 340B drug pricing program under section 340B of the Public Health Service Act ( 42 U.S.C. 256b ), and part B of title XVIII of the Social Security Act ( 42 U.S.C. 1395j et …",
   "introduced_date": "2025-05-07",
   "sponsor": "Sen. Mullin, Markwayne [R-OK]",
   "cosponsors": 2,
   "committees": "Senate Finance Committee",
   "stage": "Introduced",
   "stage_date": "2025-05-07",
   "failed_vote": "",
   "latest_action_date": "2025-05-07",
   "latest_action": "Read twice and referred to the Committee on Finance.",
   "law": "",
   "same_as": "H.R. 7871",
   "bill_url": "https://www.congress.gov/bill/119th-congress/senate-bill/1637",
   "text_version": "Introduced in Senate",
   "text_date": "2025-05-07",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119s1637is/html/BILLS-119s1637is.htm",
   "status_updated": "2026-03-11",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-s1910",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "S. 1910",
   "title": "Real Education and Access for Healthy Youth Act of 2025",
   "official_title": "A bill to provide for the overall health and well-being of young people, including the promotion and attainment of lifelong sexual health and healthy relationships, and for other purposes.",
   "role": "mention",
   "kinds": [],
   "summary": "Would let 340B covered entities apply for grants to provide sexual health services to young people.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… (c) Eligible entity In this section, the term eligible entity means— (1) a public or private youth-serving organization; or (2) a covered entity, as defined in section 340B of the Public Health Service Act ( 42 U.S.C. 256b ). (d) Applications An eligible entity desiring a grant under this section shall submit an application to the …",
   "introduced_date": "2025-05-22",
   "sponsor": "Sen. Booker, Cory A. [D-NJ]",
   "cosponsors": 6,
   "committees": "Senate Health, Education, Labor, and Pensions Committee",
   "stage": "Introduced",
   "stage_date": "2025-05-22",
   "failed_vote": "",
   "latest_action_date": "2025-05-22",
   "latest_action": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/senate-bill/1910",
   "text_version": "Introduced in Senate",
   "text_date": "2025-05-22",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119s1910is/html/BILLS-119s1910is.htm",
   "status_updated": "2025-12-05",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-s1941",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "S. 1941",
   "title": "Cure Hepatitis C Act of 2025",
   "official_title": "A bill to require the Secretary of Health and Human Services to carry out activities to eliminate hepatitis C virus in the United States.",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "Would set up a federal program to buy hepatitis C treatments, and bar providers and pharmacies from using 340B for treatments obtained through it.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 9,
   "quote": "… Health care providers, pharmacies, and sites of dispensing shall not utilize any other Federal drug discount program, including the drug discount program under section 340B of the Public Health Service Act ( 42 U.S.C. 256b ), with respect to hepatitis C treatments obtained through the program. (ii) Enforcement To ensure compliance with …",
   "introduced_date": "2025-06-04",
   "sponsor": "Sen. Cassidy, Bill [R-LA]",
   "cosponsors": 1,
   "committees": "Senate Health, Education, Labor, and Pensions Committee",
   "stage": "Introduced",
   "stage_date": "2025-06-04",
   "failed_vote": "",
   "latest_action_date": "2025-06-04",
   "latest_action": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/senate-bill/1941",
   "text_version": "Introduced in Senate",
   "text_date": "2025-06-04",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119s1941is/html/BILLS-119s1941is.htm",
   "status_updated": "2026-07-21",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-s2372",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "S. 2372",
   "title": "340B PATIENTS Act of 2025",
   "official_title": "A bill to ensure accessibility of drugs furnished through the drug discount program under section 340B of the Public Health Service Act.",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar a drug maker from putting conditions on a covered entity's purchase of 340B drugs, such as limits on where the drugs are delivered or dispensed or a demand for claims data, and adds a paragraph on contract pharmacies.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 20,
   "quote": "… to the Committee on Health, Education, Labor, and Pensions A BILL To ensure the accessibility of drugs furnished through the drug discount program under section 340B of the Public Health Service Act. 1. Short title This Act may be cited as the 340B Pharmaceutical Access To Invest in Essential, Needed Treatments &amp; Support Act of …",
   "introduced_date": "2025-07-22",
   "sponsor": "Sen. Welch, Peter [D-VT]",
   "cosponsors": 2,
   "committees": "Senate Health, Education, Labor, and Pensions Committee",
   "stage": "Introduced",
   "stage_date": "2025-07-22",
   "failed_vote": "",
   "latest_action_date": "2025-07-22",
   "latest_action": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
   "law": "",
   "same_as": "H.R. 4581",
   "bill_url": "https://www.congress.gov/bill/119th-congress/senate-bill/2372",
   "text_version": "Introduced in Senate",
   "text_date": "2025-07-22",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119s2372is/html/BILLS-119s2372is.htm",
   "status_updated": "2025-12-05",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-s2793",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "S. 2793",
   "title": "Ensuring Access to Essential Providers Act of 2025",
   "official_title": "A bill to amend title XVIII of the Social Security Act to require Medicare Advantage plans to cover items and services furnished by certain essential community providers within a service area, and for other purposes.",
   "role": "mention",
   "kinds": [],
   "summary": "Names a 340B certification in defining which community providers Medicare Advantage plans would have to cover.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… to treatment of sexually transmitted diseases) through a State or unit of local government, but only if the entity is certified by the Secretary pursuant to section 340B(a)(7) of such Act; (II) a tuberculosis clinic; (III) a comprehensive hemophilia diagnostic treatment center receiving a grant under section 501(a)(2); and (IV) a black …",
   "introduced_date": "2025-09-11",
   "sponsor": "Sen. Cassidy, Bill [R-LA]",
   "cosponsors": 1,
   "committees": "Senate Finance Committee",
   "stage": "Introduced",
   "stage_date": "2025-09-11",
   "failed_vote": "",
   "latest_action_date": "2025-09-11",
   "latest_action": "Read twice and referred to the Committee on Finance.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/senate-bill/2793",
   "text_version": "Introduced in Senate",
   "text_date": "2025-09-11",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119s2793is/html/BILLS-119s2793is.htm",
   "status_updated": "2025-09-29",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-s3345",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "S. 3345",
   "title": "PBM Price Transparency and Accountability Act",
   "official_title": "A bill to amend titles XVIII and XIX of the Social Security Act to ensure accurate payments to pharmacies under Medicaid and prevent the use of abusive spread pricing in Medicaid, and to assure pharmacy access and choice for Medicare beneficiaries and modernize and ensure PBM accountability under Medicare.",
   "role": "part",
   "kinds": [
    "medicaid",
    "reporting"
   ],
   "summary": "In its Medicaid pharmacy payment rules, would let a plan or pharmacy benefit manager pay a covered entity more than its cost for a 340B drug, up to what it would pay had the drug been bought outside the program, if the covered entity reports to the Secretary; what is reported would be published by state and by type of covered entity. It would also have Medicare Part D pharmacy benefit managers list the 340B drugs for which they had an arrangement with a covered entity.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… (as defined in 447.502 of title 42, Code of Federal Regulations, or any successor regulation) for such drug if— (aa) such drug was subject to an agreement under section 340B of the Public Health Service Act; (bb) such payment for the ingredient cost of such drug does not exceed the maximum payment that would have been made by the entity or …",
   "introduced_date": "2025-12-04",
   "sponsor": "Sen. Crapo, Mike [R-ID]",
   "cosponsors": 27,
   "committees": "Senate Finance Committee",
   "stage": "Introduced",
   "stage_date": "2025-12-04",
   "failed_vote": "",
   "latest_action_date": "2025-12-04",
   "latest_action": "Read twice and referred to the Committee on Finance.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/senate-bill/3345",
   "text_version": "Introduced in Senate",
   "text_date": "2025-12-04",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119s3345is/html/BILLS-119s3345is.htm",
   "status_updated": "2026-08-10",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-s5066",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "S. 5066",
   "title": "Health Equity and Accountability Act of 2026",
   "official_title": "A bill to improve the health of minority individuals, and for other purposes.",
   "role": "mention",
   "kinds": [],
   "summary": "Would let 340B covered entities apply for grants to provide sexual health services to young people.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… (3) Eligible entity In this section, the term eligible entity means— (A) a public or private youth-serving organization; or (B) a covered entity, as defined in section 340B of the Public Health Service Act ( 42 U.S.C. 256b ). (4) Applications An eligible entity desiring a grant under this section shall submit an application to the …",
   "introduced_date": "2026-07-22",
   "sponsor": "Sen. Padilla, Alex [D-CA]",
   "cosponsors": 4,
   "committees": "Senate Finance Committee",
   "stage": "Introduced",
   "stage_date": "2026-07-22",
   "failed_vote": "",
   "latest_action_date": "2026-07-22",
   "latest_action": "Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4233)",
   "law": "",
   "same_as": "H.R. 9877",
   "bill_url": "https://www.congress.gov/bill/119th-congress/senate-bill/5066",
   "text_version": "Introduced in Senate",
   "text_date": "2026-07-22",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119s5066is/html/BILLS-119s5066is.htm",
   "status_updated": "2026-10-14",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-s5244",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "S. 5244",
   "title": "SUSTAIN 340B Act",
   "official_title": "A bill to amend the Public Health Service Act with respect to the drug discount program, and for other purposes.",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination",
    "reporting",
    "study",
    "other"
   ],
   "summary": "A broad rewrite of the program. Its sections cover contract pharmacies, a definition of patient, an end to the rebate model pilot, transparency, program integrity, duplicate discounts, a data clearinghouse, financial help for patients, equal treatment by payers, a user fee, and studies.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 157,
   "quote": "… of contents (a) Short title This Act may be cited as the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act or the SUSTAIN 340B Act . (b) Table of contents The table of contents for this Act is as follows: Sec. 1. Short title; table of contents. Sec. 2. Sense of Congress. …",
   "introduced_date": "2026-08-05",
   "sponsor": "Sen. Moran, Jerry [R-KS]",
   "cosponsors": 5,
   "committees": "Senate Health, Education, Labor, and Pensions Committee",
   "stage": "Introduced",
   "stage_date": "2026-08-05",
   "failed_vote": "",
   "latest_action_date": "2026-08-05",
   "latest_action": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/senate-bill/5244",
   "text_version": "Introduced in Senate",
   "text_date": "2026-08-05",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119s5244is/html/BILLS-119s5244is.htm",
   "status_updated": "2026-08-20",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "us-119-s5496",
   "jurisdiction": "US",
   "session": "119th Congress",
   "session_end": "2027-01-03",
   "bill": "S. 5496",
   "title": "Health CARE Act of 2026",
   "official_title": "A bill to expand access to and lower the cost of health care.",
   "role": "part",
   "kinds": [
    "medicaid",
    "reporting"
   ],
   "summary": "In its Medicaid pharmacy payment rules, would let a plan or pharmacy benefit manager pay a covered entity more than its cost for a 340B drug, up to what it would pay had the drug been bought outside the program, if the covered entity reports to the Secretary; what is reported would be published by state and by type of covered entity. It also names 340B in its changes to Medicare drug inflation rebates.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… with plan year 2028, units of each dosage form and strength of such part D rebatable drug for which the manufacturer provides a discount under the program under section 340B of the Public Health Service Act. ; and (ii) in paragraph (6), by striking information and all that follows through rebatable covered part D drug dispensed and …",
   "introduced_date": "2026-09-24",
   "sponsor": "Sen. Warner, Mark R. [D-VA]",
   "cosponsors": 0,
   "committees": "Senate Finance Committee",
   "stage": "Introduced",
   "stage_date": "2026-09-24",
   "failed_vote": "",
   "latest_action_date": "2026-09-24",
   "latest_action": "Read twice and referred to the Committee on Finance.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.congress.gov/bill/119th-congress/senate-bill/5496",
   "text_version": "Introduced in Senate",
   "text_date": "2026-09-24",
   "text_url": "https://www.govinfo.gov/content/pkg/BILLS-119s5496is/html/BILLS-119s5496is.htm",
   "status_updated": "2026-10-14",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ar-2025-hb1882",
   "jurisdiction": "AR",
   "session": "2025 Regular Session",
   "session_end": "2025-04-11",
   "bill": "HB 1882",
   "title": "TO AMEND THE DEFINITION OF ENROLLABLE MEDICAID BENEFICIARY POPULATION AND ALLOW THE GOVERNOR TO DESIGNATE MEDICAID POPULATIONS TO BE ENROLLED UNDER THE MEDICAID PROVIDER-LED ORGANIZED CARE ACT.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "medicaid"
   ],
   "summary": "In a bill on Medicaid provider-led organized care, would exempt services provided under 340B from that system if the Governor designates certain health plan enrollees as a population to be enrolled in it.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… Care Act, is amended to add an additional subsection to read as follows: (c) The Medicaid provider-led organized care system shall exempt services provided under the 340B Drug Pricing Program if populations enrolled in qualified health insurance plans under the Arkansas Health and Opportunity for Me Program are designated by the Governor …",
   "introduced_date": "2025-03-20",
   "sponsor": "Pilkington; J. Payton",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-03-20",
   "failed_vote": "",
   "latest_action_date": "2025-05-05",
   "latest_action": "Died in House Committee at Sine Die adjournment.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.arkleg.state.ar.us/Bills/FTPDocument/?path=%2fSessionInformation%2LegislativeMeasures.txt",
   "text_version": "HB 1882",
   "text_date": "",
   "text_url": "https://www.arkleg.state.ar.us/assembly/2025/2025R/Bills/HB1882.pdf",
   "status_updated": "2025-05-08",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ar-2025-sb58",
   "jurisdiction": "AR",
   "session": "2025 Regular Session",
   "session_end": "2025-04-11",
   "bill": "SB 58",
   "title": "TO REMOVE THE PROHIBITION ON NONPROFIT, TAX EXEMPT, OR GOVERNMENTALLY-FUNDED HOSPITALS HOLDING A LICENSED PHARMACY PERMIT FOR THE SALE AT RETAIL OF DRUGS.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In a wider law on retail pharmacy permits for nonprofit and public hospitals, requires such a hospital that takes part in 340B to tell 340B eligible patients leaving its emergency room, inpatient unit or outpatient clinic that they may use the pharmacy of their choice.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… as follows: 17-92-414. Patient freedom of choice. A nonprofit, tax exempt, or governmentally funded hospital that holds a retail pharmacy permit and participates in the 340B Drug Pricing Program shall ensure that a patient who is eligible under the 340B Drug Pricing Program who is seeking to obtain pharmaceutical supplies and services upon …",
   "introduced_date": "2025-01-14",
   "sponsor": "J. Dismang; Eubanks",
   "cosponsors": 2,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-02-17",
   "failed_vote": "",
   "latest_action_date": "2025-02-17",
   "latest_action": "Notification that SB58 is now Act 52",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.arkleg.state.ar.us/Bills/FTPDocument/?path=%2fSessionInformation%2LegislativeMeasures.txt",
   "text_version": "Act 52",
   "text_date": "",
   "text_url": "https://www.arkleg.state.ar.us/Acts/FTPDocument?path=%2FACTS%2F2025R%2FPublic%2F&file=52.pdf&ddBienniumSession=2025%2F2025R",
   "status_updated": "2025-02-17",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ar-2025-sb589",
   "jurisdiction": "AR",
   "session": "2025 Regular Session",
   "session_end": "2025-04-11",
   "bill": "SB 589",
   "title": "TO CREATE THE 340B PROGRAM TRANSPARENCY ACT; AND TO AMEND THE LAW CONCERNING TRANSPARENCY AND ACCOUNTABILITY FOR CERTAIN 340B-COVERED ENTITIES.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting"
   ],
   "summary": "Would require covered entities to send the health department a yearly report on their 340B savings and how the savings were used, including charity care, patient assistance, expanded access and administrative costs.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 37,
   "quote": "… to present law. State of Arkansas 95th General Assembly A Bill Regular Session, 2025 SENATE BILL 589 By: Senator C. Penzo For An Act To Be Entitled AN ACT TO CREATE THE 340B PROGRAM TRANSPARENCY ACT; TO REQUIRE TRANSPARENCY FROM CERTAIN 340B-COVERED ENTITIES CONCERNING THE USE OF 340B PROGRAM SAVINGS; TO REQUIRE CERTAIN 340B-COVERED …",
   "introduced_date": "2025-03-31",
   "sponsor": "C. Penzo",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-03-31",
   "failed_vote": "",
   "latest_action_date": "2025-05-05",
   "latest_action": "Died in Senate Committee at Sine Die adjournment.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.arkleg.state.ar.us/Bills/FTPDocument/?path=%2fSessionInformation%2LegislativeMeasures.txt",
   "text_version": "SB 589",
   "text_date": "",
   "text_url": "https://www.arkleg.state.ar.us/assembly/2025/2025R/Bills/SB589.pdf",
   "status_updated": "2025-05-06",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ar-2025-sb86",
   "jurisdiction": "AR",
   "session": "2025 Regular Session",
   "session_end": "2025-04-11",
   "bill": "SB 86",
   "title": "TO AMEND THE PROHIBITION ON NONPROFIT, TAX EXEMPT, OR GOVERNMENTALLY FUNDED HOSPITALS FROM HOLDING A LICENSED PHARMACY PERMIT FOR THE SALE AT RETAIL OF DRUGS.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In a wider bill on hospitals holding retail pharmacy permits, would require an entity that owns pharmacies and offers prospective cash savings plans through 340B to let other network pharmacies take part in those plans.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… of a drug or medication is not a financial incentive under this section. (f) An entity that owns pharmacies and offers prospective cash savings plans through the 340B Drug Pricing Program shall allow other network 3 01/16/2025 4:11:30 PM JMB206 SB86 pharmacies to participate in the prospective cash savings plan. (g) The board shall …",
   "introduced_date": "2025-01-21",
   "sponsor": "J. Boyd; Bentley",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-21",
   "failed_vote": "",
   "latest_action_date": "2025-05-05",
   "latest_action": "Sine Die adjournment",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.arkleg.state.ar.us/Bills/FTPDocument/?path=%2fSessionInformation%2LegislativeMeasures.txt",
   "text_version": "SB 86",
   "text_date": "",
   "text_url": "https://www.arkleg.state.ar.us/assembly/2025/2025R/Bills/SB86.pdf",
   "status_updated": "2025-05-06",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "az-57th2ndregular-hb2965",
   "jurisdiction": "AZ",
   "session": "57th Legislature - Second Regular Session",
   "session_end": "2026-04-25",
   "bill": "HB 2965",
   "title": "covered entities; 340B drugs; distribution",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers and repackagers from limiting the purchase or delivery of 340B drugs to covered entities and their contract pharmacies, or requiring claims data as a condition, unless the federal health department prohibits or requires it. The attorney general could enforce it.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 19,
   "quote": "HB2965 - 572R - I Ver REFERENCE TITLE: covered entities; 340B drugs; distribution State of Arizona House of Representatives Fifty-seventh Legislature Second Regular Session 2026 HB 2965 Introduced by Representative Lopez AN ACT …",
   "introduced_date": "2026-02-04",
   "sponsor": "Chris Lopez",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-02-04",
   "failed_vote": "",
   "latest_action_date": "2026-02-05",
   "latest_action": "House Second Reading",
   "law": "",
   "same_as": "",
   "bill_url": "https://apps.azleg.gov/BillStatus/BillOverview/85170?SessionId=130",
   "text_version": "Introduced Version",
   "text_date": "",
   "text_url": "https://www.azleg.gov/legtext/57leg/2R/bills/HB2965P.htm",
   "status_updated": "2026-03-26",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ca-20252026-ab1460",
   "jurisdiction": "CA",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-11-30",
   "bill": "AB 1460",
   "title": "Prescription drug pricing.",
   "official_title": "",
   "role": "",
   "kinds": [],
   "summary": "",
   "names_program_in": [
    "summary"
   ],
   "text_mentions": null,
   "quote": "… manufacturer from engaging in discriminatory practices that would impose additional conditions, prohibit, restrict, deny, or interfere with a qualifying nonhospital 340B community clinic's purchase or delivery of a drug subject to federal pricing requirements if the qualifying nonhospital 340B community clinic utilizes a specified …",
   "introduced_date": "2025-02-21",
   "sponsor": "Rogers",
   "cosponsors": 3,
   "committees": "",
   "stage": "Passed the Assembly",
   "stage_date": "2025-05-19",
   "failed_vote": "",
   "latest_action_date": "2025-07-16",
   "latest_action": "In committee: Hearing postponed by committee.",
   "law": "",
   "same_as": "",
   "bill_url": "http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202520260AB1460",
   "text_version": "",
   "text_date": "",
   "text_url": "https://leginfo.legislature.ca.gov/faces/billPdf.xhtml?bill_id=202520260AB1460&version=20250AB146097AMD",
   "status_updated": "2026-10-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "co-2025a-sb25071",
   "jurisdiction": "CO",
   "session": "2025 Regular Session",
   "session_end": "2025-05-07",
   "bill": "SB 25-071",
   "title": "Prohibit Restrictions on 340B Drugs",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Bars drug makers from placing limits or conditions on 340B covered entities' use of contract pharmacies to dispense 340B drugs, and makes a violation a deceptive trade practice under state law.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 37,
   "quote": "… Mauro, McCormick, Ricks, Soper, Stewart K., McCluskie. CONCERNING CERTAIN PRACTICES BY PERSONS PARTICIPATING IN THE SUPPLY CHAIN OF DRUGS PURCHASED UNDER THE FEDERAL 340B DRUG PRICING PROGRAM. Be it enacted by the General Assembly of the State of Colorado: SECTION 1. In Colorado Revised Statutes, 6-1-105, add (1)(0000) as follows: …",
   "introduced_date": "2025-01-22",
   "sponsor": "Dafna Michaelson Jenet; Janice Rich; Matthew Martinez; Rick Taggart",
   "cosponsors": 22,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-05-30",
   "failed_vote": "",
   "latest_action_date": "2025-05-30",
   "latest_action": "Governor Signed",
   "law": "",
   "same_as": "",
   "bill_url": "https://leg.colorado.gov/bills/sb25-071",
   "text_version": "Signed Act (05/30/2025)",
   "text_date": "",
   "text_url": "https://leg.colorado.gov/sites/default/files/2025a_071_signed.pdf",
   "status_updated": "2025-06-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "co-2025a-sb25124",
   "jurisdiction": "CO",
   "session": "2025 Regular Session",
   "session_end": "2025-05-07",
   "bill": "SB 25-124",
   "title": "Reducing Costs of Health Care for Patients",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "reporting",
    "use-of-savings"
   ],
   "summary": "Would bar nonprofit hospitals from spending 340B net revenue on items such as executive pay, lobbying and advertising, require at least 80% to go to care for low-income patients, add 340B figures to hospital annual reports, and bar drug makers from limiting delivery of 340B drugs.",
   "names_program_in": [
    "summary",
    "text"
   ],
   "text_mentions": 38,
   "quote": "… Services Health & Human Services A BILL FOR AN ACT HOUSE 101 CONCERNING OUTPATIENT DRUGS THAT ARE SOLD AT A DISCOUNT TO 102 NONPROFIT HOSPITALS THROUGH THE FEDERAL 340B DRUG Amended 2nd Reading 103 PRICING PROGRAM. May 5, 2025 Bill Summary 3rd Reading Unamended (Note: This summary applies to this bill as introduced and does March 26, …",
   "introduced_date": "2025-02-04",
   "sponsor": "Barbara Kirkmeyer; Julie Gonzales; Kyle Brown",
   "cosponsors": 10,
   "committees": "",
   "stage": "Passed the legislature",
   "stage_date": "2025-05-06",
   "failed_vote": "",
   "latest_action_date": "2025-05-07",
   "latest_action": "Senate Considered House Amendments - Result was to Adhere",
   "law": "",
   "same_as": "",
   "bill_url": "https://leg.colorado.gov/bills/sb25-124",
   "text_version": "Rerevised (05/06/2025)",
   "text_date": "",
   "text_url": "https://leg.colorado.gov/sites/default/files/documents/2025A/bills/2025a_124_rer.pdf",
   "status_updated": "2025-05-07",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "fl-2025-hb1527",
   "jurisdiction": "FL",
   "session": "2025 Regular Session",
   "session_end": "2025-05-02",
   "bill": "HB 1527",
   "title": "Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination"
   ],
   "summary": "Would bar drug makers from blocking delivery of 340B drugs to pharmacies under contract with a 340B entity, and bar insurers and pharmacy benefit managers from paying 340B entities less or setting different terms for them than for other pharmacies.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 164,
   "quote": "F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HB 1527 2025 A bill to be entitled An act relating to prohibitions against discriminatory practices relating to 340B entities and 340B drugs; creating s. 499.0263, F.S.; providing definitions; prohibiting drug manufacturers from engaging in certain acts against the acquisitions of …",
   "introduced_date": "2025-02-28",
   "sponsor": "Franklin",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-28",
   "failed_vote": "2025-06-16 Died in Health Care Facilities & Systems Subcommittee",
   "latest_action_date": "2025-06-16",
   "latest_action": "Died in Health Care Facilities & Systems Subcommittee",
   "law": "",
   "same_as": "",
   "bill_url": "https://flsenate.gov/Session/Bill/2025/1527/ByCategory",
   "text_version": "H 1527 Filed",
   "text_date": "",
   "text_url": "https://flsenate.gov/Session/Bill/2025/1527/BillText/Filed/PDF",
   "status_updated": "2025-07-07",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "fl-2025-hb657",
   "jurisdiction": "FL",
   "session": "2025 Regular Session",
   "session_end": "2025-05-02",
   "bill": "HB 657",
   "title": "Medicaid Pharmacy Discounted Drug Prices",
   "official_title": "",
   "role": "main",
   "kinds": [
    "medicaid"
   ],
   "summary": "Would require drug makers and wholesalers to sell drugs on the Medicaid preferred list to Medicaid pharmacies at the 340B price, have Medicaid pharmacy benefit managers pay those pharmacies that price plus a dispensing fee, and limit those sales to Medicaid patients.",
   "names_program_in": [
    "summary",
    "text"
   ],
   "text_mentions": 12,
   "quote": "… An act relating to Medicaid pharmacy discounted drug prices; creating s. 409.9067, F.S.; requiring drug manufacturers to sell specified drugs to Medicaid pharmacies at 340B Drug Pricing Program discounted prices; providing delivery methods for such drugs; requiring drug manufacturers to pay rebates to the state under certain circumstances; …",
   "introduced_date": "2025-02-17",
   "sponsor": "Abbott",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-17",
   "failed_vote": "2025-06-16 Died in Health Care Facilities & Systems Subcommittee",
   "latest_action_date": "2025-06-16",
   "latest_action": "Died in Health Care Facilities & Systems Subcommittee",
   "law": "",
   "same_as": "",
   "bill_url": "https://flsenate.gov/Session/Bill/2025/657/ByCategory",
   "text_version": "H 657 Filed",
   "text_date": "",
   "text_url": "https://flsenate.gov/Session/Bill/2025/657/BillText/Filed/PDF",
   "status_updated": "2025-06-26",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "fl-2025-sb1064",
   "jurisdiction": "FL",
   "session": "2025 Regular Session",
   "session_end": "2025-05-02",
   "bill": "SB 1064",
   "title": "Medicaid Pharmacy Discounted Drug Prices",
   "official_title": "",
   "role": "main",
   "kinds": [
    "study"
   ],
   "summary": "Would order the state health care agency to study the cost of requiring drug makers and wholesalers to sell preferred-list drugs to Medicaid pharmacies at the 340B price, and to report the results to the governor and legislature.",
   "names_program_in": [
    "summary",
    "text"
   ],
   "text_mentions": 11,
   "quote": "… Health Care Administration to conduct or contract for a detailed fiscal impact study on implementing specified provisions relating to discounted drug prices under the 340B Drug Pricing Program; requiring that the study be completed and its results submitted to the Governor and the Legislature by a specified date, etc. Original Filed …",
   "introduced_date": "2025-02-24",
   "sponsor": "Collins",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-24",
   "failed_vote": "2025-06-16 Died in Health Policy",
   "latest_action_date": "2025-06-16",
   "latest_action": "Died in Health Policy",
   "law": "",
   "same_as": "",
   "bill_url": "https://flsenate.gov/Session/Bill/2025/1064/ByCategory",
   "text_version": "S 1064 Filed",
   "text_date": "",
   "text_url": "https://flsenate.gov/Session/Bill/2025/1064/BillText/Filed/HTML",
   "status_updated": "2025-06-19",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "fl-2026-hb1281",
   "jurisdiction": "FL",
   "session": "2026 Regular Session",
   "session_end": "2026-03-13",
   "bill": "HB 1281",
   "title": "Prohibitions Against Discriminatory Practices relating to 340B Entities and 340B Drugs",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination"
   ],
   "summary": "Would bar drug makers from blocking delivery of 340B drugs to pharmacies under contract with a 340B entity, and bar insurers and pharmacy benefit managers from paying 340B entities less or setting different terms for them than for other pharmacies.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 158,
   "quote": "F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HB 1281 2026 A bill to be entitled An act relating to prohibitions against discriminatory practices relating to 340B entities and 340B drugs; providing a short title; creating s. 499.061, F.S.; providing definitions; prohibiting drug manufacturers from engaging in certain acts against …",
   "introduced_date": "2026-01-08",
   "sponsor": "Franklin",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-01-08",
   "failed_vote": "2026-03-13 Died in Health Care Facilities & Systems Subcommittee",
   "latest_action_date": "2026-03-13",
   "latest_action": "Died in Health Care Facilities & Systems Subcommittee",
   "law": "",
   "same_as": "",
   "bill_url": "https://flsenate.gov/Session/Bill/2026/1281/ByCategory",
   "text_version": "H 1281 Filed",
   "text_date": "",
   "text_url": "https://flsenate.gov/Session/Bill/2026/1281/BillText/Filed/PDF",
   "status_updated": "2026-06-30",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "fl-2026-hb1453",
   "jurisdiction": "FL",
   "session": "2026 Regular Session",
   "session_end": "2026-03-13",
   "bill": "HB 1453",
   "title": "State Medicaid Program",
   "official_title": "",
   "role": "part",
   "kinds": [
    "study"
   ],
   "summary": "In a wider bill that covers Medicaid, would have the state hire a vendor to study 340B compliance, drug purchases and payment methods in Medicaid, and require Medicaid plans, pharmacy benefit managers and providers to supply the data.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 5,
   "quote": "… administered in a hospital facility setting for severe mental illness; requiring the agency to contract with a vendor to perform a fiscal impact study of the federal 340B Drug Pricing Program; providing requirements for the study; requiring specified entities to submit certain data to the agency for purposes of the study; providing that …",
   "introduced_date": "2026-01-09",
   "sponsor": "Snyder",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-01-09",
   "failed_vote": "2026-03-13 Died in Health Care Facilities & Systems Subcommittee",
   "latest_action_date": "2026-03-13",
   "latest_action": "Died in Health Care Facilities & Systems Subcommittee",
   "law": "",
   "same_as": "",
   "bill_url": "https://flsenate.gov/Session/Bill/2026/1453/ByCategory",
   "text_version": "H 1453 Filed",
   "text_date": "",
   "text_url": "https://flsenate.gov/Session/Bill/2026/1453/BillText/Filed/PDF",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "fl-2026-hb573",
   "jurisdiction": "FL",
   "session": "2026 Regular Session",
   "session_end": "2026-03-13",
   "bill": "HB 573",
   "title": "Discounted Drug Pricing Study",
   "official_title": "",
   "role": "main",
   "kinds": [
    "study"
   ],
   "summary": "Would order the state health care agency to study the cost of requiring drug makers and wholesalers to sell preferred-list drugs to Medicaid pharmacies at the 340B price, and to report the results to the governor and legislature.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 9,
   "quote": "… or contract for a detailed fiscal impact study to determine the feasibility of implementing the following provisions relating to discounted drug prices under the 340B Drug Pricing Program: (a)1. Requiring drug manufacturers to sell a drug to Medicaid pharmacies at not more than the 340B Drug Pricing Program discounted price if the …",
   "introduced_date": "2025-12-01",
   "sponsor": "Chaney",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-12-01",
   "failed_vote": "2026-03-13 Died in Health Care Facilities & Systems Subcommittee",
   "latest_action_date": "2026-03-13",
   "latest_action": "Died in Health Care Facilities & Systems Subcommittee",
   "law": "",
   "same_as": "",
   "bill_url": "https://flsenate.gov/Session/Bill/2026/573/ByCategory",
   "text_version": "H 573 Filed",
   "text_date": "",
   "text_url": "https://flsenate.gov/Session/Bill/2026/573/BillText/Filed/PDF",
   "status_updated": "2026-06-30",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "fl-2026-sb1638",
   "jurisdiction": "FL",
   "session": "2026 Regular Session",
   "session_end": "2026-03-13",
   "bill": "SB 1638",
   "title": "Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination"
   ],
   "summary": "Would bar drug makers from blocking delivery of 340B drugs to pharmacies under contract with a 340B entity, and bar insurers and pharmacy benefit managers from paying 340B entities less or setting different terms for them than for other pharmacies.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 166,
   "quote": "1638 Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs 2026-01-09T08:41:31Z Prohibiting drug manufacturers from engaging in certain acts relating to the acquisition of 340B drugs by and the delivery …",
   "introduced_date": "2026-01-09",
   "sponsor": "Jones",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-01-09",
   "failed_vote": "2026-03-13 Died in Banking and Insurance",
   "latest_action_date": "2026-03-13",
   "latest_action": "Died in Banking and Insurance",
   "law": "",
   "same_as": "",
   "bill_url": "https://flsenate.gov/Session/Bill/2026/1638/ByCategory",
   "text_version": "S 1638 Filed",
   "text_date": "",
   "text_url": "https://flsenate.gov/Session/Bill/2026/1638/BillText/Filed/HTML",
   "status_updated": "2026-06-30",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "fl-2026-sb1758",
   "jurisdiction": "FL",
   "session": "2026 Regular Session",
   "session_end": "2026-03-13",
   "bill": "SB 1758",
   "title": "Public Assistance",
   "official_title": "",
   "role": "part",
   "kinds": [
    "study"
   ],
   "summary": "In a wider bill on public assistance, would have the Medicaid agency hire a vendor to study the fiscal impact of 340B in Medicaid. Medicaid plans, pharmacy benefit managers and providers would have to supply data, with results due by June 30, 2027.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 5,
   "quote": "… administered for severe mental illness in a hospital facility setting; requiring the agency to contract with a vendor to perform a fiscal impact study of the federal 340B Drug Pricing Program; providing requirements for the study; requiring specified entities to submit certain data to the agency for purposes of the study; providing that …",
   "introduced_date": "2026-01-13",
   "sponsor": "Appropriations; Health Policy; Gaetz",
   "cosponsors": 2,
   "committees": "",
   "stage": "Passed the Senate",
   "stage_date": "2026-03-09",
   "failed_vote": "2026-03-13 Died in Messages",
   "latest_action_date": "2026-03-13",
   "latest_action": "Died in Messages",
   "law": "",
   "same_as": "",
   "bill_url": "https://flsenate.gov/Session/Bill/2026/1758/ByCategory",
   "text_version": "S 1758 c2",
   "text_date": "",
   "text_url": "https://flsenate.gov/Session/Bill/2026/1758/BillText/c2/HTML",
   "status_updated": "2026-07-07",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "fl-2026-sb886",
   "jurisdiction": "FL",
   "session": "2026 Regular Session",
   "session_end": "2026-03-13",
   "bill": "SB 886",
   "title": "Discounted Drug Pricing Study",
   "official_title": "",
   "role": "main",
   "kinds": [
    "study"
   ],
   "summary": "Would order the state health care agency to study the cost of requiring drug makers and wholesalers to sell preferred-list drugs to Medicaid pharmacies at the 340B price, and to report the results to the governor and legislature.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 9,
   "quote": "… or contract for a detailed fiscal impact study to determine the feasibility of implementing the following provisions relating to discounted drug prices under the 340B Drug Pricing Program: (a)1. Requiring drug manufacturers to sell a drug to Medicaid pharmacies at no more than the 340B Drug Pricing Program discounted price if the …",
   "introduced_date": "2025-12-12",
   "sponsor": "Rodriguez",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-12-12",
   "failed_vote": "2026-03-13 Died in Health Policy",
   "latest_action_date": "2026-03-13",
   "latest_action": "Died in Health Policy",
   "law": "",
   "same_as": "",
   "bill_url": "https://flsenate.gov/Session/Bill/2026/886/ByCategory",
   "text_version": "S 886 Filed",
   "text_date": "",
   "text_url": "https://flsenate.gov/Session/Bill/2026/886/BillText/Filed/HTML",
   "status_updated": "2026-04-08",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ga-202526-hb139",
   "jurisdiction": "GA",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-04-02",
   "bill": "HB 139",
   "title": "Pharmacies; prohibit drug manufacturer and wholesalers from preventing a licensed pharmacy from acquiring drugs from entities that participate in a particular federal drug discount program",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers and wholesale distributors from stopping a licensed pharmacy from getting or dispensing drugs under a contract pharmacy arrangement with a 340B covered entity.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… or other healthcare provider's patients at a discounted price. (2) 'Covered entity' means an entity participating in or authorized to participate in the federal 340B drug discount program, as described in 42 U.S.C. Section 256b, including H. B. 139 -1- 25 LC 46 1023 its pharmacy, or any pharmacy contracted with the participating …",
   "introduced_date": "2025-01-27",
   "sponsor": "Todd Jones; Lee Hawkins; Matt Hatchett; Chas Cannon; Mack Jackson; Gerald Greene",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-27",
   "failed_vote": "",
   "latest_action_date": "2025-01-29",
   "latest_action": "House Second Readers",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.legis.ga.gov/legislation/69539",
   "text_version": "LC 46 1023/a",
   "text_date": "",
   "text_url": "http://www.legis.ga.gov/Legislation/20252026/230367.pdf",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ga-202526-hb897",
   "jurisdiction": "GA",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-04-02",
   "bill": "HB 897",
   "title": "Urgent Insulin Safety Net Program Act; enact",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "An urgent insulin supply bill; it names 340B only in a list of what a state information sheet must include, which covers how to find providers who take part in drug discount programs such as 340B.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… (4) Information on accessing healthcare providers who participate in prescription drug discount programs, including providers who are authorized to participate in the 340B program under section 340B of the federal Public Health Service Act, 42 U.S.C. Section 256b, as amended. (b) The department shall post the information sheet provided …",
   "introduced_date": "2025-04-02",
   "sponsor": "Michelle Au; Carolyn Hugley; Sam Park; Tanya Miller; Spencer Frye; Saira Draper",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-04-02",
   "failed_vote": "",
   "latest_action_date": "2026-01-12",
   "latest_action": "House Second Readers",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.legis.ga.gov/legislation/71970",
   "text_version": "LC 57 9000/a",
   "text_date": "",
   "text_url": "http://www.legis.ga.gov/Legislation/20252026/238733.pdf",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ga-202526-hb898",
   "jurisdiction": "GA",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-04-02",
   "bill": "HB 898",
   "title": "Continuing Insulin Safety Net Act; enact",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A bill on a continuing insulin assistance program; it names 340B only in a list of what a state information sheet must include, which covers how to find providers who take part in drug discount programs such as 340B.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… (4) Information on accessing healthcare providers who participate in prescription drug discount programs, including providers who are authorized to participate in the 340B program under section 340B of the federal Public Health Service Act, 42 U.S.C. Section 256b, as amended. (b) The department shall post the information sheet provided …",
   "introduced_date": "2025-04-02",
   "sponsor": "Michelle Au; Carolyn Hugley; Sam Park; Tanya Miller; Spencer Frye; Saira Draper",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-04-02",
   "failed_vote": "",
   "latest_action_date": "2026-01-12",
   "latest_action": "House Second Readers",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.legis.ga.gov/legislation/71971",
   "text_version": "LC 57 9001/a",
   "text_date": "",
   "text_url": "http://www.legis.ga.gov/Legislation/20252026/238735.pdf",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "hi-2025-hb561",
   "jurisdiction": "HI",
   "session": "2025 Regular Session",
   "session_end": "2025-05-02",
   "bill": "HB 561",
   "title": "RELATING TO PHARMACISTS.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In a bill on pharmacists, would let a pharmacist under contract with a 340B covered entity oversee by telehealth the filling of prescriptions for patients at a facility the covered entity runs.",
   "names_program_in": [
    "summary",
    "text"
   ],
   "text_mentions": 2,
   "quote": "… and (3) The contracted pharmacist is not located at that facility. (b) For purposes of this section: \"Covered entity\" has the same meaning as defined in section 340B(a)(4) of the Public Health Service Act (42 United States Code section 256b, et seq.). \"Interactive telecommunications system\" has the same meaning as defined in title …",
   "introduced_date": "2025-01-17",
   "sponsor": "CHUN; EVSLIN; GRANDINETTI; KITAGAWA; LOWEN; MARTEN; MIYAKE; PERRUSO; POEPOE; TAKAYAMA; TAKENOUCHI; TODD",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-21",
   "failed_vote": "",
   "latest_action_date": "2025-01-21",
   "latest_action": "Introduced and Pass First Reading.",
   "law": "",
   "same_as": "",
   "bill_url": "https://capitol.hawaii.gov/session/archives/measure_indiv_Archives.aspx?billtype=HB&billnumber=561&year=2025",
   "text_version": "HB561",
   "text_date": "",
   "text_url": "https://data.capitol.hawaii.gov/sessions/session2025/bills/HB561_.HTM",
   "status_updated": "2025-12-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "hi-2025-hb562",
   "jurisdiction": "HI",
   "session": "2025 Regular Session",
   "session_end": "2025-05-02",
   "bill": "HB 562",
   "title": "RELATING TO CONSUMER PROTECTION.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar 340B covered entities from signing contracts with drug makers or wholesalers that restrict getting 340B drugs through a contract pharmacy, void certain contract terms based on maximum allowable cost, and let the attorney general sue over violations.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 15,
   "quote": "… OF HAWAII A BILL FOR AN ACT relating to consumer protection . BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: SECTION 1. The legislature finds that the federal 340B drug pricing program is essential for providing Hawaii's low‑income and uninsured populations with access to healthcare and medications. The federal program requires …",
   "introduced_date": "2025-01-17",
   "sponsor": "CHUN; AMATO; BELATTI; GRANDINETTI; IWAMOTO; LOWEN; MARTEN; MIYAKE; PERRUSO; POEPOE; TAKAYAMA; TAKENOUCHI; TAM; TODD",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-21",
   "failed_vote": "",
   "latest_action_date": "2025-01-21",
   "latest_action": "Introduced and Pass First Reading.",
   "law": "",
   "same_as": "",
   "bill_url": "https://capitol.hawaii.gov/session/archives/measure_indiv_Archives.aspx?billtype=HB&billnumber=562&year=2025",
   "text_version": "HB562",
   "text_date": "",
   "text_url": "https://data.capitol.hawaii.gov/sessions/session2025/bills/HB562_.HTM",
   "status_updated": "2025-12-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "hi-2025-hb712",
   "jurisdiction": "HI",
   "session": "2025 Regular Session",
   "session_end": "2025-05-02",
   "bill": "HB 712",
   "title": "RELATING TO HEALTH.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "reporting"
   ],
   "summary": "Bars drug makers from restricting delivery of 340B drugs to contract pharmacies, though they may ask for claims data to check for diversion or duplicate discounts. Requires covered entities to report contract pharmacy figures yearly to the hospital trade association, which posts a combined report.",
   "names_program_in": [
    "summary",
    "text"
   ],
   "text_mentions": 55,
   "quote": "… HAWAII S.D. 2 C.D. 1 A BILL FOR AN ACT RELATING TO HEALTH . BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: SECTION 1. The legislature finds that the federal 340B drug pricing program (340B program) is essential for providing health care access to low-income and uninsured populations. The 340B program requires drug manufacturers …",
   "introduced_date": "2025-01-17",
   "sponsor": "TAKAYAMA; AMATO; BELATTI; CHUN; GRANDINETTI; IWAMOTO; KAPELA; KITAGAWA; LAMOSAO; LOWEN; MARTEN; MATAYOSHI; MIYAKE; OLDS; PERRUSO; PIERICK; SAYAMA; SOUZA; TARNAS",
   "cosponsors": 0,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-05-30",
   "failed_vote": "",
   "latest_action_date": "2025-05-30",
   "latest_action": "Act 143, 05/30/2025 (Gov. Msg. No. 1243).",
   "law": "",
   "same_as": "",
   "bill_url": "https://capitol.hawaii.gov/session/archives/measure_indiv_Archives.aspx?billtype=HB&billnumber=712&year=2025",
   "text_version": "HB712_CD1",
   "text_date": "",
   "text_url": "https://data.capitol.hawaii.gov/sessions/session2025/bills/HB712_CD1_.HTM",
   "status_updated": "2025-12-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "hi-2025-sb1279",
   "jurisdiction": "HI",
   "session": "2025 Regular Session",
   "session_end": "2025-05-02",
   "bill": "SB 1279",
   "title": "RELATING TO PHARMACISTS.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In a bill on pharmacists, would let a pharmacist under contract with a 340B covered entity oversee by telehealth the filling of prescriptions for patients at a facility the covered entity runs.",
   "names_program_in": [
    "summary",
    "text"
   ],
   "text_mentions": 3,
   "quote": "… and (3) The contracted pharmacist is not located at that facility. (b) For the purposes of this section: \"Covered entity\" has the same meaning as defined in section 340B(a)(4) of the Public Health Service Act (42 U.S.C. 256b). \"Interactive telecommunications system\" has the same meaning as defined in title 42 Code of Federal Regulations …",
   "introduced_date": "2025-01-21",
   "sponsor": "AQUINO; CHANG; FEVELLA; GABBARD; SAN BUENAVENTURA",
   "cosponsors": 0,
   "committees": "",
   "stage": "Passed the legislature",
   "stage_date": "2025-04-04",
   "failed_vote": "",
   "latest_action_date": "2025-04-22",
   "latest_action": "Conference committee meeting scheduled for 04-23-25 3:30PM; Conference Room 329.",
   "law": "",
   "same_as": "",
   "bill_url": "https://capitol.hawaii.gov/session/archives/measure_indiv_Archives.aspx?billtype=SB&billnumber=1279&year=2025",
   "text_version": "SB1279_HD1",
   "text_date": "",
   "text_url": "https://data.capitol.hawaii.gov/sessions/session2025/bills/SB1279_HD1_.HTM",
   "status_updated": "2025-12-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "hi-2025-sb1280",
   "jurisdiction": "HI",
   "session": "2025 Regular Session",
   "session_end": "2025-05-02",
   "bill": "SB 1280",
   "title": "RELATING TO CONSUMER PROTECTION.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar 340B covered entities from signing contracts with drug makers or wholesalers that restrict getting 340B drugs through a contract pharmacy, void certain contract terms based on maximum allowable cost, and let the attorney general sue over violations.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 15,
   "quote": "… OF HAWAII A BILL FOR AN ACT relating to consumer protection . BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: SECTION 1. The legislature finds that the federal 340B drug pricing program is essential for providing Hawaii's low‑income and uninsured populations with access to healthcare and medications. The federal program requires …",
   "introduced_date": "2025-01-21",
   "sponsor": "AQUINO; CHANG; FEVELLA; MCKELVEY",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-23",
   "failed_vote": "",
   "latest_action_date": "2025-01-27",
   "latest_action": "Referred to CPN/HHS, JDC.",
   "law": "",
   "same_as": "",
   "bill_url": "https://capitol.hawaii.gov/session/archives/measure_indiv_Archives.aspx?billtype=SB&billnumber=1280&year=2025",
   "text_version": "SB1280",
   "text_date": "",
   "text_url": "https://data.capitol.hawaii.gov/sessions/session2025/bills/SB1280_.HTM",
   "status_updated": "2025-12-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "hi-2025-sb480",
   "jurisdiction": "HI",
   "session": "2025 Regular Session",
   "session_end": "2025-05-02",
   "bill": "SB 480",
   "title": "RELATING TO HEALTH.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers and wholesalers from limiting or denying a contract pharmacy's access to 340B drugs, and would treat a violation as an unfair or deceptive trade practice.",
   "names_program_in": [
    "summary",
    "text"
   ],
   "text_mentions": 19,
   "quote": "… 2025 STATE OF HAWAII A BILL FOR AN ACT relating to HEALTH . BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: SECTION 1. The legislature finds that the federal 340B drug pricing program is essential for providing health care access to low-income and uninsured populations. The federal 340B program requires drug manufacturers to …",
   "introduced_date": "2025-01-17",
   "sponsor": "SAN BUENAVENTURA",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-17",
   "failed_vote": "",
   "latest_action_date": "2025-02-10",
   "latest_action": "The committee on HHS deferred the measure.",
   "law": "",
   "same_as": "",
   "bill_url": "https://capitol.hawaii.gov/session/archives/measure_indiv_Archives.aspx?billtype=SB&billnumber=480&year=2025",
   "text_version": "SB480",
   "text_date": "",
   "text_url": "https://data.capitol.hawaii.gov/sessions/session2025/bills/SB480_.HTM",
   "status_updated": "2025-12-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "hi-2026-hb561",
   "jurisdiction": "HI",
   "session": "2026 Regular Session",
   "session_end": "2026-05-08",
   "bill": "HB 561",
   "title": "RELATING TO PHARMACISTS.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In a bill on pharmacists, would let a pharmacist under contract with a 340B covered entity oversee by telehealth the filling of prescriptions for patients at a facility the covered entity runs.",
   "names_program_in": [
    "summary",
    "text"
   ],
   "text_mentions": 2,
   "quote": "… and (3) The contracted pharmacist is not located at that facility. (b) For purposes of this section: \"Covered entity\" has the same meaning as defined in section 340B(a)(4) of the Public Health Service Act (42 United States Code section 256b, et seq.). \"Interactive telecommunications system\" has the same meaning as defined in title …",
   "introduced_date": "2025-01-17",
   "sponsor": "CHUN; EVSLIN; GRANDINETTI; KITAGAWA; LOWEN; MARTEN; MIYAKE; PERRUSO; POEPOE; TAKAYAMA; TAKENOUCHI; TODD",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-21",
   "failed_vote": "",
   "latest_action_date": "2025-12-08",
   "latest_action": "Carried over to 2026 Regular Session.",
   "law": "",
   "same_as": "",
   "bill_url": "https://capitol.hawaii.gov/session/measure_indiv.aspx?billtype=HB&billnumber=561&year=2026",
   "text_version": "HB561",
   "text_date": "",
   "text_url": "https://data.capitol.hawaii.gov/sessions/session2026/bills/HB561_.HTM",
   "status_updated": "2026-10-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "hi-2026-hb562",
   "jurisdiction": "HI",
   "session": "2026 Regular Session",
   "session_end": "2026-05-08",
   "bill": "HB 562",
   "title": "RELATING TO CONSUMER PROTECTION.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar 340B covered entities from signing contracts with drug makers or wholesalers that restrict getting 340B drugs through a contract pharmacy, void certain contract terms based on maximum allowable cost, and let the attorney general sue over violations.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 15,
   "quote": "… OF HAWAII A BILL FOR AN ACT relating to consumer protection . BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: SECTION 1. The legislature finds that the federal 340B drug pricing program is essential for providing Hawaii's low‑income and uninsured populations with access to healthcare and medications. The federal program requires …",
   "introduced_date": "2025-01-17",
   "sponsor": "CHUN; AMATO; BELATTI; GRANDINETTI; IWAMOTO; LOWEN; MARTEN; MIYAKE; PERRUSO; POEPOE; TAKAYAMA; TAKENOUCHI; TAM; TODD",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-21",
   "failed_vote": "",
   "latest_action_date": "2025-12-08",
   "latest_action": "Carried over to 2026 Regular Session.",
   "law": "",
   "same_as": "",
   "bill_url": "https://capitol.hawaii.gov/session/measure_indiv.aspx?billtype=HB&billnumber=562&year=2026",
   "text_version": "HB562",
   "text_date": "",
   "text_url": "https://data.capitol.hawaii.gov/sessions/session2026/bills/HB562_.HTM",
   "status_updated": "2026-10-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "hi-2026-sb1279",
   "jurisdiction": "HI",
   "session": "2026 Regular Session",
   "session_end": "2026-05-08",
   "bill": "SB 1279",
   "title": "RELATING TO PHARMACISTS.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In a bill on pharmacists, would let a pharmacist under contract with a 340B covered entity oversee by telehealth the filling of prescriptions for patients at a facility the covered entity runs.",
   "names_program_in": [
    "summary",
    "text"
   ],
   "text_mentions": 3,
   "quote": "… and (3) The contracted pharmacist is not located at that facility. (b) For the purposes of this section: \"Covered entity\" has the same meaning as defined in section 340B(a)(4) of the Public Health Service Act (42 U.S.C. 256b). \"Interactive telecommunications system\" has the same meaning as defined in title 42 Code of Federal Regulations …",
   "introduced_date": "2025-01-21",
   "sponsor": "AQUINO; CHANG; FEVELLA; GABBARD; SAN BUENAVENTURA",
   "cosponsors": 0,
   "committees": "",
   "stage": "Passed the legislature",
   "stage_date": "2025-04-04",
   "failed_vote": "",
   "latest_action_date": "2026-04-02",
   "latest_action": "Received notice of the discharge of all House Conferees (Hse. Com. No. 457).",
   "law": "",
   "same_as": "",
   "bill_url": "https://capitol.hawaii.gov/session/measure_indiv.aspx?billtype=SB&billnumber=1279&year=2026",
   "text_version": "SB1279_HD1",
   "text_date": "",
   "text_url": "https://data.capitol.hawaii.gov/sessions/session2026/bills/SB1279_HD1_.HTM",
   "status_updated": "2026-10-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "hi-2026-sb1280",
   "jurisdiction": "HI",
   "session": "2026 Regular Session",
   "session_end": "2026-05-08",
   "bill": "SB 1280",
   "title": "RELATING TO CONSUMER PROTECTION.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar 340B covered entities from signing contracts with drug makers or wholesalers that restrict getting 340B drugs through a contract pharmacy, void certain contract terms based on maximum allowable cost, and let the attorney general sue over violations.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 15,
   "quote": "… OF HAWAII A BILL FOR AN ACT relating to consumer protection . BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: SECTION 1. The legislature finds that the federal 340B drug pricing program is essential for providing Hawaii's low‑income and uninsured populations with access to healthcare and medications. The federal program requires …",
   "introduced_date": "2025-01-21",
   "sponsor": "AQUINO; CHANG; FEVELLA; MCKELVEY",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-23",
   "failed_vote": "",
   "latest_action_date": "2025-12-08",
   "latest_action": "Carried over to 2026 Regular Session.",
   "law": "",
   "same_as": "",
   "bill_url": "https://capitol.hawaii.gov/session/measure_indiv.aspx?billtype=SB&billnumber=1280&year=2026",
   "text_version": "SB1280",
   "text_date": "",
   "text_url": "https://data.capitol.hawaii.gov/sessions/session2026/bills/SB1280_.HTM",
   "status_updated": "2026-10-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "hi-2026-sb480",
   "jurisdiction": "HI",
   "session": "2026 Regular Session",
   "session_end": "2026-05-08",
   "bill": "SB 480",
   "title": "RELATING TO HEALTH.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers and wholesalers from limiting or denying a contract pharmacy's access to 340B drugs, and would treat a violation as an unfair or deceptive trade practice.",
   "names_program_in": [
    "summary",
    "text"
   ],
   "text_mentions": 19,
   "quote": "… 2025 STATE OF HAWAII A BILL FOR AN ACT relating to HEALTH . BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: SECTION 1. The legislature finds that the federal 340B drug pricing program is essential for providing health care access to low-income and uninsured populations. The federal 340B program requires drug manufacturers to …",
   "introduced_date": "2025-01-17",
   "sponsor": "SAN BUENAVENTURA",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-17",
   "failed_vote": "",
   "latest_action_date": "2025-12-08",
   "latest_action": "Carried over to 2026 Regular Session.",
   "law": "",
   "same_as": "",
   "bill_url": "https://capitol.hawaii.gov/session/measure_indiv.aspx?billtype=SB&billnumber=480&year=2026",
   "text_version": "SB480",
   "text_date": "",
   "text_url": "https://data.capitol.hawaii.gov/sessions/session2026/bills/SB480_.HTM",
   "status_updated": "2026-10-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ia-20252026-hf2009",
   "jurisdiction": "IA",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-03",
   "bill": "HF 2009",
   "title": "A bill for an act relating to manufacturers and distributors of 340B drugs.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers and distributors from denying, restricting or interfering with a covered entity's purchase of a 340B drug, or its delivery to a contract pharmacy, unless the federal health department prohibits it.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 9,
   "quote": "House File 2009 - Introduced HOUSE FILE 2009 BY BARKER A BILL FOR An Act relating to manufacturers and distributors of 340B drugs. BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA: TLSB 5704YH (1) 91 nls/ko H.F. 2009 Section 1. Section 510D.1, Code 2026, is amended by adding the …",
   "introduced_date": "2026-01-13",
   "sponsor": "BARKER",
   "cosponsors": 0,
   "committees": "",
   "stage": "Reported by committee",
   "stage_date": "2026-01-21",
   "failed_vote": "",
   "latest_action_date": "2026-01-21",
   "latest_action": "Subcommittee recommends passage.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.legis.iowa.gov/legislation/billTracking/billHistory?billName=HF%202009&ga=91",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://www.legis.iowa.gov/docs/publications/LGI/91/attachments/HF2009.html",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ia-20252026-hf590",
   "jurisdiction": "IA",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-03",
   "bill": "HF 590",
   "title": "A bill for an act relating to manufacturers and distributors of 340B drugs.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers and distributors from denying, restricting or interfering with a covered entity's purchase of a 340B drug, or its delivery to a contract pharmacy, unless the federal health department prohibits it.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 9,
   "quote": "House File 590 - Introduced HOUSE FILE 590 BY BARKER A BILL FOR An Act relating to manufacturers and distributors of 340B drugs. BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA: TLSB 2744YH (2) 91 nls/ko H.F. 590 Section 1. Section 510D.1, Code 2025, is amended by adding the …",
   "introduced_date": "2025-02-25",
   "sponsor": "BARKER",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-25",
   "failed_vote": "",
   "latest_action_date": "2025-02-25",
   "latest_action": "Introduced, referred to Health and Human Services.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.legis.iowa.gov/legislation/billTracking/billHistory?billName=HF%20590&ga=91",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://www.legis.iowa.gov/docs/publications/LGI/91/attachments/HF590.html",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ia-20252026-sf2312",
   "jurisdiction": "IA",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-03",
   "bill": "SF 2312",
   "title": "A bill for an act relating to manufacturers and distributors of 340B drugs.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers and distributors from denying, restricting or interfering with a covered entity's purchase of a 340B drug, or its delivery to a contract pharmacy, unless the federal health department prohibits it.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 9,
   "quote": "Senate File 2312 - Introduced SENATE FILE 2312 BY SWEENEY A BILL FOR An Act relating to manufacturers and distributors of 340B drugs. BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA: TLSB 5704XS (1) 91 nls/ko S.F. 2312 Section 1. Section 510D.1, Code 2026, is amended by adding the …",
   "introduced_date": "2026-02-12",
   "sponsor": "SWEENEY",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-02-12",
   "failed_vote": "",
   "latest_action_date": "2026-02-18",
   "latest_action": "Subcommittee: Sweeney, Knox, and Warme.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.legis.iowa.gov/legislation/billTracking/billHistory?billName=SF%202312&ga=91",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://www.legis.iowa.gov/docs/publications/LGI/91/attachments/SF2312.html",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "id-2025-h136",
   "jurisdiction": "ID",
   "session": "68th Legislature, 1st Regular Session (2025)",
   "session_end": "2025-04-10",
   "bill": "H 136",
   "title": "INSURANCE – Adds to existing law to establish provisions regarding 340B drug pricing program reporting.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting"
   ],
   "summary": "Requires each 340B covered entity to report yearly to state offices its 340B drug costs, payments received, payments to contract pharmacies, claim counts and how it uses its savings, by payer type. The reported data is confidential, and the state controller prepares a yearly combined report.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 15,
   "quote": "… Legislature First Regular Session - 2025 IN THE HOUSE OF REPRESENTATIVES HOUSE BILL NO. 136, As Amended in the Senate BY HEALTH AND WELFARE COMMITTEE AN ACT RELATING TO 340B DRUG PRICING PROGRAM REPORTING; AMENDING CHAPTER 3, TITLE 41, IDAHO CODE, BY THE ADDITION OF A NEW SECTION 41-351, IDAHO CODE, TO ESTABLISH PROVISIONS REGARDING 340B …",
   "introduced_date": "2025-02-04",
   "sponsor": "HEALTH AND WELFARE COMMITTEE",
   "cosponsors": 0,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-04-02",
   "failed_vote": "",
   "latest_action_date": "2025-04-02",
   "latest_action": "Reported Signed by Governor on April 1, 2025    Session Law Chapter 246    Effective: 07/01/2025",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislature.idaho.gov/sessioninfo/2025/legislation/H0136/",
   "text_version": "Engrossment 1",
   "text_date": "",
   "text_url": "https://legislature.idaho.gov/wp-content/uploads/sessioninfo/2025/legislation/H0136E1.pdf",
   "status_updated": "2025-04-07",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "id-2025-h385",
   "jurisdiction": "ID",
   "session": "68th Legislature, 1st Regular Session (2025)",
   "session_end": "2025-04-10",
   "bill": "H 385",
   "title": "PRESCRIPTION DRUGS – Adds to existing law to establish provisions regarding certain prohibited actions by pharmaceutical manufacturers.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers from blocking the delivery of 340B drugs to contract pharmacies, interfering with contracts between covered entities and those pharmacies, or requiring claims or other data as a condition of supply.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 15,
   "quote": "… to be known and des- ignated as Section 54-1740, Idaho Code, and to read as follows: 54-1740. AFFORDABLE ACCESS TO PRESCRIPTION DRUGS. (1) As used in this section: (a) \"340B drug\" means a covered outpatient drug under 42 U.S.C. 256b(b) that has been subject to an offer for reduced prices by a pharmaceutical manufacturer under 42 U.S.C. …",
   "introduced_date": "2025-03-07",
   "sponsor": "HEALTH AND WELFARE COMMITTEE",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-03-07",
   "failed_vote": "",
   "latest_action_date": "2025-03-10",
   "latest_action": "Reported Printed and Referred to Health & Welfare",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislature.idaho.gov/sessioninfo/2025/legislation/H0385/",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://legislature.idaho.gov/wp-content/uploads/sessioninfo/2025/legislation/H0385.pdf",
   "status_updated": "2025-03-11",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "id-2026-s1390",
   "jurisdiction": "ID",
   "session": "68th Legislature, 2nd Regular Session (2026)",
   "session_end": "2026-04-10",
   "bill": "S 1390",
   "title": "INSURANCE – Amends existing law to revise provisions regarding 340B drug pricing program reporting.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting"
   ],
   "summary": "Would revise the yearly 340B report that covered entities file with state offices, so it covers drugs dispensed through contract pharmacies the entity does not own, uses the most recent fiscal year, and is filed through a secure website.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 18,
   "quote": "LEGISLATURE OF THE STATE OF IDAHO Sixty-eighth Legislature Second Regular Session - 2026 IN THE SENATE SENATE BILL NO. 1390 BY STATE AFFAIRS COMMITTEE AN ACT RELATING TO 340B DRUG PRICING PROGRAM REPORTING; AMENDING SECTION 41-351, IDAHO CODE, TO REVISE PROVISIONS REGARDING 340B DRUG PRICING PROGRAM REPORTING; AND DECLARING AN EMERGENCY AND …",
   "introduced_date": "2026-03-16",
   "sponsor": "STATE AFFAIRS COMMITTEE",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-03-16",
   "failed_vote": "",
   "latest_action_date": "2026-03-17",
   "latest_action": "Reported Printed; referred to Commerce & Human Resources",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislature.idaho.gov/sessioninfo/2026/legislation/S1390/",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://legislature.idaho.gov/wp-content/uploads/sessioninfo/2026/legislation/S1390.pdf",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "il-104th-hb1443",
   "jurisdiction": "IL",
   "session": "104th Regular Session",
   "session_end": "2027-01-12",
   "bill": "HB 1443",
   "title": "HEALTH CARE AVAILABILITY",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In a wider bill to create a prescription drug affordability board, would require the board to examine how an upper limit on what is paid for a drug would affect 340B covered entities.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… 30. Protections and other Board considerations. (a) The Board shall examine how an upper payment limit would affect a covered entity, as that term is defined in Section 340B of the federal Public Health Service Act. (b) In determining whether a drug creates an affordability challenge or determining an upper payment limit amount, the Board …",
   "introduced_date": "2025-01-17",
   "sponsor": "Nabeela Syed",
   "cosponsors": 29,
   "committees": "",
   "stage": "Reported by committee",
   "stage_date": "2026-04-16",
   "failed_vote": "",
   "latest_action_date": "2026-04-17",
   "latest_action": "House Floor Amendment No. 3 Rule 19(c) / Re-referred to Rules Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://ilga.gov/Legislation/BillStatus?DocNum=1443&GAID=18&DocTypeID=HB&LegId=157490&SessionID=114",
   "text_version": "Engrossed",
   "text_date": "",
   "text_url": "https://ilga.gov/Legislation/BillStatus/FullText?LegDocId=197280&DocName=10400HB1443eng&DocNum=1443&DocTypeID=HB&LegID=157490&GAID=18&SessionID=114&SpecSess=&Session=&Print=1",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "il-104th-hb2371",
   "jurisdiction": "IL",
   "session": "104th Regular Session",
   "session_end": "2027-01-12",
   "bill": "HB 2371",
   "title": "DENTAL INSURANCE ASSIGNABILITY",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "reporting",
    "study",
    "other"
   ],
   "summary": "Bars drug makers from limiting the purchase or delivery of 340B drugs to covered entities and their contract pharmacies. Covered entities must report 340B figures to lawmakers yearly, keep a policy against duplicate discounts and dispense 340B drugs only for outpatient care in the last 18 months.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 75,
   "quote": "… finds that: (1) It is within the traditional authority of the State to regulate the acquisition and delivery of drugs to pharmacies and providers. (2) The federal 340B statute is silent on distribution of 340B-acquired drugs to 340B covered entities and their contract pharmacy partners. (3) The State's compelling interest in …",
   "introduced_date": "2025-01-31",
   "sponsor": "Anna Moeller; David Koehler",
   "cosponsors": 30,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2026-08-07",
   "failed_vote": "",
   "latest_action_date": "2026-08-07",
   "latest_action": "Public Act . . . . . . . . . 104-0758",
   "law": "",
   "same_as": "",
   "bill_url": "https://ilga.gov/Legislation/BillStatus?DocNum=2371&GAID=18&DocTypeID=HB&LegId=160084&SessionID=114",
   "text_version": "Enrolled",
   "text_date": "",
   "text_url": "https://ilga.gov/Legislation/BillStatus/FullText?LegDocId=199872&DocName=10400HB2371enr&DocNum=2371&DocTypeID=HB&LegID=160084&GAID=18&SessionID=114&SpecSess=&Session=&Print=1",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "il-104th-hb3350",
   "jurisdiction": "IL",
   "session": "104th Regular Session",
   "session_end": "2027-01-12",
   "bill": "HB 3350",
   "title": "PATIENT ACCESS 340B PHARMACY",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers from limiting the purchase or delivery of 340B drugs to covered entities and their contract pharmacies, from restricting which contract pharmacies an entity uses, and from requiring pricing or other data as a condition. A state department would enforce it.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 74,
   "quote": "… including a pharmaceutical manufacturer, may deny, restrict, prohibit, condition, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B covered entity or a 340B contract pharmacy authorized to receive 340B drugs on behalf of the 340B covered entity unless …",
   "introduced_date": "2025-02-07",
   "sponsor": "Anna Moeller",
   "cosponsors": 24,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-07",
   "failed_vote": "",
   "latest_action_date": "2025-04-24",
   "latest_action": "Added Co-Sponsor Rep. Elizabeth \"Lisa\" Hernandez",
   "law": "",
   "same_as": "",
   "bill_url": "https://ilga.gov/Legislation/BillStatus?DocNum=3350&GAID=18&DocTypeID=HB&LegId=161855&SessionID=114",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://ilga.gov/Legislation/BillStatus/FullText?LegDocId=201643&DocName=10400HB3350&DocNum=3350&DocTypeID=HB&LegID=161855&GAID=18&SessionID=114&SpecSess=&Session=&Print=1",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "il-104th-hb3794",
   "jurisdiction": "IL",
   "session": "104th Regular Session",
   "session_end": "2027-01-12",
   "bill": "HB 3794",
   "title": "PRESCRIPTION DRUGS-VARIOUS",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A bill on pharmacy benefit managers and drug rebates; it names 340B only in the existing section it amends, which already bars contract terms that treat 340B pharmacies less favorably than other pharmacies.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 36,
   "quote": "… Insurance Code is amended by changing Section 513b1 as follows: (215 ILCS 5/513b1) Sec. 513b1. Pharmacy benefit manager contracts. (a) As used in this Section: \"340B drug discount program\" means the program established under Section 340B of the federal Public Health Service Act, 42 U.S.C. 256b. \"340B entity\" means a covered entity …",
   "introduced_date": "2025-02-07",
   "sponsor": "Ryan Spain",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-07",
   "failed_vote": "",
   "latest_action_date": "2025-03-21",
   "latest_action": "Rule 19(a) / Re-referred to Rules Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://ilga.gov/Legislation/BillStatus?DocNum=3794&GAID=18&DocTypeID=HB&LegId=162663&SessionID=114",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://ilga.gov/Legislation/BillStatus/FullText?LegDocId=202447&DocName=10400HB3794&DocNum=3794&DocTypeID=HB&LegID=162663&GAID=18&SessionID=114&SpecSess=&Session=&Print=1",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "il-104th-hb4065",
   "jurisdiction": "IL",
   "session": "104th Regular Session",
   "session_end": "2027-01-12",
   "bill": "HB 4065",
   "title": "340B GRANTEE CONTRACT ACCESS",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers and others from denying or limiting the purchase of 340B drugs by grantee covered entities, or by contract pharmacies in the state acting for them, unless federal law prohibits it. A state department would enforce it.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 22,
   "quote": "… (2025-2026) 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 HB4065 Introduced 5/22/2025, by Rep. Rita Mayfield SYNOPSIS AS INTRODUCED: New Act Creates the 340B Grantee Contract Pharmacy Access Act. Provides that no person, including a pharmaceutical manufacturer, may deny, restrict, or otherwise limit the acquisition of a 340B …",
   "introduced_date": "2025-05-22",
   "sponsor": "Rita Mayfield",
   "cosponsors": 4,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-05-22",
   "failed_vote": "",
   "latest_action_date": "2026-03-27",
   "latest_action": "House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://ilga.gov/Legislation/BillStatus?DocNum=4065&GAID=18&DocTypeID=HB&LegId=163864&SessionID=114",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://ilga.gov/Legislation/BillStatus/FullText?LegDocId=205013&DocName=10400HB4065&DocNum=4065&DocTypeID=HB&LegID=163864&GAID=18&SessionID=114&SpecSess=&Session=&Print=1",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "il-104th-hb4327",
   "jurisdiction": "IL",
   "session": "104th Regular Session",
   "session_end": "2027-01-12",
   "bill": "HB 4327",
   "title": "AUDITOR GENERAL-340B AUDIT",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting",
    "study"
   ],
   "summary": "Orders the state insurance department to study how covered entities and drug makers take part in 340B and to report its findings by July 1, 2028. Covered entities and drug makers must supply the figures it asks for or face daily fines.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 82,
   "quote": "… ACT concerning auditing. Be it enacted by the People of the State of Illinois, represented in the General Assembly: Section 1. Short title. This Act may be cited as the 340B Transparency, Reporting, and Accountability Act. Section 5. Findings. The General Assembly finds that: (1) The intent of the 340B Drug Discount Program is to provide …",
   "introduced_date": "2026-01-07",
   "sponsor": "Camille Y. Lilly; David Koehler",
   "cosponsors": 38,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2026-08-07",
   "failed_vote": "",
   "latest_action_date": "2026-08-07",
   "latest_action": "Public Act . . . . . . . . . 104-0769",
   "law": "",
   "same_as": "",
   "bill_url": "https://ilga.gov/Legislation/BillStatus?DocNum=4327&GAID=18&DocTypeID=HB&LegId=164841&SessionID=114",
   "text_version": "Enrolled",
   "text_date": "",
   "text_url": "https://ilga.gov/Legislation/BillStatus/FullText?LegDocId=206189&DocName=10400HB4327enr&DocNum=4327&DocTypeID=HB&LegID=164841&GAID=18&SessionID=114&SpecSess=&Session=&Print=1",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "il-104th-hb4761",
   "jurisdiction": "IL",
   "session": "104th Regular Session",
   "session_end": "2027-01-12",
   "bill": "HB 4761",
   "title": "PHARMACY BENEFIT REIMBURSE",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A bill on what pharmacy benefit managers must pay pharmacies; it names 340B only in the existing section it amends, which already bars contract terms that treat 340B pharmacies less favorably than other pharmacies.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 37,
   "quote": "… Insurance Code is amended by changing Section 513b1 as follows: (215 ILCS 5/513b1) Sec. 513b1. Pharmacy benefit manager contracts. (a) As used in this Article: \"340B drug discount program\" means the program established under Section 340B of the federal Public Health Service Act, 42 U.S.C. 256b. \"340B entity\" means a covered entity …",
   "introduced_date": "2026-02-02",
   "sponsor": "Natalie A. Manley",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-02-02",
   "failed_vote": "",
   "latest_action_date": "2026-03-27",
   "latest_action": "Rule 19(a) / Re-referred to Rules Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://ilga.gov/Legislation/BillStatus?DocNum=4761&GAID=18&DocTypeID=HB&LegId=165894&SessionID=114",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://ilga.gov/Legislation/BillStatus/FullText?LegDocId=207240&DocName=10400HB4761&DocNum=4761&DocTypeID=HB&LegID=165894&GAID=18&SessionID=114&SpecSess=&Session=&Print=1",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "il-104th-hb4954",
   "jurisdiction": "IL",
   "session": "104th Regular Session",
   "session_end": "2027-01-12",
   "bill": "HB 4954",
   "title": "340B PRICING PROGRAM REPORT",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting"
   ],
   "summary": "Would require covered entities to report each year to the state health department on 340B drug costs, payments received, payments to contract pharmacies and use of savings, with a combined public report. Would also say drug makers may ask covered entities for dispensing data.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 64,
   "quote": "… Assembly (2025-2026) 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 HB4954 Introduced , by Rep. Martha Deuter SYNOPSIS AS INTRODUCED: New Act Creates the 340B Drug Pricing Program Reporting Act. On or before April 1, 2027 and each April 1 thereafter, requires a 340B covered entity to report the specified information and …",
   "introduced_date": "2026-02-04",
   "sponsor": "Martha Deuter",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-02-04",
   "failed_vote": "",
   "latest_action_date": "2026-04-13",
   "latest_action": "Added Co-Sponsor Rep. Joyce Mason",
   "law": "",
   "same_as": "",
   "bill_url": "https://ilga.gov/Legislation/BillStatus?DocNum=4954&GAID=18&DocTypeID=HB&LegId=166306&SessionID=114",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://ilga.gov/Legislation/BillStatus/FullText?LegDocId=207652&DocName=10400HB4954&DocNum=4954&DocTypeID=HB&LegID=166306&GAID=18&SessionID=114&SpecSess=&Session=&Print=1",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "il-104th-hb5421",
   "jurisdiction": "IL",
   "session": "104th Regular Session",
   "session_end": "2027-01-12",
   "bill": "HB 5421",
   "title": "340B INTEGRITY ACT",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting",
    "medicaid",
    "use-of-savings",
    "study"
   ],
   "summary": "Would bar covered entities from billing Medicaid for 340B drugs, require them to use 80% of 340B profits to lower what low-income patients pay for those drugs, and require yearly reports posted publicly. Would also order state reports on 340B in Medicaid and the state employee plan.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 86,
   "quote": "… Assembly (2025-2026) 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 HB5421 Introduced 2/13/2026, by Rep. Bob Morgan SYNOPSIS AS INTRODUCED: New Act Creates the 340B Integrity Act. Defines terms. Provides that, beginning January 1, 2027, 340B covered entities shall not bill any medical assistance fee-for-service or medical …",
   "introduced_date": "2026-02-06",
   "sponsor": "Bob Morgan",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-02-06",
   "failed_vote": "",
   "latest_action_date": "2026-02-13",
   "latest_action": "Referred to Rules Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://ilga.gov/Legislation/BillStatus?DocNum=5421&GAID=18&DocTypeID=HB&LegId=167245&SessionID=114",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://ilga.gov/Legislation/BillStatus/FullText?LegDocId=208591&DocName=10400HB5421&DocNum=5421&DocTypeID=HB&LegID=167245&GAID=18&SessionID=114&SpecSess=&Session=&Print=1",
   "status_updated": "2026-07-11",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "il-104th-hb5804",
   "jurisdiction": "IL",
   "session": "104th Regular Session",
   "session_end": "2027-01-12",
   "bill": "HB 5804",
   "title": "MEDICAID-MCO RX PAYMENTS",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A bill on Medicaid managed care payments to pharmacies; it names 340B only in an existing part of the section it amends, which requires eligible providers that bill Medicaid for outpatient drugs to enroll in 340B.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… (l) Any provider enrolled with the Department that bills the Department for outpatient drugs and is eligible to enroll in the federal Drug Pricing Program under Section 340B of the federal Public Health Service Act shall enroll in that program. No entity participating in the federal Drug Pricing Program under Section 340B of the federal …",
   "introduced_date": "2026-07-22",
   "sponsor": "Dave Vella",
   "cosponsors": 2,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-07-22",
   "failed_vote": "",
   "latest_action_date": "2026-09-04",
   "latest_action": "Added Co-Sponsor Rep. Theresa Mah",
   "law": "",
   "same_as": "",
   "bill_url": "https://ilga.gov/Legislation/BillStatus?DocNum=5804&GAID=18&DocTypeID=HB&LegId=168815&SessionID=114",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://ilga.gov/Legislation/BillStatus/FullText?LegDocId=211533&DocName=10400HB5804&DocNum=5804&DocTypeID=HB&LegID=168815&GAID=18&SessionID=114&SpecSess=&Session=&Print=1",
   "status_updated": "2026-09-05",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "il-104th-hr158",
   "jurisdiction": "IL",
   "session": "104th Regular Session",
   "session_end": "2027-01-12",
   "bill": "HR 158",
   "title": "AUDIT-340B PROGRAM",
   "official_title": "",
   "role": "main",
   "kinds": [
    "study"
   ],
   "summary": "A House resolution that would direct the state Auditor General to investigate how covered entities use 340B, including 340B profit, payments to contract pharmacies and whether discounts reach patients, and the effect on Medicaid and the state employee health plan.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 34,
   "quote": "… Illinois General Assembly ILGA.GOV HR0158 - 104th General Assembly (2025-2026) HR0158 LRB104 12436 ECR 22753 r HOUSE RESOLUTION WHEREAS, The original intent of the 340B Drug Pricing Program was to provide discounted medicines to eligible healthcare organizations for the purpose of improving access to affordable medications for …",
   "introduced_date": "2025-02-26",
   "sponsor": "Curtis J. Tarver, II",
   "cosponsors": 22,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-26",
   "failed_vote": "",
   "latest_action_date": "2026-07-01",
   "latest_action": "Rule 19(b) / Re-referred to Rules Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://ilga.gov/Legislation/BillStatus?DocNum=158&GAID=18&DocTypeID=HR&LegId=163093&SessionID=114",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://ilga.gov/Legislation/BillStatus/FullText?LegDocId=202960&DocName=10400HR0158&DocNum=158&DocTypeID=HR&LegID=163093&GAID=18&SessionID=114&SpecSess=&Session=&Print=1",
   "status_updated": "2026-10-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "il-104th-sb1390",
   "jurisdiction": "IL",
   "session": "104th Regular Session",
   "session_end": "2027-01-12",
   "bill": "SB 1390",
   "title": "DHFS-MCO-PBM-CONTRACTS",
   "official_title": "",
   "role": "part",
   "kinds": [
    "payer-nondiscrimination",
    "medicaid"
   ],
   "summary": "An amendment filed to this bill would amend the pharmacy benefit manager law. The amended sections carry a bar, for contracts after July 1, 2022, on terms that pay 340B entities or their pharmacies less or add fees because of 340B, and have Medicaid managed care plans pay 340B pharmacy claims.",
   "names_program_in": [
    "earlier text"
   ],
   "text_mentions": 73,
   "quote": "… 10400SB1390sam001 - 5 - LRB104 08735 BAB 23976 a 513b1.1 as follows: (215 ILCS 5/513b1) Sec. 513b1. Pharmacy benefit manager contracts. (a) As used in this Section: \"340B drug discount program\" means the program established under Section 340B of the federal Public Health Service Act, 42 U.S.C. 256b. \"340B entity\" means a covered entity …",
   "introduced_date": "2025-01-29",
   "sponsor": "David Koehler",
   "cosponsors": 3,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-29",
   "failed_vote": "",
   "latest_action_date": "2025-06-02",
   "latest_action": "Senate Committee Amendment No. 1 Rule 3-9(a) / Re-referred to Assignments",
   "law": "",
   "same_as": "",
   "bill_url": "https://ilga.gov/Legislation/BillStatus?DocNum=1390&GAID=18&DocTypeID=SB&LegId=159493&SessionID=114",
   "text_version": "Senate Amendment 001",
   "text_date": "",
   "text_url": "https://ilga.gov/Legislation/BillStatus/FullText?LegDocId=203516&DocName=10400SB1390sam001&DocNum=1390&DocTypeID=SB&LegID=159493&GAID=18&SessionID=114&SpecSess=&Session=&Print=1",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "il-104th-sb2385",
   "jurisdiction": "IL",
   "session": "104th Regular Session",
   "session_end": "2027-01-12",
   "bill": "SB 2385",
   "title": "PATIENT ACCESS 340B PHARMACY",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers from limiting the purchase or delivery of 340B drugs to covered entities and their contract pharmacies, from restricting which contract pharmacies an entity uses, and from requiring pricing or other data as a condition. A state department would enforce it.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 74,
   "quote": "… including a pharmaceutical manufacturer, may deny, restrict, prohibit, condition, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B covered entity or a 340B contract pharmacy authorized to receive 340B drugs on behalf of the 340B covered entity unless …",
   "introduced_date": "2025-02-07",
   "sponsor": "David Koehler",
   "cosponsors": 26,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-07",
   "failed_vote": "",
   "latest_action_date": "2025-06-02",
   "latest_action": "Rule 3-9(a) / Re-referred to Assignments",
   "law": "",
   "same_as": "",
   "bill_url": "https://ilga.gov/Legislation/BillStatus?DocNum=2385&GAID=18&DocTypeID=SB&LegId=162386&SessionID=114",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://ilga.gov/Legislation/BillStatus/FullText?LegDocId=202174&DocName=10400SB2385&DocNum=2385&DocTypeID=SB&LegID=162386&GAID=18&SessionID=114&SpecSess=&Session=&Print=1",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "il-104th-sb3146",
   "jurisdiction": "IL",
   "session": "104th Regular Session",
   "session_end": "2027-01-12",
   "bill": "SB 3146",
   "title": "340B PRICING PROGRAM REPORT",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting"
   ],
   "summary": "Would require covered entities to report each year to the state health department on 340B drug costs, payments received, payments to contract pharmacies and use of savings, with a combined public report. Would also say drug makers may ask covered entities for dispensing data.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 64,
   "quote": "… (2025-2026) 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB3146 Introduced 2/2/2026, by Sen. Christopher Belt SYNOPSIS AS INTRODUCED: New Act Creates the 340B Drug Pricing Program Reporting Act. On or before April 1, 2027 and each April 1 thereafter, requires a 340B covered entity to report the specified information and …",
   "introduced_date": "2026-02-02",
   "sponsor": "Adriane L. Johnson",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-02-02",
   "failed_vote": "",
   "latest_action_date": "2026-03-27",
   "latest_action": "Rule 3-9(a) / Re-referred to Assignments",
   "law": "",
   "same_as": "",
   "bill_url": "https://ilga.gov/Legislation/BillStatus?DocNum=3146&GAID=18&DocTypeID=SB&LegId=165785&SessionID=114",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://ilga.gov/Legislation/BillStatus/FullText?LegDocId=207133&DocName=10400SB3146&DocNum=3146&DocTypeID=SB&LegID=165785&GAID=18&SessionID=114&SpecSess=&Session=&Print=1",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "il-104th-sb3878",
   "jurisdiction": "IL",
   "session": "104th Regular Session",
   "session_end": "2027-01-12",
   "bill": "SB 3878",
   "title": "340B INTEGRITY ACT",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting",
    "medicaid",
    "use-of-savings",
    "study"
   ],
   "summary": "Would bar covered entities from billing Medicaid for 340B drugs, require them to use 80% of 340B profits to lower what low-income patients pay for those drugs, and require yearly reports posted publicly. Would also order state reports on 340B in Medicaid and the state employee plan.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 86,
   "quote": "… (2025-2026) 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB3878 Introduced 2/6/2026, by Sen. Julie A. Morrison SYNOPSIS AS INTRODUCED: New Act Creates the 340B Integrity Act. Defines terms. Provides that, beginning January 1, 2027, 340B covered entities shall not bill any medical assistance fee-for-service or medical …",
   "introduced_date": "2026-02-06",
   "sponsor": "Julie A. Morrison",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-02-06",
   "failed_vote": "",
   "latest_action_date": "2026-02-06",
   "latest_action": "Referred to Assignments",
   "law": "",
   "same_as": "",
   "bill_url": "https://ilga.gov/Legislation/BillStatus?DocNum=3878&GAID=18&DocTypeID=SB&LegId=167308&SessionID=114",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://ilga.gov/Legislation/BillStatus/FullText?LegDocId=208654&DocName=10400SB3878&DocNum=3878&DocTypeID=SB&LegID=167308&GAID=18&SessionID=114&SpecSess=&Session=&Print=1",
   "status_updated": "2026-07-11",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "il-104th-sb66",
   "jurisdiction": "IL",
   "session": "104th Regular Session",
   "session_end": "2027-01-12",
   "bill": "SB 66",
   "title": "HEALTH CARE AVAILABILITY",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In a wider bill creating a board that could set upper payment limits on prescription drugs, would require the board to examine how such a limit would affect 340B covered entities.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… 30. Protections and other Board considerations. (a) The Board shall examine how an upper payment limit would affect a covered entity, as that term is defined in Section 340B of the federal Public Health Service Act. (b) In determining whether a drug creates an affordability challenge or determining an upper payment limit amount, the Board …",
   "introduced_date": "2025-01-13",
   "sponsor": "Graciela Guzmán",
   "cosponsors": 18,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-13",
   "failed_vote": "",
   "latest_action_date": "2026-05-22",
   "latest_action": "Senate Committee Amendment No. 4 Rule 3-9(a) / Re-referred to Assignments",
   "law": "",
   "same_as": "",
   "bill_url": "https://ilga.gov/Legislation/BillStatus?DocNum=66&GAID=18&DocTypeID=SB&LegId=157171&SessionID=114",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://ilga.gov/Legislation/BillStatus/FullText?LegDocId=196962&DocName=10400SB0066&DocNum=66&DocTypeID=SB&LegID=157171&GAID=18&SessionID=114&SpecSess=&Session=&Print=1",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "il-104th-sb709",
   "jurisdiction": "IL",
   "session": "104th Regular Session",
   "session_end": "2027-01-12",
   "bill": "SB 709",
   "title": "REGULATION-TECH",
   "official_title": "",
   "role": "part",
   "kinds": [
    "payer-nondiscrimination",
    "medicaid"
   ],
   "summary": "An amendment filed to this bill would amend the pharmacy benefit manager law. The amended sections carry a bar, for contracts after July 1, 2022, on terms that pay 340B entities or their pharmacies less or add fees because of 340B, and have Medicaid managed care plans pay 340B pharmacy claims.",
   "names_program_in": [
    "earlier text"
   ],
   "text_mentions": 73,
   "quote": "… 10400SB0709sam001 - 5 - LRB104 07007 BAB 24876 a 513b1.1 as follows: (215 ILCS 5/513b1) Sec. 513b1. Pharmacy benefit manager contracts. (a) As used in this Section: \"340B drug discount program\" means the program established under Section 340B of the federal Public Health Service Act, 42 U.S.C. 256b. \"340B entity\" means a covered entity …",
   "introduced_date": "2025-01-24",
   "sponsor": "David Koehler",
   "cosponsors": 6,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-24",
   "failed_vote": "",
   "latest_action_date": "2025-06-02",
   "latest_action": "Rule 3-9(a) / Re-referred to Assignments",
   "law": "",
   "same_as": "",
   "bill_url": "https://ilga.gov/Legislation/BillStatus?DocNum=709&GAID=18&DocTypeID=SB&LegId=158420&SessionID=114",
   "text_version": "Senate Amendment 001",
   "text_date": "",
   "text_url": "https://ilga.gov/Legislation/BillStatus/FullText?LegDocId=204025&DocName=10400SB0709sam001&DocNum=709&DocTypeID=SB&LegID=158420&GAID=18&SessionID=114&SpecSess=&Session=&Print=1",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ks-20252026-hb2434",
   "jurisdiction": "KS",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-04-10",
   "bill": "HB 2434",
   "title": "Substitute for HB 2434 by Committee on Appropriations - Making and concerning supplemental appropriations for fiscal year 2026 and appropriations for fiscal years 2027 and 2028 for various state agencies, authorizing certain capital improvement projects and fees, authorizing certain transfers.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In the state budget, would direct prescription support money for primary care clinics to buying 340B drug inventory for community health centers and to lowering drug costs for patients at 340B clinics on a sliding fee scale.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… That prescription support expenditures shall be made from the aid to local units – primary health projects account for: (1) Purchasing drug inventory under section 340B of the federal public health service act for community health center grantees and federally qualified health center look-alikes who qualify; (2) increasing access to …",
   "introduced_date": "2026-01-12",
   "sponsor": "Troy Waymaster",
   "cosponsors": 1,
   "committees": "",
   "stage": "Passed the House",
   "stage_date": "2026-02-25",
   "failed_vote": "2026-04-10 Died in Senate Committee",
   "latest_action_date": "2026-04-10",
   "latest_action": "Died in Senate Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.kslegislature.gov/b2025_26/bills/HB2434/",
   "text_version": "Sub",
   "text_date": "",
   "text_url": "https://www.kslegislature.gov/b2025_26/documents/view-leg/?apn=b2025_26/year2/ready_for_publication/hb_2434/hb2434_01_0000.pdf",
   "status_updated": "2026-06-03",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ks-20252026-hb2455",
   "jurisdiction": "KS",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-04-10",
   "bill": "HB 2455",
   "title": "Making and concerning certain supplemental appropriations for fiscal year 2026 and appropriations for fiscal years 2027, 2028 and 2029 for various state agencies.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In the state budget, would direct prescription support money for primary care clinics to buying 340B drug inventory for community health centers and to lowering drug costs for patients at 340B clinics on a sliding fee scale.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… That prescription support expenditures shall be made from the aid to local units – primary health projects account for: (1) Purchasing drug inventory under section 340B of the federal public health service act for community health center grantees and federally qualified health center look-alikes who qualify; (2) increasing access to …",
   "introduced_date": "2026-01-15",
   "sponsor": "Committee on Appropriations",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-01-15",
   "failed_vote": "2026-04-10 Died in Committee",
   "latest_action_date": "2026-04-10",
   "latest_action": "Died in Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.kslegislature.gov/b2025_26/bills/HB2455/",
   "text_version": "As Introduced",
   "text_date": "",
   "text_url": "https://www.kslegislature.gov/b2025_26/documents/view-leg/?apn=b2025_26/year2/ready_for_publication/hb_2455/hb2455_00_0000.pdf",
   "status_updated": "2026-05-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ks-20252026-hb2513",
   "jurisdiction": "KS",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-04-10",
   "bill": "HB 2513",
   "title": "Making and concerning supplemental appropriations for fiscal year 2026 and appropriations for fiscal years 2027, 2028, 2029 and 2030 for various state agencies, authorizing certain capital improvement projects and fees, authorizing certain transfers.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In the state budget, directs prescription support money for primary care clinics to buying 340B drug inventory for community health centers and to lowering drug costs for patients at 340B clinics on a sliding fee scale.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… That prescription support expenditures shall be made from the aid to local units – primary health projects account for: (1) Purchasing drug inventory under section 340B of the federal public health service act for community health center grantees and federally qualified health center look-alikes who qualify; (2) increasing access to …",
   "introduced_date": "2026-01-22",
   "sponsor": "Joint Committee on Special Claims Against the State",
   "cosponsors": 0,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2026-04-09",
   "failed_vote": "",
   "latest_action_date": "2026-04-10",
   "latest_action": "Motion to override line item veto prevailed; Line item veto 88(k), 88(m) overridden; Yea 87, Nay 36, Absent 2",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.kslegislature.gov/b2025_26/bills/HB2513/",
   "text_version": "Enrolled",
   "text_date": "",
   "text_url": "https://www.kslegislature.gov/b2025_26/documents/view-leg/?apn=b2025_26/year2/ready_for_publication/hb_2513/hb2513_enrolled.pdf",
   "status_updated": "2026-11-03",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ks-20252026-hb2550",
   "jurisdiction": "KS",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-04-10",
   "bill": "HB 2550",
   "title": "Requiring certain 340B entities to report annually to the Kansas department of insurance on certain costs, savings and payments made under the federal 340B drug pricing program.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting"
   ],
   "summary": "Would require hospitals that take part in 340B to report each year on their 340B drug costs, payments received, payments to contract pharmacies and how they use the savings, and require the state insurance department to post the reports online.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 38,
   "quote": "… PDF Session of 2026 HOUSE BILL No. 2550 By Committee on Insurance Requested by Representative Sutton 1-27 AN ACT concerning health and healthcare; relating to certain 340B entities under the federal 340B drug pricing program; requiring such entities to annually report to the Kansas department of insurance on certain costs, savings and …",
   "introduced_date": "2026-01-27",
   "sponsor": "Committee on Insurance",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-01-27",
   "failed_vote": "2026-04-10 Died in Committee",
   "latest_action_date": "2026-04-10",
   "latest_action": "Died in Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.kslegislature.gov/b2025_26/bills/HB2550/",
   "text_version": "As Introduced",
   "text_date": "",
   "text_url": "https://www.kslegislature.gov/b2025_26/documents/view-leg/?apn=b2025_26/year2/ready_for_publication/hb_2550/hb2550_00_0000.pdf",
   "status_updated": "2026-05-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ks-20252026-sb212",
   "jurisdiction": "KS",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-04-10",
   "bill": "SB 212",
   "title": "Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "study",
    "other"
   ],
   "summary": "In a wider bill creating a prescription drug pricing board, would have the board weigh the effect on 340B entities when it sets an upper payment limit for a drug, and cover that effect in a one-time study for the legislature.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 5,
   "quote": "… act shall be known and may be cited as the prescription drug cost and affordability review act. Sec. 2. As used in sections 1 through 8, and amendments thereto: (a) \"340B-covered entity\" means an entity that is participating in the federal 340B drug pricing program authorized by 42 U.S.C. § 256b, including such entity's pharmacy or …",
   "introduced_date": "2025-02-05",
   "sponsor": "Dinah Sykes",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-05",
   "failed_vote": "2026-04-10 Died in Committee",
   "latest_action_date": "2026-04-10",
   "latest_action": "Died in Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.kslegislature.gov/b2025_26/bills/SB212/",
   "text_version": "As Introduced",
   "text_date": "",
   "text_url": "https://www.kslegislature.gov/b2025_26/documents/view-leg/?apn=b2025_26/year2/ready_for_publication/sb_212/sb212_00_0000.pdf",
   "status_updated": "2026-07-08",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ks-20252026-sb284",
   "jurisdiction": "KS",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-04-10",
   "bill": "SB 284",
   "title": "Enacting the defense of drug delivery act to prohibit manufacturer interference relating to 340B drug distribution.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers and distributors from limiting the purchase or delivery of 340B drugs to a covered entity or a location it authorizes, and bar drug makers from requiring claims or other data as a condition, with civil penalties of up to $50,000 per violation.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 12,
   "quote": "… by Senate Committee Session of 2025 SENATE BILL No. 284 By Committee on Federal and State Affairs 3-3 AN ACT concerning prescription drugs; relating to the federal 340B drug pricing program; enacting the defense of drug delivery act to prohibit manufacturer interference relating to 340B drug distribution. Be it enacted by the …",
   "introduced_date": "2025-03-03",
   "sponsor": "Committee on Federal and State Affairs",
   "cosponsors": 0,
   "committees": "",
   "stage": "Passed the Senate",
   "stage_date": "2025-03-20",
   "failed_vote": "2026-04-10 Died in House Committee",
   "latest_action_date": "2026-04-10",
   "latest_action": "Died in House Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.kslegislature.gov/b2025_26/bills/SB284/",
   "text_version": "As Amended by Senate Committee",
   "text_date": "",
   "text_url": "https://www.kslegislature.gov/b2025_26/documents/view-leg/?apn=b2025_26/year2/ready_for_publication/sb_284/sb284_01_0000.pdf",
   "status_updated": "2026-07-08",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ks-20252026-sb315",
   "jurisdiction": "KS",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-04-10",
   "bill": "SB 315",
   "title": "Substitute for SB 315 by Committee on Ways and Means - Making and concerning supplemental appropriations for fiscal year 2026 and appropriations for fiscal years 2027, 2028, 2029 and 2030 for various state agencies, authorizing certain capital improvement projects and fees, authorizing certain transfers.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In the state budget, would direct prescription support money for primary care clinics to buying 340B drug inventory for community health centers and to lowering drug costs for patients at 340B clinics on a sliding fee scale.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… That prescription support expenditures shall be made from the aid to local units – primary health projects account for: (1) Purchasing drug inventory under section 340B of the federal public health service act for community health center grantees and federally qualified health center look-alikes who qualify; (2) increasing access to …",
   "introduced_date": "2026-01-12",
   "sponsor": "Rick Billinger",
   "cosponsors": 1,
   "committees": "",
   "stage": "Passed the Senate",
   "stage_date": "2026-03-03",
   "failed_vote": "2026-04-10 Died in House Committee",
   "latest_action_date": "2026-04-10",
   "latest_action": "Died in House Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.kslegislature.gov/b2025_26/bills/SB315/",
   "text_version": "{As Amended by Senate Committee of the Whole}",
   "text_date": "",
   "text_url": "https://www.kslegislature.gov/b2025_26/documents/view-leg/?apn=b2025_26/year2/ready_for_publication/sb_315/sb315_02_0000.pdf",
   "status_updated": "2026-06-04",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ks-20252026-sb337",
   "jurisdiction": "KS",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-04-10",
   "bill": "SB 337",
   "title": "Making and concerning certain supplemental appropriations for fiscal year 2026 and appropriations for fiscal years 2027, 2028 and 2029 for various state agencies.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In the state budget, would direct prescription support money for primary care clinics to buying 340B drug inventory for community health centers and to lowering drug costs for patients at 340B clinics on a sliding fee scale.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… That prescription support expenditures shall be made from the aid to local units – primary health projects account for: (1) Purchasing drug inventory under section 340B of the federal public health service act for community health center grantees and federally qualified health center look-alikes who qualify; (2) increasing access to …",
   "introduced_date": "2026-01-15",
   "sponsor": "Committee on Ways and Means",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-01-15",
   "failed_vote": "2026-04-10 Died in Committee",
   "latest_action_date": "2026-04-10",
   "latest_action": "Died in Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.kslegislature.gov/b2025_26/bills/SB337/",
   "text_version": "As Introduced",
   "text_date": "",
   "text_url": "https://www.kslegislature.gov/b2025_26/documents/view-leg/?apn=b2025_26/year2/ready_for_publication/sb_337/sb337_00_0000.pdf",
   "status_updated": "2026-05-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ks-20252026-sb360",
   "jurisdiction": "KS",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-04-10",
   "bill": "SB 360",
   "title": "Enacting the Kansas consumer prescription protection and accountability act and providing for regulation and registration of pharmacy benefits managers.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A bill on pharmacy benefit managers; its definition of a rebate leaves out any discount or payment made to a 340B entity through 340B.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… in any way with claims administered on behalf of a health plan client. \"Rebate\" does not include any discount or payment that may be provided to or made to any 340B entity through such program. Sec. 11. K.S.A. 2025 Supp. 40-3823 is hereby amended to read as follows: 40-3823. (a) No person shall act or operate as a pharmacy benefits …",
   "introduced_date": "2026-01-22",
   "sponsor": "Committee on Financial Institutions and Insurance",
   "cosponsors": 0,
   "committees": "",
   "stage": "Passed the Senate",
   "stage_date": "2026-02-18",
   "failed_vote": "2026-04-10 Died in House Committee",
   "latest_action_date": "2026-04-10",
   "latest_action": "Died in House Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.kslegislature.gov/b2025_26/bills/SB360/",
   "text_version": "{As Amended by Senate Committee of the Whole}",
   "text_date": "",
   "text_url": "https://www.kslegislature.gov/b2025_26/documents/view-leg/?apn=b2025_26/year2/ready_for_publication/sb_360/sb360_02_0000.pdf",
   "status_updated": "2026-05-12",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ks-20252026-sb68",
   "jurisdiction": "KS",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-04-10",
   "bill": "SB 68",
   "title": "Making and concerning certain supplemental appropriations for fiscal year 2025 and appropriations for fiscal years 2026 and 2027 for various state agencies.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In the state budget, would direct prescription support money for primary care clinics to buying 340B drug inventory for community health centers and to lowering drug costs for patients at 340B clinics on a sliding fee scale.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… That prescription support expenditures shall be made from the aid to local units – primary health projects account for: (1) Purchasing drug inventory under section 340B of the federal public health service act for community health center grantees and federally qualified health center look-alikes who qualify; (2) increasing access to …",
   "introduced_date": "2025-01-23",
   "sponsor": "Committee on Ways and Means",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-23",
   "failed_vote": "2026-04-10 Died in Committee",
   "latest_action_date": "2026-04-10",
   "latest_action": "Died in Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.kslegislature.gov/b2025_26/bills/SB68/",
   "text_version": "As Introduced",
   "text_date": "",
   "text_url": "https://www.kslegislature.gov/b2025_26/documents/view-leg/?apn=b2025_26/year2/ready_for_publication/sb_68/sb68_00_0000.pdf",
   "status_updated": "2026-07-08",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ky-2025rs-hb685",
   "jurisdiction": "KY",
   "session": "2025 Regular Session",
   "session_end": "2025-04-15",
   "bill": "HB 685",
   "title": "AN ACT relating to the 340B Drug Pricing Program.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting",
    "study"
   ],
   "summary": "Would require nonprofit hospitals in 340B to report each year on their 340B drug costs, payments, contract pharmacies and how they spend 340B profits, with reports posted online. Would also order a study of 340B's effect on the state employee health plan and a report on Medicaid.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 31,
   "quote": "UNOFFICIAL COPY 25 RS BR 1525 AN ACT relating to the 340B Drug Pricing Program. Be it enacted by the General Assembly of the Commonwealth of Kentucky: SECTION 1. A NEW SECTION OF KRS CHAPTER 216 IS CREATED TO READ AS FOLLOWS: …",
   "introduced_date": "2025-02-18",
   "sponsor": "",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-18",
   "failed_vote": "",
   "latest_action_date": "2025-02-26",
   "latest_action": "to Health Services (H)",
   "law": "",
   "same_as": "",
   "bill_url": "https://apps.legislature.ky.gov/record/25RS/hb685.html",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://apps.legislature.ky.gov/recorddocuments/bill/25RS/hb685/orig_bill.pdf",
   "status_updated": "2025-07-23",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ky-2025rs-sb14",
   "jurisdiction": "KY",
   "session": "2025 Regular Session",
   "session_end": "2025-04-15",
   "bill": "SB 14",
   "title": "AN ACT relating to pharmaceutical manufacturers.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers from refusing or withholding 340B pricing from a covered entity, or its owned or contract pharmacy, when they offer the same drug at the 340B price in another state, and from adding conditions, limits or delays not required by law.",
   "names_program_in": [
    "summary",
    "text"
   ],
   "text_mentions": 10,
   "quote": "… by the General Assembly of the Commonwealth of Kentucky: SECTION 1. A NEW SECTION OF KRS CHAPTER 315 IS CREATED TO READ AS FOLLOWS: (1) As used in this section: (a) \"340B covered entity\": 1. Means a health care facility that is registered as a covered entity under 42 U.S.C. sec. 256b, as amended; and 2. Includes any pharmacy owned or …",
   "introduced_date": "2025-01-07",
   "sponsor": "",
   "cosponsors": 0,
   "committees": "",
   "stage": "Passed the Senate",
   "stage_date": "2025-02-13",
   "failed_vote": "",
   "latest_action_date": "2025-02-14",
   "latest_action": "to Committee on Committees (H)",
   "law": "",
   "same_as": "",
   "bill_url": "https://apps.legislature.ky.gov/record/25RS/sb14.html",
   "text_version": "Current/Final",
   "text_date": "",
   "text_url": "https://apps.legislature.ky.gov/recorddocuments/bill/25RS/sb14/bill.pdf",
   "status_updated": "2025-07-23",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "la-2026-hr368",
   "jurisdiction": "LA",
   "session": "2026 Regular Session",
   "session_end": "2026-06-01",
   "bill": "HR 368",
   "title": "MEDICAID: Requests the La. Department of Health to include certain information in its Monthly Medicaid Forecast Report",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A resolution asking the health department to add detail to its monthly Medicaid forecast report; it lists 340B adjustments among the pharmacy spending items to be shown separately.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… basis with separate disclosure of federal rebates pursuant to the Centers for Medicare and Medicaid Services Outpatient Drug Rebate program, state supplemental rebates, 340B program adjustments, and net pharmacy expenditures, together with rebate yield percentages. (6) A provider-type total payment data crosswalk that, for each major …",
   "introduced_date": "2026-05-28",
   "sponsor": "Tony Bacala",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-05-28",
   "failed_vote": "",
   "latest_action_date": "2026-06-01",
   "latest_action": "Read by title, roll called, yeas 7, nays 89. The resolution was rejected.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.legis.la.gov/Legis/BillInfo.aspx?i=252150",
   "text_version": "HR368 Original",
   "text_date": "",
   "text_url": "https://www.legis.la.gov/Legis/ViewDocument.aspx?d=1478211",
   "status_updated": "2026-07-07",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-h1107",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "H 1107",
   "title": "An Act prohibiting discrimination against 340b drug discount program participants",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination"
   ],
   "summary": "Would bar insurers and other payers from paying a 340B covered entity or its contract pharmacy less, or setting different terms, because it dispenses 340B drugs. Would also bar drug makers and distributors from blocking delivery of 340B drugs to contract pharmacies.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 129,
   "quote": "… Court assembled: The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill: An Act prohibiting discrimination against 340b drug discount program participants. _______________ PETITION OF: NAME: DISTRICT/ADDRESS: DATE ADDED: Daniel Cahill 10th Essex 1/16/2025 Russell E. Holmes 6th Suffolk …",
   "introduced_date": "2025-02-27",
   "sponsor": "Daniel Cahill",
   "cosponsors": 20,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-27",
   "failed_vote": "",
   "latest_action_date": "2025-09-18",
   "latest_action": "Accompanied a new draft, see H4490",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/H1107",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/H1107.pdf",
   "status_updated": "2026-07-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-h1274",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "H 1274",
   "title": "An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program",
   "official_title": "",
   "role": "main",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "Would bar pharmacy benefit managers and other payers from paying a 340B covered entity or its contract pharmacy less than others for the same drug, charging it added fees, shutting it out of networks, or steering patients away from it.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 17,
   "quote": "… respectfully petition for the adoption of the accompanying bill: An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program. _______________ PETITION OF: NAME: DISTRICT/ADDRESS: DATE ADDED: Brian W. Murray 10th Worcester 1/14/2025 James B. Eldridge Middlesex and …",
   "introduced_date": "2025-02-27",
   "sponsor": "Brian W. Murray",
   "cosponsors": 3,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-27",
   "failed_vote": "",
   "latest_action_date": "2025-09-18",
   "latest_action": "Accompanied a new draft, see H4494",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/H1274",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/H1274.pdf",
   "status_updated": "2026-07-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-h1296",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "H 1296",
   "title": "An Act to protect 340B providers",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination"
   ],
   "summary": "Would bar insurers, pharmacy benefit managers and other payers from paying less for 340B drugs or setting different terms for 340B entities. Would also bar drug makers and distributors from blocking delivery of 340B drugs to contract pharmacies or demanding data as a condition.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 345,
   "quote": "… Massachusetts in General Court assembled: The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill: An Act to protect 340B providers. _______________ PETITION OF: NAME: DISTRICT/ADDRESS: DATE ADDED: Sean Reid 11th Essex 1/17/2025 Adam J. Scanlon 14th Bristol 7/29/2025 of 1 HOUSE DOCKET, NO. …",
   "introduced_date": "2025-02-27",
   "sponsor": "Sean Reid",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-27",
   "failed_vote": "",
   "latest_action_date": "2025-09-18",
   "latest_action": "Accompanied a new draft, see H4495",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/H1296",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/H1296.pdf",
   "status_updated": "2026-07-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-h1374",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "H 1374",
   "title": "An Act establishing a state-wide drug repository program",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A bill to set up a statewide program for donated medicine; it names 340B only where it lets a recipient replenish medicine already given to eligible patients, in line with the federal 340B law.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… 9 of this act; and (3) replenish medicine of the same drug name and strength previously dispensed or administered to eligible patients in accordance with federal 340b statute. (d) A drug manufacturer, repackager, dispenser, or wholesaler other than a returns processor participating in this program shall comply with the requirements …",
   "introduced_date": "2025-02-27",
   "sponsor": "Bradley H. Jones, Jr.",
   "cosponsors": 4,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-27",
   "failed_vote": "",
   "latest_action_date": "2026-03-16",
   "latest_action": "Accompanied a study order, see H5234",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/H1374",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/H1374.pdf",
   "status_updated": "2026-07-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-h4490",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "H 4490",
   "title": "An Act prohibiting discrimination against 340b drug discount program participants",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination"
   ],
   "summary": "Would bar insurers and other payers from paying a 340B covered entity or its contract pharmacy less, or setting different terms, because it dispenses 340B drugs. Would also bar drug makers and distributors from blocking delivery of 340B drugs to contract pharmacies.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 128,
   "quote": "… Commonwealth of Massachusetts _______________ In the One Hundred and Ninety-Fourth General Court (2025-2026) _______________ An Act prohibiting discrimination against 340b drug discount program participants. Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows: …",
   "introduced_date": "2025-09-18",
   "sponsor": "Joint Committee on Financial Services",
   "cosponsors": 21,
   "committees": "",
   "stage": "Reported by committee",
   "stage_date": "2025-09-18",
   "failed_vote": "",
   "latest_action_date": "2026-06-17",
   "latest_action": "Reporting date extended to Friday, July 31, 2026",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/H4490",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/H4490.pdf",
   "status_updated": "2026-07-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-h4494",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "H 4494",
   "title": "An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program",
   "official_title": "",
   "role": "main",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "Would bar pharmacy benefit managers and other payers from paying a 340B covered entity or its contract pharmacy less than others for the same drug, charging it added fees, shutting it out of networks, or steering patients away from it.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 15,
   "quote": "… the petition (accompanied by bill, House, No. 1274) of Brian W. Murray, James B. Eldridge and Michael O. Moore for legislation to prohibit discrimination against 340B drug discount program participants, reports recommending that the accompanying bill (House, No. 4494) ought to pass. For the committee, JAMES M. MURPHY. FILED ON: …",
   "introduced_date": "2025-09-18",
   "sponsor": "Joint Committee on Financial Services",
   "cosponsors": 4,
   "committees": "",
   "stage": "Reported by committee",
   "stage_date": "2025-09-18",
   "failed_vote": "",
   "latest_action_date": "2026-06-17",
   "latest_action": "Reporting date extended to Friday, July 31, 2026",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/H4494",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/H4494.pdf",
   "status_updated": "2026-07-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-h4495",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "H 4495",
   "title": "An Act to protect 340B providers",
   "official_title": "",
   "role": "main",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "Would bar pharmacy benefit managers and other payers from paying a 340B covered entity or its contract pharmacy less than others for the same drug, charging it added fees, shutting it out of networks, or steering patients away from it.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 15,
   "quote": "… September 18, 2025. The committee on Financial Services, to whom was referred the petition (accompanied by bill, House, No. 1296) of Sean Reid relative to 340B pharmacies, reports recommending that the accompanying bill (House, No. 4495) ought to pass. For the committee, JAMES M. MURPHY. FILED ON: 9/8/2025 HOUSE . . . . . . . …",
   "introduced_date": "2025-09-18",
   "sponsor": "Joint Committee on Financial Services",
   "cosponsors": 2,
   "committees": "",
   "stage": "Reported by committee",
   "stage_date": "2025-09-18",
   "failed_vote": "",
   "latest_action_date": "2026-06-17",
   "latest_action": "Reporting date extended to Friday, July 31, 2026",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/H4495",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/H4495.pdf",
   "status_updated": "2026-07-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-h5700",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "H 5700",
   "title": "An Act making appropriations for the fiscal year 2026 to provide for supplementing certain existing appropriations and for certain other activities and projects",
   "official_title": "",
   "role": "part",
   "kinds": [
    "medicaid"
   ],
   "summary": "In a wider supplemental budget bill, would keep the state Medicaid program from broadly excluding or limiting payment for 340B drugs dispensed to managed care members until federal approval of a 340B hospital stabilization payment program takes effect and an impact report is filed.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 5,
   "quote": "… care entity, implement or enforce, a general 1481 exclusion from coverage of, or a general limitation on reimbursement for, drugs acquired 1482 through the federal 340B Drug Pricing Program under 42 U.S.C. §256b and dispensed through a 1483 pharmacy to MassHealth members enrolled in a managed care entity, including any exclusion or …",
   "introduced_date": "2026-10-21",
   "sponsor": "",
   "cosponsors": 0,
   "committees": "",
   "stage": "Passed the House",
   "stage_date": "2026-10-21",
   "failed_vote": "",
   "latest_action_date": "2026-10-29",
   "latest_action": "Placed in the Orders of the Day for Thursday, November 5, 2026",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/H5700",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/H5700.pdf",
   "status_updated": "2026-10-30",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-h779",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "H 779",
   "title": "An Act to protect 340B providers in the MassHealth program",
   "official_title": "",
   "role": "main",
   "kinds": [
    "medicaid"
   ],
   "summary": "Would bar the state Medicaid program from limiting hospitals' access to 340B drugs without 180 days' notice and a report to lawmakers, and from limiting payment for 340B drugs given to its members, except for up to 25 very costly drugs and seven GLP-1 drugs it designates.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 7,
   "quote": "… Massachusetts in General Court assembled: The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill: An Act to protect 340B providers in the MassHealth program. _______________ PETITION OF: NAME: DISTRICT/ADDRESS: DATE ADDED: Kate Lipper-Garabedian 32nd Middlesex 1/16/2025 Vanna Howard 17th …",
   "introduced_date": "2025-02-27",
   "sponsor": "Kate Lipper-Garabedian",
   "cosponsors": 3,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-27",
   "failed_vote": "",
   "latest_action_date": "2026-06-17",
   "latest_action": "Reporting date extended to Friday, July 31, 2026",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/H779",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/H779.pdf",
   "status_updated": "2026-07-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-h785",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "H 785",
   "title": "An Act protecting 340B contract pharmacies",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers and distributors from blocking the purchase of 340B drugs by, or their delivery to, any location a covered entity authorizes, and from demanding claims or usage data as a condition, unless federal law says otherwise.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 20,
   "quote": "… Massachusetts in General Court assembled: The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill: An Act protecting 340B contract pharmacies. _______________ PETITION OF: NAME: DISTRICT/ADDRESS: DATE ADDED: Brian W. Murray 10th Worcester 1/16/2025 Bud L. Williams 11th Hampden 4/18/2025 of …",
   "introduced_date": "2025-02-27",
   "sponsor": "Brian W. Murray",
   "cosponsors": 1,
   "committees": "",
   "stage": "Reported by committee",
   "stage_date": "2025-09-18",
   "failed_vote": "",
   "latest_action_date": "2026-06-17",
   "latest_action": "Reporting date extended to Friday, July 31, 2026",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/H785",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/H785.pdf",
   "status_updated": "2026-07-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-hd1139",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "HD 1139",
   "title": "An Act 340B Contract Pharmacy Protection Act",
   "official_title": "",
   "role": "",
   "kinds": [],
   "summary": "",
   "names_program_in": [
    "title"
   ],
   "text_mentions": null,
   "quote": "An Act 340B Contract Pharmacy Protection Act",
   "introduced_date": "",
   "sponsor": "Brian W. Murray",
   "cosponsors": 0,
   "committees": "",
   "stage": "",
   "stage_date": "",
   "failed_vote": "",
   "latest_action_date": "",
   "latest_action": "",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/HD1139",
   "text_version": "",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/HD1139.pdf",
   "status_updated": "2025-01-14",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-s3103",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "S 3103",
   "title": "Amendment S.3103",
   "official_title": "",
   "role": "part",
   "kinds": [
    "reporting"
   ],
   "summary": "In a wider proposed amendment on how nonprofit hospitals set drug charges, would make a hospital under review disclose whether a drug was bought through 340B and whether 340B drugs are priced differently, and have a state commission report on any such difference.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 26,
   "quote": "… and any internal target margin or pricing rationale used in connection with the drug; (iv) whether the drug was acquired, dispensed, replenished or accounted for as a 340B- acquired drug; (v) whether the hospital used a different chargemaster price, markup formula, markup multiple, markup range or other pricing methodology for a …",
   "introduced_date": "2026-05-20",
   "sponsor": "Michael F. Rush",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-05-20",
   "failed_vote": "",
   "latest_action_date": "2026-05-20",
   "latest_action": "See S4",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/S3103",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/S3103.pdf",
   "status_updated": "2026-07-24",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-s3140",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "S 3140",
   "title": "Amendment S.3140",
   "official_title": "",
   "role": "part",
   "kinds": [
    "reporting"
   ],
   "summary": "In a wider proposed amendment on how nonprofit hospitals set drug charges, would make a hospital under review disclose whether a drug was bought through 340B and whether 340B drugs are priced differently, and have a state commission report on any such difference.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 26,
   "quote": "… and any internal target margin or pricing rationale used in connection with the drug; (iv) whether the drug was acquired, dispensed, replenished or accounted for as a 340B- acquired drug; (v) whether the hospital used a different chargemaster price, markup formula, markup multiple, markup range or other pricing methodology for a …",
   "introduced_date": "",
   "sponsor": "Michael F. Rush",
   "cosponsors": 0,
   "committees": "",
   "stage": "",
   "stage_date": "",
   "failed_vote": "",
   "latest_action_date": "",
   "latest_action": "",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/S3140",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/S3140.pdf",
   "status_updated": "2026-06-22",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-s779",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "S 779",
   "title": "An Act to protect 340B providers",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination"
   ],
   "summary": "Would bar insurers, pharmacy benefit managers and other payers from paying less for 340B drugs or setting different terms for 340B entities. Would also bar drug makers and distributors from blocking delivery of 340B drugs to contract pharmacies or demanding data as a condition.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 345,
   "quote": "… Massachusetts in General Court assembled: The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill: An Act to protect 340B providers. _______________ PETITION OF: NAME: DISTRICT/ADDRESS: Jason M. Lewis Fifth Middlesex of 1 SENATE DOCKET, NO. 1970 FILED ON: 1/17/2025 SENATE . . . . . . . . . …",
   "introduced_date": "2025-02-27",
   "sponsor": "Jason M. Lewis",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-27",
   "failed_vote": "",
   "latest_action_date": "2025-12-04",
   "latest_action": "Accompanied a study order, see S2787",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/S779",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/S779.pdf",
   "status_updated": "2026-07-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-s819",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "S 819",
   "title": "An Act prohibiting discrimination against 340b drug discount program participants",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination"
   ],
   "summary": "Would bar insurers and other payers from paying a 340B covered entity or its contract pharmacy less, or setting different terms, because it dispenses 340B drugs. Would also bar drug makers and distributors from blocking delivery of 340B drugs to contract pharmacies.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 130,
   "quote": "… Court assembled: The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill: An Act prohibiting discrimination against 340b drug discount program participants. _______________ PETITION OF: NAME: DISTRICT/ADDRESS: Pavel M. Payano First Essex Joanne M. Comerford Hampshire, Franklin and …",
   "introduced_date": "2025-02-27",
   "sponsor": "Pavel M. Payano",
   "cosponsors": 12,
   "committees": "",
   "stage": "Reported by committee",
   "stage_date": "2025-12-04",
   "failed_vote": "",
   "latest_action_date": "2026-05-18",
   "latest_action": "Committee recommended ought to pass and referred to the committee on Senate Ways and Means",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/S819",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/S819.pdf",
   "status_updated": "2026-07-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-s845",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "S 845",
   "title": "An Act to protect 340B providers in the Medicaid program",
   "official_title": "",
   "role": "main",
   "kinds": [
    "medicaid"
   ],
   "summary": "Would bar the state Medicaid program from limiting hospitals' access to 340B drugs without 180 days' notice and a report to lawmakers, and from limiting payment for 340B drugs given to its members, except for up to 25 very costly drugs and seven GLP-1 drugs it designates.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 7,
   "quote": "… Massachusetts in General Court assembled: The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill: An Act to protect 340B providers in the Medicaid program. _______________ PETITION OF: NAME: DISTRICT/ADDRESS: Brendan P. Crighton Third Essex of 1 SENATE DOCKET, NO. 1715 FILED ON: 1/16/2025 …",
   "introduced_date": "2025-02-27",
   "sponsor": "Brendan P. Crighton",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-27",
   "failed_vote": "",
   "latest_action_date": "2026-01-29",
   "latest_action": "Accompanied a study order, see S2931",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/S845",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/S845.pdf",
   "status_updated": "2026-07-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-s848",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "S 848",
   "title": "An Act relating to covered entity reporting to increase accountability to safeguard benefit for vulnerable patients",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting"
   ],
   "summary": "Would require each covered entity to report yearly to a state health data center on its 340B drug costs and payments by payer type, its spending on patient discounts and charity care, and its payments to contract pharmacies. The center would post the reports publicly.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 8,
   "quote": "… 12C of the General laws is hereby amended by inserting after section 9, the following new section:- Section 9A. (a) DEFINITIONS. For the purposes of this section: (1) “340B program,” means the federal drug pricing program described in 42 U.S.C. 256b. (2) “Center for Health Information and Analysis,” the center established by the provisions …",
   "introduced_date": "2025-02-27",
   "sponsor": "John J. Cronin",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-27",
   "failed_vote": "",
   "latest_action_date": "2026-01-29",
   "latest_action": "Accompanied a study order, see S2931",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/S848",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/S848.pdf",
   "status_updated": "2026-07-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ma-194th-s868",
   "jurisdiction": "MA",
   "session": "194th Legislature (2025-2026)",
   "session_end": "2026-07-31",
   "bill": "S 868",
   "title": "An Act enhancing health care market oversight and pharmaceutical access",
   "official_title": "",
   "role": "part",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "In a wider bill on health care market oversight and drug access, would bar drug makers and distributors from blocking delivery of 340B drugs to pharmacies under contract with health centers and certain safety net hospitals, or demanding claims data as a condition.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 24,
   "quote": "… 1686 Section 47DDD. (a) As used in this section, the following words shall have the following 1687 meanings unless the context clearly requires otherwise: 1688 “340B drug”, a drug that has been subject to any offer for reduced prices by a 1689 manufacturer pursuant to 42 U.S.C. 256b and is purchased by a 340B grantee as defined in …",
   "introduced_date": "2025-02-27",
   "sponsor": "Cindy F. Friedman",
   "cosponsors": 4,
   "committees": "",
   "stage": "Reported by committee",
   "stage_date": "2025-06-16",
   "failed_vote": "",
   "latest_action_date": "2025-06-16",
   "latest_action": "Bill reported favorably by committee and referred to the committee on Senate Ways and Means",
   "law": "",
   "same_as": "",
   "bill_url": "https://malegislature.gov/Bills/194/S868",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://malegislature.gov/Bills/194/S868.pdf",
   "status_updated": "2026-07-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "me-132-ld180",
   "jurisdiction": "ME",
   "session": "132nd Legislature (2025-2026)",
   "session_end": "2026-04-29",
   "bill": "LD 180",
   "title": "An Act Regarding The Interactions Of Pharmacy Benefits Managers And So-Called 340B Entities And Reimbursements By Pharmacy Benefits Managers To Pharmacies",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "The law as passed bars insurers and pharmacy benefit managers from paying a pharmacy less than they pay their own affiliated pharmacies, and does not name 340B. The bill as introduced would have barred them from discriminating against 340B entities and their contract pharmacies.",
   "names_program_in": [
    "title",
    "earlier text"
   ],
   "text_mentions": 14,
   "quote": "… Legislative Document No. 180 H.P. 113 House of Representatives, January 14, 2025 An Act Regarding the Interactions of Pharmacy Benefits Managers and So-called 340B Entities and Reimbursements by Pharmacy Benefits Managers to Pharmacies Reference to the Committee on Health Coverage, Insurance and Financial Services suggested and …",
   "introduced_date": "2025-01-14",
   "sponsor": "Kristi MATHIESON",
   "cosponsors": 1,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-06-17",
   "failed_vote": "",
   "latest_action_date": "2025-06-17",
   "latest_action": "Signed by Governor",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislature.maine.gov/LawMakerWeb/summary.asp?ID=280095795",
   "text_version": "LD 180 HP 113",
   "text_date": "",
   "text_url": "http://www.mainelegislature.org/legis/bills/getPDF.asp?paper=HP0113&item=1&snum=132",
   "status_updated": "2026-10-17",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mi-20252026-hb4544",
   "jurisdiction": "MI",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-12-31",
   "bill": "HB 4544",
   "title": "Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "study"
   ],
   "summary": "In a wider bill creating a prescription drug affordability board, would have the board weigh the effect on 340B entities when it sets an upper payment limit for a drug, and include that effect in a one-time study for lawmakers.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 6,
   "quote": "… a person administering a self-funded plan, or a pharmacy benefit manager. (r) \"Wholesale acquisition cost\" means that term as defined in 42 USC 1395w-3a(c)(6)(B). (s) \"340B Program entity\" means an entity authorized to participate in the federal 340B Program under section 340B of the public health service act, 42 USC 256b. Sec. 5. (1) The …",
   "introduced_date": "2025-06-03",
   "sponsor": "Matt Longjohn",
   "cosponsors": 35,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-06-03",
   "failed_vote": "",
   "latest_action_date": "2025-06-04",
   "latest_action": "bill electronically reproduced 06/03/2025",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislature.mi.gov/Bills/Bill?ObjectName=2025-HB-4544",
   "text_version": "House Introduced Bill",
   "text_date": "",
   "text_url": "https://legislature.mi.gov/documents/2025-2026/billintroduced/House/htm/2025-HIB-4544.htm",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mi-20252026-hb4878",
   "jurisdiction": "MI",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-12-31",
   "bill": "HB 4878",
   "title": "Health: pharmaceuticals; reporting certain information and regulating certain conduct related to drugs and the federal 340B program; provide for. Creates new act.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "reporting",
    "use-of-savings"
   ],
   "summary": "Would bar drug makers and wholesalers from limiting access to 340B drugs for a covered entity or its contract pharmacy, require hospitals to report their 340B costs and payments each year, and require hospitals to put 340B savings into patient services or community benefit programs.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 33,
   "quote": "HOUSE BILL NO. 4878 A bill to require the reporting of certain information and to prescribe conduct related to drugs and the federal 340B program; to prescribe civil sanctions; to allow for the promulgation of rules; and to provide for the powers and duties of certain state officers and entities. the …",
   "introduced_date": "2025-09-11",
   "sponsor": "Curtis VanderWall",
   "cosponsors": 0,
   "committees": "",
   "stage": "Reported by committee",
   "stage_date": "2026-01-28",
   "failed_vote": "",
   "latest_action_date": "2026-01-28",
   "latest_action": "recommendation concurred in",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislature.mi.gov/Bills/Bill?ObjectName=2025-HB-4878",
   "text_version": "House Introduced Bill",
   "text_date": "",
   "text_url": "https://legislature.mi.gov/documents/2025-2026/billintroduced/House/htm/2025-HIB-4878.htm",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mi-20252026-sb317",
   "jurisdiction": "MI",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-12-31",
   "bill": "SB 317",
   "title": "Health: pharmaceuticals; program for the wholesale importation of pharmaceuticals from Canada; provide for. Creates new act.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In a wider bill on importing prescription drugs from Canada, would have the state seek federal approval so that 340B covered entities can take part in the import program without putting their 340B eligibility at risk.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 4,
   "quote": "… department shall also seek the appropriate federal approval, waiver, exemption, or agreement necessary to allow a covered entity enrolled in or eligible for the federal 340B program to participate in this state's program to the fullest extent possible without jeopardizing eligibility for the federal 340B program. As used in this subsection, …",
   "introduced_date": "2025-05-20",
   "sponsor": "Ruth A. Johnson",
   "cosponsors": 6,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-05-20",
   "failed_vote": "",
   "latest_action_date": "2025-05-20",
   "latest_action": "REFERRED TO COMMITTEE ON HEALTH POLICY",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislature.mi.gov/Bills/Bill?ObjectName=2025-SB-0317",
   "text_version": "Senate Introduced Bill",
   "text_date": "",
   "text_url": "https://legislature.mi.gov/documents/2025-2026/billintroduced/Senate/htm/2025-SIB-0317.htm",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mi-20252026-sb94",
   "jurisdiction": "MI",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-12-31",
   "bill": "SB 94",
   "title": "Health: pharmaceuticals; drug manufacturers from engaging in certain conduct with pharmacies participating with a 340B program; prohibit. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17757c.   TIE BAR WITH: SB 0095'25",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "reporting"
   ],
   "summary": "Would bar drug makers and wholesalers from limiting a 340B entity's purchase of 340B drugs or their delivery to its contract pharmacies. Would require each 340B entity to file a yearly report on its 340B program, which a state department would post online.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 29,
   "quote": "… wholesale distributor-broker shall not do any of the following: (a) Deny, restrict, prohibit, condition, discriminate against, or otherwise limit the acquisition of a 340B drug by a 340B entity. (b) Deny, restrict, prohibit, condition, discriminate against, or otherwise limit the acquisition of a 340B drug by, or the delivery of a 340B …",
   "introduced_date": "2025-02-20",
   "sponsor": "Sam Singh",
   "cosponsors": 9,
   "committees": "",
   "stage": "Passed the Senate",
   "stage_date": "2025-03-06",
   "failed_vote": "",
   "latest_action_date": "2025-03-06",
   "latest_action": "referred to Committee on Health Policy",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislature.mi.gov/Bills/Bill?ObjectName=2025-SB-0094",
   "text_version": "As Passed by the Senate",
   "text_date": "",
   "text_url": "https://legislature.mi.gov/documents/2025-2026/billengrossed/Senate/htm/2025-SEBS-0094.htm",
   "status_updated": "2026-06-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mn-20252026-hf2703",
   "jurisdiction": "MN",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-20",
   "bill": "HF 2703",
   "title": "Prohibition extended on manufacturers interfering with access to 340B drugs.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would repeal the July 1, 2027 expiration of the state law on access to 340B drugs, which the bill describes as a ban on drug makers interfering with that access, so the law would stay in force.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 2,
   "quote": "… # Line numbers 1.1 1.2 1.3 1.4 1.5 1.6 1.7 A bill for an act relating to drug manufacturers; extending a prohibition on manufacturers interfering with access to 340B drugs; repealing Minnesota Statutes 2024, section 62J.96, subdivision 3. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA: Section 1. new text begin REPEALER. …",
   "introduced_date": "2025-03-24",
   "sponsor": "Johnson, P.",
   "cosponsors": 3,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-03-24",
   "failed_vote": "",
   "latest_action_date": "2026-04-13",
   "latest_action": "Author stricken Stephenson",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.revisor.mn.gov/bills/94/2025/0/HF/2703?body=House",
   "text_version": "Introduction",
   "text_date": "2025-03-24",
   "text_url": "https://www.revisor.mn.gov/bills/94/2025/0/HF/2703/versions/0/",
   "status_updated": "2026-09-21",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mn-20252026-hf3609",
   "jurisdiction": "MN",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-20",
   "bill": "HF 3609",
   "title": "Disallowance of drug manufacturers from restricting delivery of 340B prescription drugs continued, enforcement provided, and expiration date removed.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would keep the state law that stops drug makers from restricting delivery of 340B drugs by repealing its July 1, 2027 expiration, and would make a violation an unfair or deceptive trade practice that the attorney general can enforce.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 2,
   "quote": "… 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 A bill for an act relating to health care; continuing to disallow drug manufacturers from restricting delivery of 340B prescription drugs; providing for enforcement; removing an expiration date; amending Minnesota Statutes 2024, section 62J.96, by adding a subdivision; repealing …",
   "introduced_date": "2026-02-23",
   "sponsor": "Zeleznikar",
   "cosponsors": 17,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-02-23",
   "failed_vote": "",
   "latest_action_date": "2026-04-28",
   "latest_action": "Author added Repinski",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.revisor.mn.gov/bills/94/2026/0/HF/3609?body=House",
   "text_version": "Introduction",
   "text_date": "2026-02-20",
   "text_url": "https://www.revisor.mn.gov/bills/94/2026/0/HF/3609/versions/0/",
   "status_updated": "2026-09-21",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mn-20252026-hf3756",
   "jurisdiction": "MN",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-20",
   "bill": "HF 3756",
   "title": "Definition for covered insulin provided for the insulin safety net program and manufacturer registration fee.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "An insulin safety net bill; it names 340B only in a list of help that navigators give, which includes finding providers who take part in drug discount programs such as 340B.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… periods; (3) accessing information on providers who participate in prescription drug discount programs, including providers who are authorized to participate in the 340B program under section 340b of the federal Public Health Services Act, United States Code, title 42, section 256b; and (4) accessing new text begin covered new text end …",
   "introduced_date": "2026-02-26",
   "sponsor": "Backer",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-02-26",
   "failed_vote": "",
   "latest_action_date": "2026-02-26",
   "latest_action": "Introduction and first reading, referred to Health Finance and Policy",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.revisor.mn.gov/bills/94/2026/0/HF/3756?body=House",
   "text_version": "Introduction",
   "text_date": "2026-02-25",
   "text_url": "https://www.revisor.mn.gov/bills/94/2026/0/HF/3756/versions/0/",
   "status_updated": "2026-09-21",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mn-20252026-hf3922",
   "jurisdiction": "MN",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-20",
   "bill": "HF 3922",
   "title": "Fair pricing in community pharmacy reimbursement required.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A community pharmacy payment bill; its minimum payment rule would not apply to 340B covered entities, and payment for 340B drugs would stay as set by federal and state law.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… expenses. new text end new text begin Nothing in this section shall require reimbursement at or above NADAC or WAC for covered entities participating in the federal 340B program, as defined in United States Code, title 42, section 256b. Reimbursement for 340B-purchased drugs shall be determined in accordance with federal and state law. …",
   "introduced_date": "2026-03-02",
   "sponsor": "Nadeau",
   "cosponsors": 4,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-03-02",
   "failed_vote": "",
   "latest_action_date": "2026-04-13",
   "latest_action": "Author added Harder",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.revisor.mn.gov/bills/94/2026/0/HF/3922?body=House",
   "text_version": "Introduction",
   "text_date": "2026-03-02",
   "text_url": "https://www.revisor.mn.gov/bills/94/2026/0/HF/3922/versions/0/",
   "status_updated": "2026-09-21",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mn-20252026-hf3931",
   "jurisdiction": "MN",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-20",
   "bill": "HF 3931",
   "title": "Use of spread pricing by pharmacy benefit managers prohibited, license application fees increased, permissible sources of income limited, fiduciary duties imposed, and money appropriated.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A wider bill on pharmacy benefit managers; it keeps, under a new subdivision heading, the existing rule that they may not shut 340B entities or their contract pharmacies out of networks or pay them differently from similar pharmacies.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 6,
   "quote": "… the same limits imposed in which the pharmacy benefit manager or health carrier does not have an ownership interest. new text begin Subd. 4. new text end new text begin 340B entity limits on provider network participation prohibited. new text end deleted text begin (f) deleted text end A pharmacy benefit manager or health carrier must not …",
   "introduced_date": "2026-03-05",
   "sponsor": "Elkins",
   "cosponsors": 3,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-03-05",
   "failed_vote": "",
   "latest_action_date": "2026-03-05",
   "latest_action": "Introduction and first reading, referred to Health Finance and Policy",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.revisor.mn.gov/bills/94/2026/0/HF/3931?body=House",
   "text_version": "Introduction",
   "text_date": "2026-03-03",
   "text_url": "https://www.revisor.mn.gov/bills/94/2026/0/HF/3931/versions/0/",
   "status_updated": "2026-09-21",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mn-20252026-hf4140",
   "jurisdiction": "MN",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-20",
   "bill": "HF 4140",
   "title": "Minnesota Community Pharmacy Patient Access and Fair Reimbursement Act established, and rulemaking required.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A community pharmacy payment bill; its payment standard would not apply to drugs bought under 340B, and payment for those drugs would follow existing state and federal law.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… entities; exclusions. new text end new text begin (a) Nothing in this section requires reimbursement at or above NADAC or WAC for drugs purchased under the federal 340B Drug Pricing Program. Reimbursement for drugs purchased under the 340B program must comply with applicable state and federal law. new text end new text begin (b) This …",
   "introduced_date": "2026-03-09",
   "sponsor": "Reyer",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-03-09",
   "failed_vote": "",
   "latest_action_date": "2026-03-09",
   "latest_action": "Introduction and first reading, referred to Health Finance and Policy",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.revisor.mn.gov/bills/94/2026/0/HF/4140?body=House",
   "text_version": "Introduction",
   "text_date": "2026-03-09",
   "text_url": "https://www.revisor.mn.gov/bills/94/2026/0/HF/4140/versions/0/",
   "status_updated": "2026-09-21",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mn-20252026-hf4442",
   "jurisdiction": "MN",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-20",
   "bill": "HF 4442",
   "title": "State rapid start program established; operation of local rapid start programs to treat patients who are HIV-positive provided; prior authorization, cost sharing, and step therapy for antiretroviral therapy and HIV prevention services prohibited; and money appropriated.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "An HIV rapid start treatment bill; it names 340B only in a definition, noting that a federally funded sexually transmitted infection program may also be a 340B covered entity and buy drugs at reduced prices.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… Health Service Act for sexually transmitted infection and sexually transmitted disease prevention programs. A 318 grantee may also be a covered entity under the federal 340B Drug Pricing Program and may purchase prescription drugs at reduced prices. new text end new text begin (d) \"AIDS Drug Assistance Program\" or \"ADAP\" means the state …",
   "introduced_date": "2026-03-18",
   "sponsor": "Pérez-Vega",
   "cosponsors": 4,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-03-18",
   "failed_vote": "",
   "latest_action_date": "2026-04-16",
   "latest_action": "Author added Xiong",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.revisor.mn.gov/bills/94/2026/0/HF/4442?body=House",
   "text_version": "Introduction",
   "text_date": "2026-03-17",
   "text_url": "https://www.revisor.mn.gov/bills/94/2026/0/HF/4442/versions/0/",
   "status_updated": "2026-10-22",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mn-20252026-hf4466",
   "jurisdiction": "MN",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-20",
   "bill": "HF 4466",
   "title": "Health and human services finance and policy bill.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A health and human services finance and policy bill; it names 340B only in insulin safety net text, in a list of help that navigators give, which includes finding providers who take part in drug discount programs such as 340B.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… periods; (3) accessing information on providers who participate in prescription drug discount programs, including providers who are authorized to participate in the 340B program under section 340b of the federal Public Health Services Act, United States Code, title 42, section 256b; and (4) accessing new text begin covered new text end …",
   "introduced_date": "2026-03-18",
   "sponsor": "Bierman",
   "cosponsors": 0,
   "committees": "",
   "stage": "Reported by committee",
   "stage_date": "2026-04-20",
   "failed_vote": "",
   "latest_action_date": "2026-05-05",
   "latest_action": "HF indefinitely postponed",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.revisor.mn.gov/bills/94/2026/0/HF/4466?body=House",
   "text_version": "2nd Engrossment",
   "text_date": "2026-05-04",
   "text_url": "https://www.revisor.mn.gov/bills/94/2026/0/HF/4466/versions/2/",
   "status_updated": "2026-09-21",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mn-20252026-hf4609",
   "jurisdiction": "MN",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-20",
   "bill": "HF 4609",
   "title": "Health plans required to cover infertility treatment and standard fertility preservation services, medical assistance and MinnesotaCare required to cover infertility treatment and standard fertility preservation services, and money appropriated.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "An infertility treatment coverage bill; it reprints, without change, the existing Medicaid rule that covers 340B drugs dispensed by covered entities and pharmacies they own but not by contract pharmacies.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 5,
   "quote": "… that drugs listed in United States Code, title 42, section 1396r-8(d)(2)(E), shall not be covered. (f) Medical assistance covers drugs acquired through the federal 340B Drug Pricing Program and dispensed by 340B covered entities and ambulatory pharmacies under common ownership of the 340B covered entity. Medical assistance does not …",
   "introduced_date": "2026-03-23",
   "sponsor": "Kotyza-Witthuhn",
   "cosponsors": 15,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-03-23",
   "failed_vote": "",
   "latest_action_date": "2026-04-09",
   "latest_action": "Authors added Elkins and Berg",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.revisor.mn.gov/bills/94/2026/0/HF/4609?body=House",
   "text_version": "Introduction",
   "text_date": "2026-03-23",
   "text_url": "https://www.revisor.mn.gov/bills/94/2026/0/HF/4609/versions/0/",
   "status_updated": "2026-09-21",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mn-20252026-sf2959",
   "jurisdiction": "MN",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-20",
   "bill": "SF 2959",
   "title": "Manufacturers interfering with access to 340B drugs prohibition extension",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would repeal the July 1, 2027 expiration of the state law on access to 340B drugs, which the bill describes as a ban on drug makers interfering with that access, so the law would stay in force.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 2,
   "quote": "… # Line numbers 1.1 1.2 1.3 1.4 1.5 1.6 1.7 A bill for an act relating to drug manufacturers; extending a prohibition on manufacturers interfering with access to 340B drugs; repealing Minnesota Statutes 2024, section 62J.96, subdivision 3. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA: Section 1. new text begin REPEALER. …",
   "introduced_date": "2025-03-24",
   "sponsor": "Mann",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-03-24",
   "failed_vote": "",
   "latest_action_date": "2026-02-17",
   "latest_action": "Author stricken Mitchell",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.revisor.mn.gov/bills/94/2025/0/SF/2959?body=Senate",
   "text_version": "Introduction",
   "text_date": "2025-03-21",
   "text_url": "https://www.revisor.mn.gov/bills/94/2025/0/SF/2959/versions/0/",
   "status_updated": "2026-09-25",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mn-20252026-sf3271",
   "jurisdiction": "MN",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-20",
   "bill": "SF 3271",
   "title": "Independent audits of 340B entity reporting by nonprofit public interest organizations authorization; revenue from prescription drugs obtained under the 340B program to be used for charity care; enforcement by the attorney general authorization",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting",
    "use-of-savings"
   ],
   "summary": "Would require covered entities to spend 25 percent of their 340B net revenue on charity care each year, let nonprofit public interest organizations audit their 340B reporting, and let the attorney general enforce the charity care rule.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 25,
   "quote": "… 2.14 2.15 2.16 2.17 2.18 2.19 2.20 2.21 2.22 2.23 2.24 2.25 2.26 2.27 2.28 2.29 2.30 2.31 2.32 A bill for an act relating to health; authorizing independent audits of 340B entity reporting by nonprofit public interest organizations; requiring revenue from prescription drugs obtained under the 340B program to be used for charity care; …",
   "introduced_date": "2025-04-03",
   "sponsor": "Abeler",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-04-03",
   "failed_vote": "",
   "latest_action_date": "2025-04-03",
   "latest_action": "Referred to Health and Human Services",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.revisor.mn.gov/bills/94/2025/0/SF/3271?body=Senate",
   "text_version": "Introduction",
   "text_date": "2025-04-02",
   "text_url": "https://www.revisor.mn.gov/bills/94/2025/0/SF/3271/versions/0/",
   "status_updated": "2026-09-25",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mn-20252026-sf3615",
   "jurisdiction": "MN",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-20",
   "bill": "SF 3615",
   "title": "Health plans requirement to cover infertility treatment and standard fertility preservation services",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "An infertility treatment coverage bill; it reprints, without change, the existing Medicaid rule that covers 340B drugs dispensed by covered entities and pharmacies they own but not by contract pharmacies.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 5,
   "quote": "… that drugs listed in United States Code, title 42, section 1396r-8(d)(2)(E), shall not be covered. (f) Medical assistance covers drugs acquired through the federal 340B Drug Pricing Program and dispensed by 340B covered entities and ambulatory pharmacies under common ownership of the 340B covered entity. Medical assistance does not …",
   "introduced_date": "2026-02-17",
   "sponsor": "Oumou Verbeten",
   "cosponsors": 3,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-02-17",
   "failed_vote": "",
   "latest_action_date": "2026-03-25",
   "latest_action": "Author added Hemmingsen-Jaeger",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.revisor.mn.gov/bills/94/2026/0/SF/3615?body=Senate",
   "text_version": "Introduction",
   "text_date": "2026-02-16",
   "text_url": "https://www.revisor.mn.gov/bills/94/2026/0/SF/3615/versions/0/",
   "status_updated": "2026-09-25",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mn-20252026-sf3769",
   "jurisdiction": "MN",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-20",
   "bill": "SF 3769",
   "title": "340B prescription drugs delivery restrictions prohibition",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would keep the state law that stops drug makers from restricting delivery of 340B drugs by repealing its July 1, 2027 expiration, and would make a violation an unfair or deceptive trade practice that the attorney general can enforce.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 2,
   "quote": "… 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 A bill for an act relating to health care; continuing to disallow drug manufacturers from restricting delivery of 340B prescription drugs; providing for enforcement; removing an expiration date; amending Minnesota Statutes 2024, section 62J.96, by adding a subdivision; repealing …",
   "introduced_date": "2026-02-23",
   "sponsor": "Klein",
   "cosponsors": 22,
   "committees": "",
   "stage": "Passed the Senate",
   "stage_date": "2026-04-07",
   "failed_vote": "",
   "latest_action_date": "2026-04-09",
   "latest_action": "Senate file first reading, referred to Health Finance and Policy",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.revisor.mn.gov/bills/94/2026/0/SF/3769?body=Senate",
   "text_version": "Introduction",
   "text_date": "2026-02-19",
   "text_url": "https://www.revisor.mn.gov/bills/94/2026/0/SF/3769/versions/0/",
   "status_updated": "2026-09-25",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mn-20252026-sf4062",
   "jurisdiction": "MN",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-20",
   "bill": "SF 4062",
   "title": "Prohibit the use of spread pricing by pharmacy benefit managers",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A wider bill on pharmacy benefit managers; it keeps, under a new subdivision heading, the existing rule that they may not shut 340B entities or their contract pharmacies out of networks or pay them differently from similar pharmacies.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 6,
   "quote": "… the same limits imposed in which the pharmacy benefit manager or health carrier does not have an ownership interest. new text begin Subd. 4. new text end new text begin 340B entity limits on provider network participation prohibited. new text end deleted text begin (f) deleted text end A pharmacy benefit manager or health carrier must not …",
   "introduced_date": "2026-03-02",
   "sponsor": "Mann",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-03-02",
   "failed_vote": "",
   "latest_action_date": "2026-03-04",
   "latest_action": "Author added Boldon",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.revisor.mn.gov/bills/94/2026/0/SF/4062?body=Senate",
   "text_version": "Introduction",
   "text_date": "2026-02-27",
   "text_url": "https://www.revisor.mn.gov/bills/94/2026/0/SF/4062/versions/0/",
   "status_updated": "2026-09-25",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mn-20252026-sf4138",
   "jurisdiction": "MN",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-20",
   "bill": "SF 4138",
   "title": "Definition for covered insulin for the insulin safety net program and manufacturer registration fee provision",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "An insulin safety net bill; it names 340B only in a list of help that navigators give, which includes finding providers who take part in drug discount programs such as 340B.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… periods; (3) accessing information on providers who participate in prescription drug discount programs, including providers who are authorized to participate in the 340B program under section 340b of the federal Public Health Services Act, United States Code, title 42, section 256b; and (4) accessing new text begin covered new text end …",
   "introduced_date": "2026-03-04",
   "sponsor": "Utke",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-03-04",
   "failed_vote": "",
   "latest_action_date": "2026-03-04",
   "latest_action": "Referred to Health and Human Services",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.revisor.mn.gov/bills/94/2026/0/SF/4138?body=Senate",
   "text_version": "Introduction",
   "text_date": "2026-03-03",
   "text_url": "https://www.revisor.mn.gov/bills/94/2026/0/SF/4138/versions/0/",
   "status_updated": "2026-09-25",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mn-20252026-sf4365",
   "jurisdiction": "MN",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-20",
   "bill": "SF 4365",
   "title": "Omnibus Commerce and Consumer Protection policy bill",
   "official_title": "",
   "role": "part",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "In a wider commerce and consumer protection bill, would repeal the July 1, 2027 expiration of the state law on access to 340B drugs, so that law would stay in force.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… information submitted to the board under section 62J.90 . Subd. 6. Exemption. Notwithstanding section 15.059 , the advisory council shall not expire. 62J.96 ACCESS TO 340B DRUGS. Subd. 3. Expiration. This section expires July 1, 2027. 237.065 RATE FOR SCHOOL OR PURCHASING COOPERATIVE. Subdivision 1. Basic service; flat rate. Each …",
   "introduced_date": "2026-03-11",
   "sponsor": "Klein",
   "cosponsors": 0,
   "committees": "",
   "stage": "Reported by committee",
   "stage_date": "2026-04-20",
   "failed_vote": "",
   "latest_action_date": "2026-04-28",
   "latest_action": "Rule 45-amend, subst. General Orders HF4188, SF indefinitely postponed",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.revisor.mn.gov/bills/94/2026/0/SF/4365?body=Senate",
   "text_version": "2nd Engrossment",
   "text_date": "2026-04-27",
   "text_url": "https://www.revisor.mn.gov/bills/94/2026/0/SF/4365/versions/2/",
   "status_updated": "2026-09-25",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mn-20252026-sf4659",
   "jurisdiction": "MN",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-20",
   "bill": "SF 4659",
   "title": "State rapid start program establishment to treat patients who are HIV-positive (Rapid Start HIV Treatment Act of 2026)",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "An HIV rapid start treatment bill; it names 340B only in a definition, noting that a federally funded sexually transmitted infection program may also be a 340B covered entity and buy drugs at reduced prices.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… Health Service Act for sexually transmitted infection and sexually transmitted disease prevention programs. A 318 grantee may also be a covered entity under the federal 340B Drug Pricing Program and may purchase prescription drugs at reduced prices. new text end new text begin (d) \"AIDS Drug Assistance Program\" or \"ADAP\" means the state …",
   "introduced_date": "2026-03-23",
   "sponsor": "Dibble",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-03-23",
   "failed_vote": "",
   "latest_action_date": "2026-03-23",
   "latest_action": "Referred to Health and Human Services",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.revisor.mn.gov/bills/94/2026/0/SF/4659?body=Senate",
   "text_version": "Introduction",
   "text_date": "2026-03-18",
   "text_url": "https://www.revisor.mn.gov/bills/94/2026/0/SF/4659/versions/0/",
   "status_updated": "2026-09-25",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mo-2025-hb781",
   "jurisdiction": "MO",
   "session": "2025 Regular Session",
   "session_end": "2025-05-16",
   "bill": "HB 781",
   "title": "Creates provisions relating to the 340B drug program",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting",
    "use-of-savings"
   ],
   "summary": "Would require covered entities to use all proceeds from 340B drugs to lower out-of-pocket costs for, or give direct care to, uninsured patients with incomes up to 400% of the federal poverty level, and to certify and report that use to the state each year.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 17,
   "quote": "… INTRODUCED BY REPRESENTATIVE KEATHLEY. 0839H.01I JOSEPH ENGLER, Chief Clerk AN ACT To amend chapter 191, RSMo, by adding thereto one new section relating to the 340B drug program. Be it enacted by the General Assembly of the state of Missouri, as follows: Section A. Chapter 191, RSMo, is amended by adding thereto one new section, to …",
   "introduced_date": "2025-01-08",
   "sponsor": "Ben Keathley",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-08",
   "failed_vote": "",
   "latest_action_date": "2025-05-15",
   "latest_action": "Referred: Emerging Issues(H)",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.house.mo.gov/BillContent.aspx?bill=HB781&year=2025&code=R&style=new",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://documents.house.mo.gov/billtracking/bills251/hlrbillspdf/0839H.01I.pdf",
   "status_updated": "2025-05-15",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mo-2025-hb784",
   "jurisdiction": "MO",
   "session": "2025 Regular Session",
   "session_end": "2025-05-16",
   "bill": "HB 784",
   "title": "Creates provisions relating to 340B drugs",
   "official_title": "",
   "role": "main",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "Would bar insurers and pharmacy benefit managers from paying covered entities that are not hospitals, and their contract pharmacies, less for 340B drugs, setting different fees or terms for them, refusing to cover 340B drugs, or requiring 340B drugs to be marked on claims.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 13,
   "quote": "… is amended by adding thereto one new section, to be known as section 376.417, to read as follows: 376.417. 1. As used in this section, the following terms mean: (1) \"340B drug\", the same meaning given to the term in section 376.414; (2) \"Covered entity\", any entity described in subparagraphs (A) to (K) of subsection (a)(4) of Section …",
   "introduced_date": "2025-01-08",
   "sponsor": "Tara Peters",
   "cosponsors": 1,
   "committees": "",
   "stage": "Reported by committee",
   "stage_date": "2025-03-04",
   "failed_vote": "",
   "latest_action_date": "2025-05-06",
   "latest_action": "Dropped from Calendar - Pursuant to House Rules (H)",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.house.mo.gov/BillContent.aspx?bill=HB784&year=2025&code=R&style=new",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://documents.house.mo.gov/billtracking/bills251/hlrbillspdf/1554H.01I.pdf",
   "status_updated": "2025-05-06",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mo-2025-hb785",
   "jurisdiction": "MO",
   "session": "2025 Regular Session",
   "session_end": "2025-05-16",
   "bill": "HB 785",
   "title": "Creates provisions relating to 340B drugs",
   "official_title": "",
   "role": "main",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "Would bar insurers and pharmacy benefit managers from paying covered entities that are not hospitals, and their contract pharmacies, less for 340B drugs or below a national average cost benchmark, setting different terms for them, or interfering with a patient's choice to use them.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 21,
   "quote": "… is amended by adding thereto one new section, to be known as section 376.417, to read as follows: 376.417. 1. As used in this section, the following terms mean: (1) \"340B drug\", the same meaning given to the term in section 376.414; (2) \"340B drug-pricing program\", the drug discount program established under Section 340B of the Public …",
   "introduced_date": "2025-01-08",
   "sponsor": "Tara Peters",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-08",
   "failed_vote": "",
   "latest_action_date": "2025-05-15",
   "latest_action": "Referred: Emerging Issues(H)",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.house.mo.gov/BillContent.aspx?bill=HB785&year=2025&code=R&style=new",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://documents.house.mo.gov/billtracking/bills251/hlrbillspdf/1568H.01I.pdf",
   "status_updated": "2025-05-15",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mo-2026-hb2081",
   "jurisdiction": "MO",
   "session": "2026 Regular Session",
   "session_end": "2026-05-15",
   "bill": "HB 2081",
   "title": "Creates provisions relating to reporting requirements for entities that participate in the 340B drug pricing program",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting"
   ],
   "summary": "Would require hospitals in 340B to report each year to the state health department what they paid for and were paid for 340B drugs, payments to contract pharmacies and how they use the savings. The department would publish a combined report; late filers would pay $1,000 a day.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 38,
   "quote": "… INTRODUCED BY REPRESENTATIVE KEATHLEY. 4030H.01I JOSEPH ENGLER, Chief Clerk AN ACT To amend chapter 191, RSMo, by adding thereto one new section relating to the 340B drug pricing program, with penalty provisions. Be it enacted by the General Assembly of the state of Missouri, as follows: Section A. Chapter 191, RSMo, is amended by …",
   "introduced_date": "2025-12-01",
   "sponsor": "Ben Keathley",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-12-01",
   "failed_vote": "",
   "latest_action_date": "2026-05-15",
   "latest_action": "Referred: Emerging Issues(H)",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.house.mo.gov/BillContent.aspx?bill=HB2081&year=2026&code=R&style=new",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://documents.house.mo.gov/billtracking/bills261/hlrbillspdf/4030H.01I.pdf",
   "status_updated": "2026-08-07",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mo-2026-hb2146",
   "jurisdiction": "MO",
   "session": "2026 Regular Session",
   "session_end": "2026-05-15",
   "bill": "HB 2146",
   "title": "Modifies provisions relating to the operation of, and investment of moneys by, certain hospitals",
   "official_title": "",
   "role": "part",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "In a wider bill on hospitals and health care providers, a Senate committee version would bar insurers and pharmacy benefit managers from paying covered entities that are not hospitals less for 340B drugs, setting different terms for them, or refusing to cover 340B drugs.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 13,
   "quote": "… receives less than three percent of its annual revenues from hospital district or state taxes. 376.417. 1. As used in this section, the following terms mean: (1) \"340B drug\", the same meaning given to the term in section 376.414; (2) \"Covered entity\", any entity described in subparagraphs (A) to (K) of subsection (a)(4) of Section …",
   "introduced_date": "2025-12-03",
   "sponsor": "Jim Kalberloh",
   "cosponsors": 1,
   "committees": "",
   "stage": "Passed the House",
   "stage_date": "2026-03-11",
   "failed_vote": "",
   "latest_action_date": "2026-05-07",
   "latest_action": "Placed on Informal Calendar",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.house.mo.gov/BillContent.aspx?bill=HB2146&year=2026&code=R&style=new",
   "text_version": "Senate Committee Substitute",
   "text_date": "",
   "text_url": "https://documents.house.mo.gov/billtracking/bills261/hlrbillspdf/5669S.03C.pdf",
   "status_updated": "2026-10-31",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mo-2026-hb2372",
   "jurisdiction": "MO",
   "session": "2026 Regular Session",
   "session_end": "2026-05-15",
   "bill": "HB 2372",
   "title": "Modifies provisions relating to health care",
   "official_title": "",
   "role": "part",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "In a wider health care law, bars insurers and pharmacy benefit managers from paying certain 340B covered entities and their contract pharmacies less for a 340B drug, setting different terms for them, or refusing to cover 340B drugs. Civil penalties run up to $5,000 per violation per day.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 13,
   "quote": "… or approved by the board. The board shall determine the subject and scope of the examinations. 376.417. 1. As used in this section, the following terms mean: (1) \"340B drug\", the same meaning given to the term in section 376.414; (2) \"Covered entity\", any entity described in subparagraphs (A) to (K) of subsection (a)(4) of Section …",
   "introduced_date": "2025-12-11",
   "sponsor": "Tara Peters",
   "cosponsors": 4,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2026-07-13",
   "failed_vote": "",
   "latest_action_date": "2026-07-13",
   "latest_action": "Delivered to Secretary of State (G)",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.house.mo.gov/BillContent.aspx?bill=HB2372&year=2026&code=R&style=new",
   "text_version": "Truly Agreed and Finally Passed",
   "text_date": "",
   "text_url": "https://documents.house.mo.gov/billtracking/bills261/hlrbillspdf/5868S.08T.pdf",
   "status_updated": "2026-10-31",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mo-2026-sb1178",
   "jurisdiction": "MO",
   "session": "2026 Regular Session",
   "session_end": "2026-05-15",
   "bill": "SB 1178",
   "title": "Enacts requirements for certain reporting regarding the federal 340B drug program",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting"
   ],
   "summary": "Would require hospitals in 340B to report each year to the state health department what they paid for and were paid for 340B drugs, payments to contract pharmacies and how they use the savings. The department would publish a combined report; late filers would pay $1,000 a day.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 36,
   "quote": "… ASSEMBLY INTRODUCED BY SENATOR FITZWATER. 3818S.01I KRISTINA MARTIN, Secretary AN ACT To amend chapter 191, RSMo, by adding thereto one new section relating to the 340B drug program. Be it enacted by the General Assembly of the State of Missouri, as follows: Section A. Chapter 191, RSMo, is amended by adding thereto one new section, to …",
   "introduced_date": "2025-12-01",
   "sponsor": "Travis Fitzwater",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-12-01",
   "failed_vote": "",
   "latest_action_date": "2026-02-04",
   "latest_action": "Hearing Conducted S Families, Seniors and Health Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.senate.mo.gov/BillTracking/Bills/BillInformation?year=2026&billid=139",
   "text_version": "3818S.01I - Introduced",
   "text_date": "",
   "text_url": "https://www.senate.mo.gov/26info/pdf-bill/intro/SB1178.pdf",
   "status_updated": "2026-10-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mo-2026-sb1213",
   "jurisdiction": "MO",
   "session": "2026 Regular Session",
   "session_end": "2026-05-15",
   "bill": "SB 1213",
   "title": "Enacts requirements for certain reporting regarding the federal 340B drug program",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting"
   ],
   "summary": "Would require every 340B covered entity to report each year to the state health department what it paid for and was paid for 340B drugs, payments to contract pharmacies and how it uses the savings. The department would publish a combined report; late filers would pay $1,000 a day.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 35,
   "quote": "… GENERAL ASSEMBLY INTRODUCED BY SENATOR NICOLA. 3819S.02I KRISTINA MARTIN, Secretary AN ACT To amend chapter 191, RSMo, by adding thereto one new section relating to the 340B drug program. Be it enacted by the General Assembly of the State of Missouri, as follows: Section A. Chapter 191, RSMo, is amended by adding thereto one new section, to …",
   "introduced_date": "2025-12-01",
   "sponsor": "Joe Nicola",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-12-01",
   "failed_vote": "",
   "latest_action_date": "2026-02-04",
   "latest_action": "Hearing Conducted S Families, Seniors and Health Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.senate.mo.gov/BillTracking/Bills/BillInformation?year=2026&billid=474",
   "text_version": "3819S.02I - Introduced",
   "text_date": "",
   "text_url": "https://www.senate.mo.gov/26info/pdf-bill/intro/SB1213.pdf",
   "status_updated": "2026-10-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mo-2026-sb1340",
   "jurisdiction": "MO",
   "session": "2026 Regular Session",
   "session_end": "2026-05-15",
   "bill": "SB 1340",
   "title": "Modifies provisions relating to payments for prescription drugs, including 340B drugs",
   "official_title": "",
   "role": "main",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "Would bar insurers and pharmacy benefit managers from paying covered entities that are not hospitals, and their contract pharmacies, less for 340B drugs, setting different fees or terms for them, refusing to cover 340B drugs, or requiring 340B drugs to be marked on claims.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 13,
   "quote": "… is amended by adding thereto one new section, to be known as section 376.417, to read as follows: 376.417. 1. As used in this section, the following terms mean: (1) \"340B drug\", the same meaning given to the term in section 376.414; (2) \"Covered entity\", any entity described in subparagraphs (A) to (K) of subsection (a)(4) of Section …",
   "introduced_date": "2025-12-01",
   "sponsor": "Curtis Trent",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-12-01",
   "failed_vote": "",
   "latest_action_date": "2026-01-27",
   "latest_action": "Second Read and Referred S Families, Seniors and Health Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.senate.mo.gov/BillTracking/Bills/BillInformation?year=2026&billid=285",
   "text_version": "5573S.01I - Introduced",
   "text_date": "",
   "text_url": "https://www.senate.mo.gov/26info/pdf-bill/intro/SB1340.pdf",
   "status_updated": "2026-10-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ms-2025-hb1455",
   "jurisdiction": "MS",
   "session": "2025 Regular Session",
   "session_end": "2025-04-06",
   "bill": "HB 1455",
   "title": "Defending Affordable Prescription Drug Costs Act; delete certain prohibitions against distributors.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would amend the state law that bars drug makers and distributors from interfering with 340B drugs going to contract pharmacies. Its title says it would take distributors out of that ban.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 5,
   "quote": "… 41-149-7. (1) A manufacturer * * * or distributor shall not deny, restrict, prohibit, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a pharmacy that is under contract with a 340B entity and is authorized under such contract to receive and dispense 340B drugs on …",
   "introduced_date": "2025-01-20",
   "sponsor": "Barton",
   "cosponsors": 0,
   "committees": "",
   "stage": "Passed the House",
   "stage_date": "2025-02-13",
   "failed_vote": "",
   "latest_action_date": "2025-03-04",
   "latest_action": "Died In Committee",
   "law": "",
   "same_as": "",
   "bill_url": "http://billstatus.ls.state.ms.us/documents/2025/pdf/HB/1400-1499/HB1455PS.pdf",
   "text_version": "Current version",
   "text_date": "",
   "text_url": "http://billstatus.ls.state.ms.us/documents/2025/html/HB/1400-1499/HB1455PS.htm",
   "status_updated": "2025-03-05",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ms-2025-hb1474",
   "jurisdiction": "MS",
   "session": "2025 Regular Session",
   "session_end": "2025-04-06",
   "bill": "HB 1474",
   "title": "Department of Health; require to conduct a review of quality of medical care provided to inmates of Department of Corrections.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In a wider bill on health care for state prison inmates, would have the health department help the corrections department get hepatitis C drugs for inmates at 340B prices.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… a Hepatitis C Program for state inmates. The Department of Health shall assist the Department of Corrections in obtaining Hepatitis C medications for inmates at 340B drug pricing. (16) The Department of Health and the Department of Corrections shall develop a plan for improving the health of female inmates. SECTION 2. (1) No inmate …",
   "introduced_date": "2025-01-20",
   "sponsor": "Currie",
   "cosponsors": 1,
   "committees": "",
   "stage": "Passed the legislature",
   "stage_date": "2025-03-05",
   "failed_vote": "",
   "latest_action_date": "2025-03-31",
   "latest_action": "Died In Conference",
   "law": "",
   "same_as": "",
   "bill_url": "http://billstatus.ls.state.ms.us/documents/2025/pdf/HB/1400-1499/HB1474PS.pdf",
   "text_version": "Current version",
   "text_date": "",
   "text_url": "http://billstatus.ls.state.ms.us/documents/2025/html/HB/1400-1499/HB1474PS.htm",
   "status_updated": "2025-04-01",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ms-2025-hb856",
   "jurisdiction": "MS",
   "session": "2025 Regular Session",
   "session_end": "2025-04-06",
   "bill": "HB 856",
   "title": "Pharmacy Practice Act; extend repealer on and make various changes to.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A pharmacy practice law; it names 340B only in a definition, which says a covered entity and its contract pharmacies' 340B transactions are not a pharmacy services administrative organization.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… managers on behalf of pharmacies and providing pharmacies with credentialing, billing, audit, general business and analytic support. A covered entity as defined in 42 USC Section 256b, including its pharmacy or the transactions related to the 340B drug discount program of any pharmacy contracted with the participating covered entity to dispense drugs …",
   "introduced_date": "2025-01-16",
   "sponsor": "Creekmore",
   "cosponsors": 0,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-04-23",
   "failed_vote": "",
   "latest_action_date": "2025-04-23",
   "latest_action": "Approved by Governor",
   "law": "",
   "same_as": "",
   "bill_url": "http://billstatus.ls.state.ms.us/documents/2025/pdf/HB/0800-0899/HB0856SG.pdf",
   "text_version": "Current version",
   "text_date": "",
   "text_url": "http://billstatus.ls.state.ms.us/documents/2025/html/HB/0800-0899/HB0856SG.htm",
   "status_updated": "2025-04-25",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ms-2025-sb2751",
   "jurisdiction": "MS",
   "session": "2025 Regular Session",
   "session_end": "2025-04-06",
   "bill": "SB 2751",
   "title": "340B drug discount program entities; remove distributor from prohibition of certain discriminating actions related to.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would amend the state law that bars drug makers and distributors from interfering with 340B drugs going to contract pharmacies. Its title says it would take distributors out of that ban.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 6,
   "quote": "… OF 1972, TO REMOVE DISTRIBUTOR FROM PROHIBITION OF CERTAIN DISCRIMINATORY ACTIONS RELATED TO ENTITIES THAT ARE PARTICIPATING OR AUTHORIZED TO PARTICIPATE IN THE FEDERAL 340B DRUG DISCOUNT PROGRAM; AND FOR RELATED PURPOSES. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI: SECTION 1. Section 41-149-7, Mississippi Code of 1972, is …",
   "introduced_date": "2025-01-20",
   "sponsor": "Hopson",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-20",
   "failed_vote": "",
   "latest_action_date": "2025-02-04",
   "latest_action": "Died In Committee",
   "law": "",
   "same_as": "",
   "bill_url": "http://billstatus.ls.state.ms.us/documents/2025/pdf/SB/2700-2799/SB2751IN.pdf",
   "text_version": "Current version",
   "text_date": "",
   "text_url": "http://billstatus.ls.state.ms.us/documents/2025/html/SB/2700-2799/SB2751IN.htm",
   "status_updated": "2025-02-05",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ms-2026-hb1434",
   "jurisdiction": "MS",
   "session": "2026 Regular Session",
   "session_end": "2026-04-15",
   "bill": "HB 1434",
   "title": "Auto-injectable epinephrine devices; authorize restaurants to obtain from Health Dept or from pharmacies under a standing order.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A bill on epinephrine devices in restaurants; it names 340B only in a pharmacy law definition, which says a covered entity and its contract pharmacies' 340B transactions are not a pharmacy services administrative organization.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… managers on behalf of pharmacies and providing pharmacies with credentialing, billing, audit, general business and analytic support. A covered entity as defined in 42 USC Section 256b, including its pharmacy or the transactions related to the 340B drug discount program of any pharmacy contracted with the participating covered entity to dispense drugs …",
   "introduced_date": "2026-01-16",
   "sponsor": "Gibbs (72nd)",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-01-16",
   "failed_vote": "",
   "latest_action_date": "2026-02-03",
   "latest_action": "Died In Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://billstatus.ls.state.ms.us/documents/2026/pdf/HB/1400-1499/HB1434IN.pdf",
   "text_version": "Current version",
   "text_date": "",
   "text_url": "http://billstatus.ls.state.ms.us/documents/2026/html/HB/1400-1499/HB1434IN.htm",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ms-2026-hb1666",
   "jurisdiction": "MS",
   "session": "2026 Regular Session",
   "session_end": "2026-04-15",
   "bill": "HB 1666",
   "title": "Pharmacy Benefit Prompt Act; revise.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A pharmacy benefit manager bill; it names 340B only in a definition, which says a covered entity and its contract pharmacies' 340B transactions are not a pharmacy services administrative organization.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… managers on behalf of pharmacies and providing pharmacies with credentialing, billing, audit, general business and analytic support. A covered entity as defined in 42 USC Section 256b, including its pharmacy or the transactions related to the 340B drug discount program of any pharmacy contracted with the participating covered entity to dispense drugs …",
   "introduced_date": "2026-01-19",
   "sponsor": "Zuber",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-01-19",
   "failed_vote": "",
   "latest_action_date": "2026-02-03",
   "latest_action": "Died In Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://billstatus.ls.state.ms.us/documents/2026/pdf/HB/1600-1699/HB1666IN.pdf",
   "text_version": "Current version",
   "text_date": "",
   "text_url": "http://billstatus.ls.state.ms.us/documents/2026/html/HB/1600-1699/HB1666IN.htm",
   "status_updated": "2026-03-17",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ms-2026-hb1672",
   "jurisdiction": "MS",
   "session": "2026 Regular Session",
   "session_end": "2026-04-15",
   "bill": "HB 1672",
   "title": "Pharmacy Benefit Prompt Pay Act; revise.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A pharmacy benefit manager bill; it names 340B only in a definition, which says a covered entity and its contract pharmacies' 340B transactions are not a pharmacy services administrative organization.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… of pharmacies and providing pharmacies or pharmacists with credentialing, billing, audit, general business and analytic support. A covered entity, as defined in 42 USC Section 256b, including its pharmacy or the transactions related to the 340B drug discount program of a pharmacy contracted with the participating covered entity to dispense drugs …",
   "introduced_date": "2026-01-19",
   "sponsor": "Scoggin",
   "cosponsors": 2,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-01-19",
   "failed_vote": "",
   "latest_action_date": "2026-02-03",
   "latest_action": "Died In Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://billstatus.ls.state.ms.us/documents/2026/pdf/HB/1600-1699/HB1672IN.pdf",
   "text_version": "Current version",
   "text_date": "",
   "text_url": "http://billstatus.ls.state.ms.us/documents/2026/html/HB/1600-1699/HB1672IN.htm",
   "status_updated": "2026-03-17",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ms-2026-hb533",
   "jurisdiction": "MS",
   "session": "2026 Regular Session",
   "session_end": "2026-04-15",
   "bill": "HB 533",
   "title": "Pharmacists; authorize to test for and administer treatment for minor, nonchronic health conditions.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A bill on pharmacists testing for and treating minor conditions; it names 340B only in a pharmacy law definition, which says a covered entity and its contract pharmacies' 340B transactions are not a pharmacy services administrative organization.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… managers on behalf of pharmacies and providing pharmacies with credentialing, billing, audit, general business and analytic support. A covered entity as defined in 42 USC Section 256b, including its pharmacy or the transactions related to the 340B drug discount program of any pharmacy contracted with the participating covered entity to dispense drugs …",
   "introduced_date": "2026-01-12",
   "sponsor": "Yancey",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-01-12",
   "failed_vote": "",
   "latest_action_date": "2026-02-03",
   "latest_action": "Died In Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://billstatus.ls.state.ms.us/documents/2026/pdf/HB/0500-0599/HB0533IN.pdf",
   "text_version": "Current version",
   "text_date": "",
   "text_url": "http://billstatus.ls.state.ms.us/documents/2026/html/HB/0500-0599/HB0533IN.htm",
   "status_updated": "2026-03-17",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ms-2026-sb2555",
   "jurisdiction": "MS",
   "session": "2026 Regular Session",
   "session_end": "2026-04-15",
   "bill": "SB 2555",
   "title": "Pharmacists; authorize to test for and administer treatment for minor, nonchronic health conditions.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A bill on pharmacists testing for and treating minor conditions; it names 340B only in a pharmacy law definition, which says a covered entity and its contract pharmacies' 340B transactions are not a pharmacy services administrative organization.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… managers on behalf of pharmacies and providing pharmacies with credentialing, billing, audit, general business and analytic support. A covered entity as defined in 42 USC Section 256b, including its pharmacy or the transactions related to the 340B drug discount program of any pharmacy contracted with the participating covered entity to dispense drugs …",
   "introduced_date": "2026-01-19",
   "sponsor": "McCaughn",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-01-19",
   "failed_vote": "",
   "latest_action_date": "2026-02-03",
   "latest_action": "Died In Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://billstatus.ls.state.ms.us/documents/2026/pdf/SB/2500-2599/SB2555IN.pdf",
   "text_version": "Current version",
   "text_date": "",
   "text_url": "http://billstatus.ls.state.ms.us/documents/2026/html/SB/2500-2599/SB2555IN.htm",
   "status_updated": "2026-03-17",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ms-2026-sb2575",
   "jurisdiction": "MS",
   "session": "2026 Regular Session",
   "session_end": "2026-04-15",
   "bill": "SB 2575",
   "title": "Pharmacy Benefit Prompt Pay Act; revise various existing and create additional provisions related to.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A pharmacy benefit manager bill; it names 340B only in a definition, which says a covered entity and its contract pharmacies' 340B transactions are not a pharmacy services administrative organization.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… of pharmacies and providing pharmacies or pharmacists with credentialing, billing, audit, general business and analytic support. A covered entity as defined in 42 USC § 256b, including its pharmacy or the transactions related to the 340B drug discount program of any pharmacy contracted with the participating covered entity to dispense drugs …",
   "introduced_date": "2026-01-19",
   "sponsor": "Parks",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-01-19",
   "failed_vote": "",
   "latest_action_date": "2026-02-03",
   "latest_action": "Died In Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://billstatus.ls.state.ms.us/documents/2026/pdf/SB/2500-2599/SB2575IN.pdf",
   "text_version": "Current version",
   "text_date": "",
   "text_url": "http://billstatus.ls.state.ms.us/documents/2026/html/SB/2500-2599/SB2575IN.htm",
   "status_updated": "2026-03-17",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ms-2026-sb2576",
   "jurisdiction": "MS",
   "session": "2026 Regular Session",
   "session_end": "2026-04-15",
   "bill": "SB 2576",
   "title": "Pharmacy benefit managers; revise provisions related to.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A pharmacy benefit manager bill; it names 340B only in a definition, which says a covered entity and its contract pharmacies' 340B transactions are not a pharmacy services administrative organization.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… on behalf of pharmacies and providing pharmacies with credentialing, billing, auditing, general business and analytic support. A covered entity as defined in 42 USC Section 256b, including its pharmacy or the transactions related to the 340B drug discount program of any pharmacy contracted with the participating covered entity to dispense drugs …",
   "introduced_date": "2026-01-19",
   "sponsor": "England",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-01-19",
   "failed_vote": "",
   "latest_action_date": "2026-02-03",
   "latest_action": "Died In Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://billstatus.ls.state.ms.us/documents/2026/pdf/SB/2500-2599/SB2576IN.pdf",
   "text_version": "Current version",
   "text_date": "",
   "text_url": "http://billstatus.ls.state.ms.us/documents/2026/html/SB/2500-2599/SB2576IN.htm",
   "status_updated": "2026-03-17",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mt-2025-hb740",
   "jurisdiction": "MT",
   "session": "2025 Regular Session",
   "session_end": "2025-05-03",
   "bill": "HB 740",
   "title": "Revise laws relating to pharmacies, pharmacy benefit managers, and other entities",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A law on pharmacies and pharmacy benefit managers; the passage names 340B only in a definition, where a federally certified health entity means a 340B covered entity.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… which pharmacy reimbursement is based on an aggregation of more than one claim, rather than on a per- claim basis. (2)(3) \"Federally certified health entity\" means a 340B covered entity as described in 42 U.S.C. 256b(a)(4). (4) \"Independent pharmacy\" means a pharmacy as defined in 37-7-101 that: (a) is licensed with the board of pharmacy …",
   "introduced_date": "2024-12-08",
   "sponsor": "Marta Bertoglio",
   "cosponsors": 0,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-05-05",
   "failed_vote": "",
   "latest_action_date": "2025-05-08",
   "latest_action": "Chapter Number Assigned",
   "law": "",
   "same_as": "",
   "bill_url": "https://bills.legmt.gov/#/laws/bill/2/LC2354?open_tab=sum",
   "text_version": "HB0740_X.pdf",
   "text_date": "",
   "text_url": "https://api.legmt.gov/docs/v1/documents/getContent?documentId=313861",
   "status_updated": "2026-08-10",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "mt-2027-lc472",
   "jurisdiction": "MT",
   "session": "2027 Regular Session",
   "session_end": "2027-04-30",
   "bill": "LC 472",
   "title": "Revise unfair trade practices and consumer protections involving prescription drugs, contract pharmacies and reporting under the federal 340B program",
   "official_title": "",
   "role": "",
   "kinds": [],
   "summary": "",
   "names_program_in": [
    "title"
   ],
   "text_mentions": null,
   "quote": "Revise unfair trade practices and consumer protections involving prescription drugs, contract pharmacies and reporting under the federal 340B program",
   "introduced_date": "2026-09-24",
   "sponsor": "",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-09-24",
   "failed_vote": "",
   "latest_action_date": "2026-09-24",
   "latest_action": "(LC) Drafter Assigned",
   "law": "",
   "same_as": "",
   "bill_url": "https://bills.legmt.gov/#/lc/bill/3/LC0472",
   "text_version": "",
   "text_date": "",
   "text_url": "",
   "status_updated": "2026-10-16",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "nc-2025-hb163",
   "jurisdiction": "NC",
   "session": "2025-2026 Session",
   "session_end": "2026-07-01",
   "bill": "HB 163",
   "title": "Pharmacy Benefits Manager Provisions.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "In a wider bill on pharmacy benefit managers, would apply the pharmacy of choice rules to pharmacy benefit managers, in the same way as to insurers, with respect to 340B covered entities and 340B contract pharmacies.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 4,
   "quote": "… organizations that provide or administer coverages and benefits for prescription drugs. This section shall apply to pharmacy benefits managers with respect to 340B covered entities and 340B contract pharmacies, as defined in G.S. 58-56A-1. This section shall not apply to any entity that has its own facility, employs or contracts …",
   "introduced_date": "2025-02-21",
   "sponsor": "Rhyne; Blackwell; Huneycutt",
   "cosponsors": 32,
   "committees": "",
   "stage": "Passed the House",
   "stage_date": "2025-04-29",
   "failed_vote": "",
   "latest_action_date": "2025-04-30",
   "latest_action": "Regular Message Sent To Senate",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.ncleg.gov/BillLookUp/2025/H163",
   "text_version": "Edition 3",
   "text_date": "",
   "text_url": "https://www.ncleg.gov/Sessions/2025/Bills/House/PDF/H163v3.pdf",
   "status_updated": "2026-11-05",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "nc-2025-sb479",
   "jurisdiction": "NC",
   "session": "2025-2026 Session",
   "session_end": "2026-07-01",
   "bill": "SB 479",
   "title": "SCRIPT Act.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "payer-nondiscrimination",
    "medicaid"
   ],
   "summary": "In a wider law on pharmacies and pharmacy benefit managers, applies the pharmacy of choice rules to pharmacy benefit managers with respect to 340B covered entities and 340B contract pharmacies. Medicaid claims for 340B drugs are paid as the approved Medicaid State Plan sets out.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 8,
   "quote": "… organizations that provide or administer coverages and benefits for prescription drugs. This section shall apply to pharmacy benefits managers with respect to 340B covered entities and 340B contract pharmacies, as defined in G.S. 58-56A-1. This section shall not apply to any entity that has its own facility, employs or contracts …",
   "introduced_date": "2025-03-25",
   "sponsor": "Sawrey; Britt",
   "cosponsors": 24,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-07-09",
   "failed_vote": "",
   "latest_action_date": "2025-07-09",
   "latest_action": "Signed by Gov. 7/9/2025",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.ncleg.gov/BillLookUp/2025/S479",
   "text_version": "SL 2025-69",
   "text_date": "",
   "text_url": "https://www.ncleg.gov/Sessions/2025/Bills/Senate/PDF/S479v8.pdf",
   "status_updated": "2026-11-05",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "nc-2025-sb517",
   "jurisdiction": "NC",
   "session": "2025-2026 Session",
   "session_end": "2026-07-01",
   "bill": "SB 517",
   "title": "Fair Pricing and Trnspncy/340B Covered Entities.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting",
    "other"
   ],
   "summary": "Would bar certain 340B hospitals from accepting more than their acquisition cost as payment for a 340B drug. Would also have every covered entity report 340B costs, payments and contract pharmacy figures each year, with the reports posted online by a state department.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 40,
   "quote": "GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2025 S 1 SENATE BILL 517 Short Title: Fair Pricing & Trnspncy/340B Covered Entities. (Public) Sponsors: Senators Galey, Burgin, and Sawrey (Primary Sponsors). Referred to: Rules and Operations of the Senate March 26, 2025 A BILL TO BE …",
   "introduced_date": "2025-03-25",
   "sponsor": "Galey; Burgin",
   "cosponsors": 2,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-03-25",
   "failed_vote": "",
   "latest_action_date": "2025-03-26",
   "latest_action": "Passed 1st Reading",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.ncleg.gov/BillLookUp/2025/S517",
   "text_version": "Edition 1",
   "text_date": "",
   "text_url": "https://www.ncleg.gov/Sessions/2025/Bills/Senate/PDF/S517v1.pdf",
   "status_updated": "2026-11-05",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "nd-69-hb1473",
   "jurisdiction": "ND",
   "session": "69th Legislative Assembly (2025-26)",
   "session_end": "2025-05-02",
   "bill": "HB 1473",
   "title": "AN ACT to create and enact a new subsection to section 43-15.3-08 of the North Dakota Century Code, relating to prohibited acts of drug manufacturers; and to provide a penalty.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Makes it a misdemeanor for a drug maker to deny, restrict or interfere with a contract pharmacy acquiring 340B drugs on behalf of a covered entity, or to stop a contract pharmacy from dispensing them by denying access to the drug.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… the covered entity's patients on its behalf. (2) \"Covered entity\" means an entity participating or authorized to participate in a federal drug discount program under 42 U.S.C. 256b. (3) \"Drug\" means a drug purchased under reduced pricing under section 340B of the federal Public Health Service Act [42 U.S.C. 201 et seq.] by a covered entity. b. …",
   "introduced_date": "2025-01-17",
   "sponsor": "Jon O. Nelson",
   "cosponsors": 7,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-04-04",
   "failed_vote": "",
   "latest_action_date": "2025-04-07",
   "latest_action": "Filed with Secretary Of State 04/03",
   "law": "",
   "same_as": "",
   "bill_url": "https://ndlegis.gov/assembly/69-2025/regular/bill-overview/bo1473.html",
   "text_version": "Enrollment",
   "text_date": "",
   "text_url": "https://ndlegis.gov/assembly/69-2025/regular/documents/25-1047-02000.pdf",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ne-109-lb168",
   "jurisdiction": "NE",
   "session": "109th Legislature (2025-2026)",
   "session_end": "2026-04-19",
   "bill": "LB 168",
   "title": "Adopt the 340B Contract Pharmacy Protection Act",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Bars drug makers and their agents from denying or restricting delivery of 340B drugs to any location a 340B entity authorizes to receive them, and from requiring data as a condition, unless federal law requires it. The attorney general or a county attorney may sue to halt violations.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 21,
   "quote": "… 31; Lippincott, 34; McKeon, 41; Murman, 38; Raybould, 28; Spivey, 13; Conrad, 46; Fredrickson, 20; Brandt, 32. A BILL FOR AN ACT relating to health care; to adopt the 340B Contract Pharmacy Protection Act; to provide severability; and to declare an emergency. Be it enacted by the people of the State of Nebraska, Section 1. Sections 1 to 5 …",
   "introduced_date": "2025-01-13",
   "sponsor": "Hardin",
   "cosponsors": 3,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-04-10",
   "failed_vote": "",
   "latest_action_date": "2025-04-10",
   "latest_action": "Approved by Governor on April 9, 2025",
   "law": "",
   "same_as": "",
   "bill_url": "https://nebraskalegislature.gov/bills/search_by_date.php?SessionDay=2025",
   "text_version": "Slip Law",
   "text_date": "",
   "text_url": "https://nebraskalegislature.gov/FloorDocs/109/PDF/Slip/LB168.pdf",
   "status_updated": "2026-10-31",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "nh-2025-sb253",
   "jurisdiction": "NH",
   "session": "2025 Regular Session",
   "session_end": "2025-06-30",
   "bill": "SB 253",
   "title": "relative to participation in the federal 340B Drug Pricing Program.",
   "official_title": "",
   "role": "",
   "kinds": [],
   "summary": "",
   "names_program_in": [
    "title"
   ],
   "text_mentions": null,
   "quote": "relative to participation in the federal 340B Drug Pricing Program.",
   "introduced_date": "2025-01-23",
   "sponsor": "Tara Reardon",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-23",
   "failed_vote": "2025-03-06 Inexpedient to Legislate, MA, VV === BILL KILLED ===; 03/06/2025;  SJ 6",
   "latest_action_date": "2025-03-06",
   "latest_action": "Inexpedient to Legislate, MA, VV === BILL KILLED ===; 03/06/2025;  SJ 6",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.gencourt.state.nh.us/bill_status/legacy/bs2016/bill_docket.aspx?lsr=1102&sy=2025&sortoption=&txtsessionyear=2025",
   "text_version": "",
   "text_date": "",
   "text_url": "",
   "status_updated": "2025-11-29",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "nh-2026-hb1755",
   "jurisdiction": "NH",
   "session": "2026 Regular Session",
   "session_end": "2026-06-30",
   "bill": "HB 1755",
   "title": "relative to the 340B discounted drug purchasing program.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting",
    "other"
   ],
   "summary": "Would require hospitals in 340B to report yearly figures on 340B drug costs, payments, use of savings, charity care and patients sent to collections. The state would publish totals, and its charitable trusts director would review the data.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 45,
   "quote": "HB 1755-FN - AS INTRODUCED 2026 SESSION 26-3133 05/06 HOUSE BILL 1755-FN AN ACT relative to the 340B discounted drug purchasing program. SPONSORS: Rep. Polozov, Merr. 10; Rep. Litchfield, Rock. 32; Rep. Ulery, Hills. 13 COMMITTEE: Health, Human Services and Elderly …",
   "introduced_date": "2025-12-17",
   "sponsor": "Yury Polozov",
   "cosponsors": 2,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-12-17",
   "failed_vote": "",
   "latest_action_date": "2026-10-23",
   "latest_action": "Interim Study Report: Not Recommended for Future Legislation  10/22/2026 (Vote 12-1;)",
   "law": "",
   "same_as": "",
   "bill_url": "https://gc.nh.gov/bill_Status/billinfo.aspx?id=2345&inflect=2",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://gc.nh.gov/bill_Status/pdf.aspx?id=24515&q=billVersion",
   "status_updated": "2026-10-24",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "nh-2026-sb477",
   "jurisdiction": "NH",
   "session": "2026 Regular Session",
   "session_end": "2026-06-30",
   "bill": "SB 477",
   "title": "relative to increasing transparency in the 340B Drug Pricing Program.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting",
    "medicaid",
    "other"
   ],
   "summary": "Would require 340B covered entities to file yearly reports that the state publishes, have Medicaid flag 340B claims to prevent duplicate discounts, and make hospitals post a 340B patient notice. Hospitals with over $2 million in net 340B savings would file a rural benefit plan.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 16,
   "quote": "SB 477-FN - AS INTRODUCED 2026 SESSION 26-2036 05/06 SENATE BILL 477-FN AN ACT relative to increasing transparency in the 340B Drug Pricing Program. SPONSORS: Sen. McGough, Dist 11; Sen. Gannon, Dist 23; Sen. Pearl, Dist 17; Sen. Birdsell, Dist 19; Sen. Innis, Dist 7; Rep. Miles, Hills. 12; …",
   "introduced_date": "2025-11-21",
   "sponsor": "Tim McGough",
   "cosponsors": 9,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-11-21",
   "failed_vote": "",
   "latest_action_date": "2026-03-05",
   "latest_action": "Refer to Interim Study, MA, VV; 03/05/2026;  SJ 5",
   "law": "",
   "same_as": "",
   "bill_url": "https://gc.nh.gov/bill_Status/billinfo.aspx?id=1225&inflect=2",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://gc.nh.gov/bill_Status/pdf.aspx?id=22038&q=billVersion",
   "status_updated": "2026-08-22",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "nj-222-a3872",
   "jurisdiction": "NJ",
   "session": "2026-2027 Regular Session",
   "session_end": "2027-12-31",
   "bill": "A 3872",
   "title": "Requires prescription drug services covered under Medicaid program to be provided via fee-for-service delivery system.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "medicaid"
   ],
   "summary": "In a wider bill moving Medicaid prescription drug services to fee-for-service, would set what Medicaid pays for drugs dispensed by a 340B covered entity: the lower of several measures, one being actual cost capped at the 340B ceiling price, plus a $10.92 dispensing fee.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 4,
   "quote": "… effect on the date the drug is dispensed to the Medicaid beneficiary. c. Reimbursement for covered outpatient drugs dispensed by a covered entity as defined in section 340B(a)(4) of the federal Public Health Service Act shall be calculated based on the lower of: (1) the Actual Acquisition Cost, which shall not exceed the federal 340B …",
   "introduced_date": "2026-01-13",
   "sponsor": "Coughlin, Craig J.",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-01-13",
   "failed_vote": "",
   "latest_action_date": "2026-01-13",
   "latest_action": "Introduced, Referred to Assembly Aging and Human Services Committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.njleg.state.nj.us/bill-search/2026/A3872",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://pub.njleg.state.nj.us/Bills/2026/A4000/3872_I1.HTM",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "nm-2025-hb78",
   "jurisdiction": "NM",
   "session": "2025 Regular Session",
   "session_end": "2025-03-22",
   "bill": "HB 78",
   "title": "PROHIBIT DISCRIMINATION AGAINST 340B ENTITIES",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Bars drug makers from denying or restricting delivery of 340B drugs to pharmacies under contract with federally qualified health centers and lookalikes, from interfering with those pharmacies' dispensing, or from demanding claims data as a condition.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 13,
   "quote": "AN ACT RELATING TO PRESCRIPTION DRUGS; PROHIBITING DISCRIMINATION AGAINST ENTITIES PARTICIPATING IN THE FEDERAL 340B DRUG PRICING PROGRAM. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO: SECTION 1. PROHIBITION OF DISCRIMINATION AGAINST 340B ENTITIES.-- A. As used in this …",
   "introduced_date": "2025-01-10",
   "sponsor": "Thomson, Elizabeth \"Liz\"; Stefanics, Elizabeth \"Liz\"",
   "cosponsors": 0,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-04-09",
   "failed_vote": "",
   "latest_action_date": "2025-04-09",
   "latest_action": "Signed",
   "law": "",
   "same_as": "",
   "bill_url": "http://www.nmlegis.gov/Legislation/Legislation?chamber=H&legType=B&legNo=78&year=25",
   "text_version": "Final Version",
   "text_date": "",
   "text_url": "http://www.nmlegis.gov/Sessions/25%20Regular/final/HB0078.PDF",
   "status_updated": "2025-04-23",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "nv-83-sb149",
   "jurisdiction": "NV",
   "session": "2025 Regular Session",
   "session_end": "2025-06-01",
   "bill": "SB 149",
   "title": "Revises provisions governing the administration of pharmacy benefits under Medicaid. (BDR 38-224)",
   "official_title": "",
   "role": "part",
   "kinds": [
    "payer-nondiscrimination",
    "medicaid"
   ],
   "summary": "In a wider bill setting up one state pharmacy benefit manager for Medicaid, would require that the method for paying pharmacies not discriminate against pharmacies owned or contracted by 340B covered entities, unless federal Medicaid officials require it.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 21,
   "quote": "… for reimbursement must not discriminate against pharmacies owned or contracted by a health care facility that is registered as a covered entity pursuant to 42 U.S.C. § 256b, except where required by the Centers for Medicare and Medicaid Services of the United States Department of Health and Human Services. (c) Dispensing fees paid to …",
   "introduced_date": "2025-01-30",
   "sponsor": "Jeff Stone",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-30",
   "failed_vote": "",
   "latest_action_date": "2025-04-12",
   "latest_action": "(Pursuant to Joint Standing Rule No. 14.3.1, no further action allowed.)",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.leg.state.nv.us/App/NELIS/REL/83rd2025/Bill/12108/Overview",
   "text_version": "As Introduced",
   "text_date": "",
   "text_url": "https://www.leg.state.nv.us/Session/83rd2025/Bills/SB/SB149.pdf",
   "status_updated": "2025-08-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "nv-83-sb389",
   "jurisdiction": "NV",
   "session": "2025 Regular Session",
   "session_end": "2025-06-01",
   "bill": "SB 389",
   "title": "Revises provisions relating to the administration of pharmacy benefits under Medicaid and certain other health plans. (BDR 38-240)",
   "official_title": "",
   "role": "part",
   "kinds": [
    "medicaid"
   ],
   "summary": "In a wider law on a state pharmacy benefit manager for Medicaid, has the state set how Medicaid pays pharmacies owned by 340B covered entities. The bar on pharmacy benefit managers paying less for 340B drugs does not apply to the state manager when it handles Medicaid.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 22,
   "quote": "… subsection 2 of NRS 422.4053. (c) The methodology for reimbursement to pharmacies owned by a health care facility that is registered as a covered entity pursuant to 42 U.S.C. § 256b under a contract entered into pursuant to subsection 1 of NRS 422.4053 or paragraph (a) of subsection 2 of NRS 422.4053. (d) Dispensing fees paid to pharmacies and …",
   "introduced_date": "2025-03-17",
   "sponsor": "Melanie Scheible; Jeff Stone",
   "cosponsors": 1,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-06-06",
   "failed_vote": "",
   "latest_action_date": "2025-06-06",
   "latest_action": "Approved by the Governor.\rChapter 390.",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.leg.state.nv.us/App/NELIS/REL/83rd2025/Bill/12689/Overview",
   "text_version": "As Enrolled",
   "text_date": "",
   "text_url": "https://www.leg.state.nv.us/Session/83rd2025/Bills/SB/SB389_EN.pdf",
   "status_updated": "2025-08-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-a10842",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "A 10842",
   "title": "Directs the department of health to establish an alternative payment methodology (APM) for Federally Qualified Health Centers to preserve and improve patient access to fertility care",
   "official_title": "",
   "role": "part",
   "kinds": [
    "medicaid"
   ],
   "summary": "In a bill on fertility care at federally qualified health centers, would add a health department payment for Medicaid patients' injectable fertility drugs, up to $700,000 a year in state money, equal to the difference between a center's 2024 cost under 340B and average wholesale acquisition cost.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… between (a) the aggregate amount the federally qualified health center paid to acquire eligible injectable fertility drugs for Medicaid patients under section 340B of the federal public health services act between January 1, 2024 and December 31, 2024 and (b) the aggregate amount the federally qualified health center would have …",
   "introduced_date": "2026-04-06",
   "sponsor": "Aron Wieder",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-04-06",
   "failed_vote": "",
   "latest_action_date": "2026-04-21",
   "latest_action": "PRINT NUMBER 10842A",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/A10842?summary=&detail=",
   "text_version": "A10842A",
   "text_date": "",
   "text_url": "http://legislation.nysenate.gov/pdf/bills/2025/A10842A",
   "status_updated": "2026-04-21",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-a1466",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "A 1466",
   "title": "Provides for establishment of the New York Health plan",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A bill to set up a single statewide health plan; it says drugs not dispensed through a pharmacy would be paid for under the plan's rules, including use of 340B as appropriate.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… A. 1466 14 (ii) Where prescription drugs are not dispensed through a pharmacy, payment shall be made as otherwise provided in this article, including use of the 340B program as appropriate. (d) Payment for health care services established under this article shall be considered payment in full. A participating provider shall not …",
   "introduced_date": "2025-01-09",
   "sponsor": "Amy Paulin",
   "cosponsors": 73,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-09",
   "failed_vote": "",
   "latest_action_date": "2026-01-07",
   "latest_action": "REFERRED TO HEALTH",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/A1466?summary=&detail=",
   "text_version": "A1466",
   "text_date": "",
   "text_url": "http://assembly.state.ny.us/leg/?sh=printbill&bn=A1466&term=2025&Text=Y",
   "status_updated": "2026-09-17",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-a2397",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "A 2397",
   "title": "Requires DOH to develop a payment methodology for federally qualified health centers and rural health centers that dispense ovulation enhancing drugs",
   "official_title": "",
   "role": "part",
   "kinds": [
    "medicaid"
   ],
   "summary": "In a bill on the state's payment method for health centers and rural health clinics that are 340B covered entities, would require that method to also cover the cost of all ovulation enhancing drugs they dispense.",
   "names_program_in": [
    "summary",
    "text"
   ],
   "text_mentions": 3,
   "quote": "… two thousand twenty, as amended by section one of part C of chapter fifty-seven of the laws of two thousand twenty-one, for such covered entities as defined in section 340B of the federal public health service act, 42 USC § 256b, for drugs that would otherwise be eligible for pricing under section 340B of the federal public health service …",
   "introduced_date": "2025-01-16",
   "sponsor": "Amy Paulin",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-16",
   "failed_vote": "",
   "latest_action_date": "2026-01-07",
   "latest_action": "REFERRED TO HEALTH",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/A2397?summary=&detail=",
   "text_version": "A2397",
   "text_date": "",
   "text_url": "http://assembly.state.ny.us/leg/?sh=printbill&bn=A2397&term=2025&Text=Y",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-a4100",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "A 4100",
   "title": "Establishes an emergency insulin program",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In a wider bill to set up an emergency insulin program, would require certain health facilities that take part in 340B, along with large pharmacy chains, to register as emergency insulin sites and keep a standing order to dispense insulin.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… or more locations in the state, and any facility established pursuant to article twenty-eight of this chapter which has a drug discount program authorized by section 340B of the Federal Public Health Service act 42 U.S.C § 256b shall pursue or main- tain a non-patient-specific prescription with an authorized health care professional to …",
   "introduced_date": "2025-01-31",
   "sponsor": "Brian Cunningham",
   "cosponsors": 2,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-31",
   "failed_vote": "",
   "latest_action_date": "2026-01-07",
   "latest_action": "REFERRED TO HEALTH",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/A4100?summary=&detail=",
   "text_version": "A4100",
   "text_date": "",
   "text_url": "http://assembly.state.ny.us/leg/?sh=printbill&bn=A4100&term=2025&Text=Y",
   "status_updated": "2026-04-22",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-a4604",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "A 4604",
   "title": "Relates to creating a wholesale prescription drug importation program",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In a wider bill to set up a state program to import prescription drugs wholesale, would have the health commissioner seek federal approvals so 340B covered entities can take part without putting their 340B eligibility at risk.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… or agreements, or a combination thereof, as needed to enable all covered entities enrolled in or eligible for the drug discount program authorized by section 340B of the federal public health service act (42 U.S.C. § 256b) to participate in the wholesale prescription drug importation program to the fullest extent possible without …",
   "introduced_date": "2025-02-04",
   "sponsor": "Jo Anne Simon",
   "cosponsors": 39,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-04",
   "failed_vote": "",
   "latest_action_date": "2026-01-07",
   "latest_action": "REFERRED TO HIGHER EDUCATION",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/A4604?summary=&detail=",
   "text_version": "A4604",
   "text_date": "",
   "text_url": "http://assembly.state.ny.us/leg/?sh=printbill&bn=A4604&term=2025&Text=Y",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-a6222",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "A 6222",
   "title": "Relates to establishing the \"340B prescription drug anti-discrimination act\"",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination"
   ],
   "summary": "Would bar drug makers, pharmacy benefit managers and drug distributors from limiting the dispensing of drugs by covered entities or their contract pharmacies, denying them drugs because they take part in 340B, or setting terms that differ from those for others.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 13,
   "quote": "… SANTABARBARA, LUNSFORD, LEMONDES, ZACCARO -- read once and referred to the Committee on Health AN ACT to amend the public health law, in relation to establishing the 340B prescription drug anti-discrimination act The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: Section 1. Short title. This …",
   "introduced_date": "2025-02-27",
   "sponsor": "Amy Paulin",
   "cosponsors": 46,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-27",
   "failed_vote": "",
   "latest_action_date": "2026-01-07",
   "latest_action": "REFERRED TO HEALTH",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/A6222?summary=&detail=",
   "text_version": "A6222",
   "text_date": "",
   "text_url": "http://assembly.state.ny.us/leg/?sh=printbill&bn=A6222&term=2025&Text=Y",
   "status_updated": "2026-05-08",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-a6987",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "A 6987",
   "title": "Requires covered entities report to the department of health regarding certain 340B drug discounts",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting"
   ],
   "summary": "Would require covered entities, other than federally qualified health centers, to report each year to the health department on 340B drug costs, payments received, contract pharmacy numbers and payments, and charity care. The department would post the reports online.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 21,
   "quote": "… ordered reprinted as amended and recommitted to said committee AN ACT to amend the public health law, in relation to requiring trans- parency requirements for certain 340B drugs The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: Section 1. The public health law is amended by adding a new …",
   "introduced_date": "2025-03-18",
   "sponsor": "Amanda Septimo",
   "cosponsors": 8,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-03-18",
   "failed_vote": "",
   "latest_action_date": "2026-05-06",
   "latest_action": "PRINT NUMBER 6987A",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/A6987?summary=&detail=",
   "text_version": "A6987A",
   "text_date": "",
   "text_url": "http://legislation.nysenate.gov/pdf/bills/2025/A6987A",
   "status_updated": "2026-05-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-a7817",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "A 7817",
   "title": "Relates to pharmacy benefits where a physician is authorized to dispense certain medications and practices medicine in the oncology setting",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A bill on Medicaid pharmacy benefits where an oncology physician dispenses drugs; the section it amends carries a rule, with dates in 2023 and 2025, that Medicaid pay covered entities for drugs eligible for 340B pricing on actual acquisition cost plus a professional dispensing fee.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… the fee for service program; provided that, subject to the availability of federal financial participation, when reimbursing covered entities, as defined under section 340B of the public health service act (42 U.S.C. §256b), for drugs that would other- wise be eligible for pricing under section 340B of the public health service act, the …",
   "introduced_date": "2025-04-11",
   "sponsor": "Amy Paulin",
   "cosponsors": 2,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-04-11",
   "failed_vote": "",
   "latest_action_date": "2026-03-10",
   "latest_action": "PRINT NUMBER 7817A",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/A7817?summary=&detail=",
   "text_version": "A7817A",
   "text_date": "",
   "text_url": "http://legislation.nysenate.gov/pdf/bills/2025/A7817A",
   "status_updated": "2026-03-24",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-a8747",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "A 8747",
   "title": "Directs the department of health to establish an alternative payment methodology (APM) for Federally Qualified Health Centers to preserve and improve patient access to fertility care",
   "official_title": "",
   "role": "part",
   "kinds": [
    "medicaid"
   ],
   "summary": "In a bill on fertility care at federally qualified health centers, would add a health department payment for Medicaid patients' injectable fertility drugs, equal to the difference between what a center paid for them under 340B in 2024 and the cost at average wholesale acquisition cost.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… between (a) the aggregate amount the federally qualified health center paid to acquire eligible injectable fertility drugs for Medicaid patients under section 340B of the federal public health services act between January 1, 2024 and December 31, 2024 and (b) the aggregate amount the federally qualified health center would have …",
   "introduced_date": "2025-06-02",
   "sponsor": "Kalman Yeger",
   "cosponsors": 5,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-06-02",
   "failed_vote": "",
   "latest_action_date": "2026-03-24",
   "latest_action": "ENACTING CLAUSE STRICKEN",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/A8747?summary=&detail=",
   "text_version": "A8747A",
   "text_date": "",
   "text_url": "http://legislation.nysenate.gov/pdf/bills/2025/A8747A",
   "status_updated": "2026-03-24",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-k718",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "K 718",
   "title": "Congratulating Mark Malahosky upon the occasion of his retirement after 35 years of distinguished service in the field of pharmacy and healthcare",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A resolution honoring a retiring pharmacist; it notes his expertise in 340B and his roles in two groups of 340B providers.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… role in expanding access to care and ensuring medication affordability for the most vulnerable populations; and WHEREAS, Mark Malahosky became a renowned expert on the 340B Drug Pricing Program, which enables safety net providers to purchase medications at a reduced cost and reinvest the savings into comprehensive care for underserved …",
   "introduced_date": "2025-06-06",
   "sponsor": "Harry B. Bronson",
   "cosponsors": 0,
   "committees": "",
   "stage": "Passed the Assembly",
   "stage_date": "2025-06-06",
   "failed_vote": "",
   "latest_action_date": "2025-06-06",
   "latest_action": "ADOPTED",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/K718?summary=&detail=",
   "text_version": "K718",
   "text_date": "",
   "text_url": "http://assembly.state.ny.us/leg/?sh=printbill&bn=K718&term=2025&Text=Y",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-r1722",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "R 1722",
   "title": "Senate budget resolution in response to the 2026-2027 Executive Budget submission",
   "official_title": "",
   "role": "part",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination",
    "other"
   ],
   "summary": "A Senate resolution on the state budget; it puts forward language to bar drug makers, pharmacy benefit managers and other third parties from placing one-sided limits on 340B providers, and directs added funds to providers in financial hardship from 340B changes.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… Center. -The Senate directs the Department of Health to make additional investments to providers who have demonstrated financial hardship resulting from reforms in the 340B programs. Capital Projects (S.9004-B) * The Senate modifies the Executive All Funds recommendation of $1.4 billion and increases by $306 million for a total of $1.7 …",
   "introduced_date": "2026-03-09",
   "sponsor": "Andrea Stewart-Cousins",
   "cosponsors": 0,
   "committees": "",
   "stage": "Passed the Senate",
   "stage_date": "2026-03-12",
   "failed_vote": "",
   "latest_action_date": "2026-03-12",
   "latest_action": "ADOPTED",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/R1722?summary=&detail=",
   "text_version": "R1722",
   "text_date": "",
   "text_url": "http://assembly.state.ny.us/leg/?sh=printbill&bn=R1722&term=2025&Text=Y",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-s1794",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "S 1794",
   "title": "Requires DOH to develop a payment methodology for federally qualified health centers and rural health centers that dispense ovulation enhancing drugs",
   "official_title": "",
   "role": "part",
   "kinds": [
    "medicaid"
   ],
   "summary": "In a bill on the state's payment method for health centers and rural health clinics that are 340B covered entities, would require that method to also cover the cost of all ovulation enhancing drugs they dispense.",
   "names_program_in": [
    "summary",
    "text"
   ],
   "text_mentions": 3,
   "quote": "… two thousand twenty, as amended by section one of part C of chapter fifty-seven of the laws of two thousand twenty-one, for such covered entities as defined in section 340B of the federal public health service act, 42 USC § 256b, for drugs that would otherwise be eligible for pricing under section 340B of the federal public health service …",
   "introduced_date": "2025-01-13",
   "sponsor": "Nathalia Fernandez",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-13",
   "failed_vote": "",
   "latest_action_date": "2026-01-07",
   "latest_action": "REFERRED TO HEALTH",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/S1794?summary=&detail=",
   "text_version": "S1794",
   "text_date": "",
   "text_url": "http://assembly.state.ny.us/leg/?sh=printbill&bn=S1794&term=2025&Text=Y",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-s1913",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "S 1913",
   "title": "Relates to establishing the \"340B prescription drug anti-discrimination act\"",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination"
   ],
   "summary": "Would bar drug makers, pharmacy benefit managers and drug distributors from limiting the dispensing of drugs by covered entities or their contract pharmacies, denying them drugs because they take part in 340B, or setting terms that differ from those for others.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 13,
   "quote": "… -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to establishing the 340B prescription drug anti-discrimination act The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: Section 1. Short title. This …",
   "introduced_date": "2025-01-14",
   "sponsor": "Gustavo Rivera",
   "cosponsors": 22,
   "committees": "",
   "stage": "Passed the Senate",
   "stage_date": "2026-06-04",
   "failed_vote": "",
   "latest_action_date": "2026-06-05",
   "latest_action": "REFERRED TO HEALTH",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/S1913?summary=&detail=",
   "text_version": "S1913",
   "text_date": "",
   "text_url": "http://assembly.state.ny.us/leg/?sh=printbill&bn=S1913&term=2025&Text=Y",
   "status_updated": "2026-06-06",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-s1917",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "S 1917",
   "title": "Establishes an emergency insulin program",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In a wider bill to set up an emergency insulin program, would require certain health facilities that take part in 340B, along with large pharmacy chains, to register as emergency insulin sites and keep a standing order to dispense insulin.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… or more locations in the state, and any facility established pursuant to article twenty-eight of this chapter which has a drug discount program authorized by section 340B of the Federal Public Health Service act 42 U.S.C § 256b shall pursue or main- tain a non-patient-specific prescription with an authorized health care professional to …",
   "introduced_date": "2025-01-14",
   "sponsor": "Gustavo Rivera",
   "cosponsors": 6,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-14",
   "failed_vote": "",
   "latest_action_date": "2026-05-05",
   "latest_action": "REPORTED AND COMMITTED TO FINANCE",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/S1917?summary=&detail=",
   "text_version": "S1917A",
   "text_date": "",
   "text_url": "http://legislation.nysenate.gov/pdf/bills/2025/S1917A",
   "status_updated": "2026-05-06",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-s3425",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "S 3425",
   "title": "Provides for establishment of the New York Health plan",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A bill to set up a single statewide health plan; it says drugs not dispensed through a pharmacy would be paid for under the plan's rules, including use of 340B as appropriate.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… in this paragraph. (ii) Where prescription drugs are not dispensed through a pharmacy, payment shall be made as otherwise provided in this article, including use of the 340B program as appropriate. S. 3425 14 (d) Payment for health care services established under this article shall be considered payment in full. A participating provider …",
   "introduced_date": "2025-01-27",
   "sponsor": "Gustavo Rivera",
   "cosponsors": 33,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-27",
   "failed_vote": "",
   "latest_action_date": "2026-01-07",
   "latest_action": "REFERRED TO HEALTH",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/S3425?summary=&detail=",
   "text_version": "S3425",
   "text_date": "",
   "text_url": "http://assembly.state.ny.us/leg/?sh=printbill&bn=S3425&term=2025&Text=Y",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-s371",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "S 371",
   "title": "Relates to creating a wholesale prescription drug importation program",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In a wider bill to set up a state program to import prescription drugs wholesale, would have the health commissioner seek federal approvals so 340B covered entities can take part without putting their 340B eligibility at risk.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… or agreements, or a combination thereof, as needed to enable all covered entities enrolled in or eligible for the drug discount program authorized by section 340B of the federal public health service act (42 U.S.C. § 256b) to participate in the wholesale S. 371 3 prescription drug importation program to the fullest extent …",
   "introduced_date": "2025-01-08",
   "sponsor": "James Skoufis",
   "cosponsors": 2,
   "committees": "",
   "stage": "Passed the Senate",
   "stage_date": "2025-05-20",
   "failed_vote": "",
   "latest_action_date": "2026-02-24",
   "latest_action": "REFERRED TO HIGHER EDUCATION",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/S371?summary=&detail=",
   "text_version": "S371",
   "text_date": "",
   "text_url": "http://assembly.state.ny.us/leg/?sh=printbill&bn=S371&term=2025&Text=Y",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-s6000",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "S 6000",
   "title": "Directs the department of health to establish an alternative payment methodology (APM) for Federally Qualified Health Centers to preserve and improve patient access to fertility care",
   "official_title": "",
   "role": "part",
   "kinds": [
    "medicaid"
   ],
   "summary": "In a bill on state payment for fertility care at federally qualified health centers, would pay them the gap between what they would have been paid for certain fertility drugs under 340B in 2024 and what a managed care plan would have paid.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… determined by the department and shall equal the difference between what the eligible provider would have been paid for certain classes of fertility drugs under section 340B of the federal public health services act between January 1, 2024 and December 31, 2024 and the amount that the eligible provider would have been reimbursed for such …",
   "introduced_date": "2025-03-04",
   "sponsor": "Simcha Felder",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-03-04",
   "failed_vote": "",
   "latest_action_date": "2025-05-27",
   "latest_action": "RECOMMIT, ENACTING CLAUSE STRICKEN",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/S6000?summary=&detail=",
   "text_version": "S6000",
   "text_date": "",
   "text_url": "http://assembly.state.ny.us/leg/?sh=printbill&bn=S6000&term=2025&Text=Y",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-s8257",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "S 8257",
   "title": "Directs the department of health to establish an alternative payment methodology (APM) for Federally Qualified Health Centers to preserve and improve patient access to fertility care",
   "official_title": "",
   "role": "part",
   "kinds": [
    "medicaid"
   ],
   "summary": "In a bill on fertility care at federally qualified health centers, would add a health department payment for Medicaid patients' injectable fertility drugs, equal to the difference between what a center paid for them under 340B in 2024 and the cost at average wholesale acquisition cost.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… between (a) the aggregate amount the federally qualified health center paid to acquire eligible injectable fertility drugs for Medicaid patients under section 340B of the federal public health services act between January 1, 2024 and December 31, 2024 and (b) the aggregate amount the federally qualified health center would have …",
   "introduced_date": "2025-05-27",
   "sponsor": "Sam Sutton",
   "cosponsors": 4,
   "committees": "",
   "stage": "Passed the Senate",
   "stage_date": "2025-06-09",
   "failed_vote": "",
   "latest_action_date": "2026-01-27",
   "latest_action": "REFERRED TO HEALTH",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/S8257?summary=&detail=",
   "text_version": "S8257A",
   "text_date": "",
   "text_url": "http://legislation.nysenate.gov/pdf/bills/2025/S8257A",
   "status_updated": "2026-04-21",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-s8380",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "S 8380",
   "title": "Requires covered entities report to the department of health regarding certain 340B drug discounts",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting"
   ],
   "summary": "Would require covered entities, other than federally qualified health centers, to report each year to the health department on 340B drug costs, payments received, contract pharmacy numbers and payments, and charity care. The department would post the reports online.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 21,
   "quote": "… ordered reprinted as amended and recommitted to said committee AN ACT to amend the public health law, in relation to requiring trans- parency requirements for certain 340B drugs The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: Section 1. The public health law is amended by adding a new …",
   "introduced_date": "2025-06-06",
   "sponsor": "Siela Bynoe",
   "cosponsors": 4,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-06-06",
   "failed_vote": "",
   "latest_action_date": "2026-05-12",
   "latest_action": "PRINT NUMBER 8380A",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/S8380?summary=&detail=",
   "text_version": "S8380A",
   "text_date": "",
   "text_url": "http://legislation.nysenate.gov/pdf/bills/2025/S8380A",
   "status_updated": "2026-05-15",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ny-20252026-s9434",
   "jurisdiction": "NY",
   "session": "2025 Regular Session",
   "session_end": "2026-12-31",
   "bill": "S 9434",
   "title": "Relates to pharmacy benefits where a physician is authorized to dispense certain medications and practices medicine in the oncology setting",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A bill on Medicaid drug benefits where cancer doctors dispense medicines; the law section it amends includes wording that the state pay covered entities for 340B-eligible drugs based on actual acquisition cost plus a dispensing fee.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… the fee for service program; provided that, subject to the availability of federal financial participation, when reimbursing covered entities, as defined under section 340B of the public health service act (42 U.S.C. §256b), for drugs that would other- wise be eligible for pricing under section 340B of the public health service act, the …",
   "introduced_date": "2026-03-12",
   "sponsor": "Gustavo Rivera",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-03-12",
   "failed_vote": "",
   "latest_action_date": "2026-05-12",
   "latest_action": "REPORTED AND COMMITTED TO FINANCE",
   "law": "",
   "same_as": "",
   "bill_url": "https://legislation.nysenate.gov/api/3/bills/2025-2026/S9434?summary=&detail=",
   "text_version": "S9434",
   "text_date": "",
   "text_url": "http://assembly.state.ny.us/leg/?sh=printbill&bn=S9434&term=2025&Text=Y",
   "status_updated": "2026-05-12",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "oh-136-hb276",
   "jurisdiction": "OH",
   "session": "136th Legislature (2025-2026)",
   "session_end": "2026-12-31",
   "bill": "HB 276",
   "title": "Prohibit certain actions re: reimbursing 340B covered entities",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers, repackagers and logistics providers from limiting the purchase or delivery of 340B drugs to 340B grantees, a defined group of covered entities, or demanding claims data as a condition. Fines could reach $50,000 per violation.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 21,
   "quote": "… 3902.72 (3902.75); and to enact new section 3902.72 of the Revised Code to prohibit drug manufacturers from taking certain actions regarding reimbursements made to 340B covered entities. BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO: Section 1. That sections 3902.50 and 3902.70 be amended; section 3902.72 (3902.75) be …",
   "introduced_date": "2025-05-14",
   "sponsor": "Marilyn John; Adam Holmes",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-05-14",
   "failed_vote": "",
   "latest_action_date": "2025-05-21",
   "latest_action": "Referred to committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.legislature.ohio.gov/legislation/136/hb276",
   "text_version": "As Introduced",
   "text_date": "",
   "text_url": "https://search-prod.lis.state.oh.us/api/v2/general_assembly_136/legislation/hb276/00_IN/html/",
   "status_updated": "2026-03-17",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "oh-136-hb780",
   "jurisdiction": "OH",
   "session": "136th Legislature (2025-2026)",
   "session_end": "2026-12-31",
   "bill": "HB 780",
   "title": "Enact the Medicaid Savings Act",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A wider Medicaid bill that would end the care management system; it updates definitions used in existing rules on what a pharmacy must pass on to a 340B covered entity.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 8,
   "quote": "… any other component of pharmacist care that is included in the practice of pharmacy. Sec. 3902.70. As used in this section and section 3902.71 of the Revised Code: (A) \"340B covered entity\" means an entity described in section 340B(a)(4) of the \"Public Health Service Act,\" 42 U.S.C. 256b(a)(4) and includes any pharmacy under contract with …",
   "introduced_date": "2026-03-24",
   "sponsor": "Karen Brownlee",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-03-24",
   "failed_vote": "",
   "latest_action_date": "2026-03-25",
   "latest_action": "Referred to committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.legislature.ohio.gov/legislation/136/hb780",
   "text_version": "As Introduced",
   "text_date": "",
   "text_url": "https://search-prod.lis.state.oh.us/api/v2/general_assembly_136/legislation/hb780/00_IN/html/",
   "status_updated": "2026-04-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "oh-136-hb890",
   "jurisdiction": "OH",
   "session": "136th Legislature (2025-2026)",
   "session_end": "2026-12-31",
   "bill": "HB 890",
   "title": "Enact Prescription Relief, Inflation Cost Elimination (PRICE) Act",
   "official_title": "",
   "role": "part",
   "kinds": [
    "payer-nondiscrimination",
    "study"
   ],
   "summary": "In a wider bill creating a prescription drug affordability board, would bar payers from paying a 340B covered entity less than any upper payment limit set for a drug, and would have the board weigh and study how such limits affect 340B covered entities.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 4,
   "quote": "… , 3901.856 , 3901.857 , and 3901.858 of the Revised Code be enacted to read as follows: Sec. 3901.85. As used in sections 3901.85 to 3901.858 of the Revised Code: (A) \"340B covered entity\" has the same meaning as in section 5167.01 of the Revised Code. (B) \"Biological product\" and \"biosimilar\" have the same meanings as in 42 U.S.C. 262. …",
   "introduced_date": "2026-05-12",
   "sponsor": "Derrick Hall",
   "cosponsors": 5,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-05-12",
   "failed_vote": "",
   "latest_action_date": "2026-05-20",
   "latest_action": "Referred to committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.legislature.ohio.gov/legislation/136/hb890",
   "text_version": "As Introduced",
   "text_date": "",
   "text_url": "https://search-prod.lis.state.oh.us/api/v2/general_assembly_136/legislation/hb890/00_IN/html/",
   "status_updated": "2026-05-21",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "oh-136-hb96",
   "jurisdiction": "OH",
   "session": "136th Legislature (2025-2026)",
   "session_end": "2026-12-31",
   "bill": "HB 96",
   "title": "Make state operating appropriations for FY 2026-27",
   "official_title": "",
   "role": "part",
   "kinds": [
    "reporting",
    "other"
   ],
   "summary": "In the state operating budget, requires each 340B covered entity to report yearly to the health department on 340B costs, payments, contract pharmacies and spending of 340B profits, for public posting. A contracted pharmacy must pay the covered entity all it collects for a drug, less an agreed fee.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 47,
   "quote": "… to Sub. H.B. 544 of the 127th general assembly and shall be used in accordance with section 3701.84 of the Revised Code. Sec. 3701.88. (A) As used in this section: \"340B covered entity\" means an entity described in section 340B(a)(4) of the \"Public Health Service Act,\" 42 U.S.C. 256b(a)(4). \"340B drug\" means a covered outpatient drug …",
   "introduced_date": "2025-02-11",
   "sponsor": "Brian Stewart",
   "cosponsors": 25,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-06-30",
   "failed_vote": "",
   "latest_action_date": "2025-10-01",
   "latest_action": "Item passed notwithstanding objections of the Governor",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.legislature.ohio.gov/legislation/136/hb96",
   "text_version": "As Enrolled",
   "text_date": "",
   "text_url": "https://search-prod.lis.state.oh.us/api/v2/general_assembly_136/legislation/hb96/07_EN/html/",
   "status_updated": "2026-10-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "oh-136-sb198",
   "jurisdiction": "OH",
   "session": "136th Legislature (2025-2026)",
   "session_end": "2026-12-31",
   "bill": "SB 198",
   "title": "Prohibit certain actions re: reimbursing 340B covered entities",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers, repackagers and logistics providers from limiting the purchase or delivery of 340B drugs to 340B grantees, a defined group of covered entities, or demanding claims data as a condition. Fines could reach $50,000 per violation.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 21,
   "quote": "… 3902.72 (3902.75); and to enact new section 3902.72 of the Revised Code to prohibit drug manufacturers from taking certain actions regarding reimbursements made to 340B covered entities. BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO: Section 1. That sections 3902.50 and 3902.70 be amended; section 3902.72 (3902.75) be …",
   "introduced_date": "2025-05-13",
   "sponsor": "Kyle Koehler",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-05-13",
   "failed_vote": "",
   "latest_action_date": "2025-05-14",
   "latest_action": "Referred to committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.legislature.ohio.gov/legislation/136/sb198",
   "text_version": "As Introduced",
   "text_date": "",
   "text_url": "https://search-prod.lis.state.oh.us/api/v2/general_assembly_136/legislation/sb198/00_IN/html/",
   "status_updated": "2026-03-17",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "oh-136-sb386",
   "jurisdiction": "OH",
   "session": "136th Legislature (2025-2026)",
   "session_end": "2026-12-31",
   "bill": "SB 386",
   "title": "Enact the Medicaid Savings Act",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A wider Medicaid bill that would end the care management system; it updates definitions used in existing rules on what a pharmacy must pass on to a 340B covered entity.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 8,
   "quote": "… any other component of pharmacist care that is included in the practice of pharmacy. Sec. 3902.70. As used in this section and section 3902.71 of the Revised Code: (A) \"340B covered entity\" means an entity described in section 340B(a)(4) of the \"Public Health Service Act,\" 42 U.S.C. 256b(a)(4) and includes any pharmacy under contract with …",
   "introduced_date": "2026-03-23",
   "sponsor": "Louis W. Blessing, III; Beth Liston",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-03-23",
   "failed_vote": "",
   "latest_action_date": "2026-03-25",
   "latest_action": "Referred to committee",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.legislature.ohio.gov/legislation/136/sb386",
   "text_version": "As Introduced",
   "text_date": "",
   "text_url": "https://search-prod.lis.state.oh.us/api/v2/general_assembly_136/legislation/sb386/00_IN/html/",
   "status_updated": "2026-04-10",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ok-2025-hb2048",
   "jurisdiction": "OK",
   "session": "2025 Regular Session",
   "session_end": "2025-05-30",
   "bill": "HB 2048",
   "title": "Prescriptions; 340B Nondiscrimination Act; definitions; discriminatory actions; reimbursement; manufacturer; distributor; enforcement; Attorney General; Insurance Commissioner; violations; federal preemption; effective date.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination",
    "other"
   ],
   "summary": "Would bar insurers and pharmacy benefit managers from paying 340B entities less or adding fees because of 340B, and bar drug makers from restricting delivery of 340B drugs to them or their contract pharmacies. A 340B entity would have to contract with any willing pharmacy within 15 miles.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 71,
   "quote": "An Act ENROLLED HOUSE BILL NO. 2048 By: Stinson, Deck, Moore, Archer and Hefner of the House and Howard of the Senate An Act relating to prescriptions; creating the 340B Nondiscrimination Act; defining terms; prohibiting certain discriminatory actions related to reimbursement of certain entities; making certain provisions inapplicable …",
   "introduced_date": "2025-02-03",
   "sponsor": "Stinson; Howard",
   "cosponsors": 0,
   "committees": "",
   "stage": "Sent to the governor",
   "stage_date": "2025-05-12",
   "failed_vote": "",
   "latest_action_date": "2025-05-29",
   "latest_action": "Filed with Secretary of State",
   "law": "",
   "same_as": "",
   "bill_url": "http://www.oklegislature.gov/BillInfo.aspx?Bill=HB2048&session=2500",
   "text_version": "Enrolled (final version)",
   "text_date": "",
   "text_url": "https://www.oklegislature.gov/cf_pdf/2025-26%20ENR/hB/HB2048%20ENR.PDF",
   "status_updated": "2025-05-30",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ok-2025-sb1030",
   "jurisdiction": "OK",
   "session": "2025 Regular Session",
   "session_end": "2025-05-30",
   "bill": "SB 1030",
   "title": "Prescription drug pricing; prohibiting certain action. Effective date.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination"
   ],
   "summary": "Would bar insurers and pharmacy benefit managers from paying 340B entities less or setting different terms for them than for other pharmacies, and would bar drug makers and distributors from withholding 340B pricing or limiting drugs dispensed under contract pharmacy agreements.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 70,
   "quote": "STATE OF OKLAHOMA 1st Session of the 60th Legislature (2025) SENATE BILL 1030 By: Howard AS INTRODUCED An Act relating to prescription drug pricing; creating the 340B Drug Pricing Nondiscrimination Act; providing short title; defining terms; prohibiting certain reimbursement rates; prohibiting certain terms or conditions on a 340B …",
   "introduced_date": "2025-02-03",
   "sponsor": "Howard; Stinson",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-03",
   "failed_vote": "",
   "latest_action_date": "2025-03-05",
   "latest_action": "Coauthored by Representative Deck",
   "law": "",
   "same_as": "",
   "bill_url": "http://www.oklegislature.gov/BillInfo.aspx?Bill=SB1030&session=2500",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://www.oklegislature.gov/cf_pdf/2025-26%20INT/SB/SB1030%20INT.PDF",
   "status_updated": "2025-03-06",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ok-2025-sb1063",
   "jurisdiction": "OK",
   "session": "2025 Regular Session",
   "session_end": "2025-05-30",
   "bill": "SB 1063",
   "title": "Prescriptions; creating the Oklahoma Health Care Safety Net and Affordable Prescriptions Accessibility Act; prohibiting certain actions; providing for enforcement by Attorney General and Insurance Commissioner. Effective date.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination"
   ],
   "summary": "Would bar insurers and pharmacy benefit managers from paying 340B entities less or setting different terms for them than for other pharmacies, and would bar drug makers and distributors from blocking delivery of 340B drugs to contract pharmacies.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 42,
   "quote": "… in the Oklahoma Statutes as Section 5400 of Title 36, unless there is created a duplication in numbering, reads as follows: As used in this act: Req. No. 759 Page 1 1. “340B drug” means a drug that has been subject to any offer for reduced prices by a manufacturer pursuant to 42 U.S.C., Section 256b, and is purchased by a covered entity as …",
   "introduced_date": "2025-02-03",
   "sponsor": "Rosino",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-03",
   "failed_vote": "",
   "latest_action_date": "2025-02-04",
   "latest_action": "Second Reading referred to Health and Human Services",
   "law": "",
   "same_as": "",
   "bill_url": "http://www.oklegislature.gov/BillInfo.aspx?Bill=SB1063&session=2500",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://www.oklegislature.gov/cf_pdf/2025-26%20INT/SB/SB1063%20INT.PDF",
   "status_updated": "2025-11-26",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ok-2026-hb2048",
   "jurisdiction": "OK",
   "session": "2026 Regular Session",
   "session_end": "2026-05-29",
   "bill": "HB 2048",
   "title": "Prescriptions; 340B Nondiscrimination Act; definitions; discriminatory actions; reimbursement; manufacturer; distributor; enforcement; Attorney General; Insurance Commissioner; violations; federal preemption; effective date.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination",
    "other"
   ],
   "summary": "Would bar insurers and pharmacy benefit managers from paying 340B entities less or adding fees because of 340B, and bar drug makers from restricting delivery of 340B drugs to them or their contract pharmacies. A 340B entity would have to contract with any willing pharmacy within 15 miles.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 71,
   "quote": "An Act ENROLLED HOUSE BILL NO. 2048 By: Stinson, Deck, Moore, Archer and Hefner of the House and Howard of the Senate An Act relating to prescriptions; creating the 340B Nondiscrimination Act; defining terms; prohibiting certain discriminatory actions related to reimbursement of certain entities; making certain provisions inapplicable …",
   "introduced_date": "2025-02-03",
   "sponsor": "Stinson; Howard",
   "cosponsors": 0,
   "committees": "",
   "stage": "Sent to the governor",
   "stage_date": "2025-05-12",
   "failed_vote": "",
   "latest_action_date": "2025-05-29",
   "latest_action": "Filed with Secretary of State",
   "law": "",
   "same_as": "",
   "bill_url": "http://www.oklegislature.gov/BillInfo.aspx?Bill=HB2048&session=2600",
   "text_version": "Enrolled (final version)",
   "text_date": "",
   "text_url": "https://www.oklegislature.gov/cf_pdf/2025-26%20ENR/hB/HB2048%20ENR.PDF",
   "status_updated": "2026-07-09",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ok-2026-sb1030",
   "jurisdiction": "OK",
   "session": "2026 Regular Session",
   "session_end": "2026-05-29",
   "bill": "SB 1030",
   "title": "Prescription drug pricing; prohibiting certain action. Effective date.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination"
   ],
   "summary": "Would bar insurers and pharmacy benefit managers from paying 340B entities less or setting different terms for them than for other pharmacies, and would bar drug makers and distributors from withholding 340B pricing or limiting drugs dispensed under contract pharmacy agreements.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 70,
   "quote": "STATE OF OKLAHOMA 1st Session of the 60th Legislature (2025) SENATE BILL 1030 By: Howard AS INTRODUCED An Act relating to prescription drug pricing; creating the 340B Drug Pricing Nondiscrimination Act; providing short title; defining terms; prohibiting certain reimbursement rates; prohibiting certain terms or conditions on a 340B …",
   "introduced_date": "2025-02-03",
   "sponsor": "Howard; Stinson",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-03",
   "failed_vote": "",
   "latest_action_date": "2025-03-05",
   "latest_action": "Coauthored by Representative Deck",
   "law": "",
   "same_as": "",
   "bill_url": "http://www.oklegislature.gov/BillInfo.aspx?Bill=SB1030&session=2600",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://www.oklegislature.gov/cf_pdf/2025-26%20INT/SB/SB1030%20INT.PDF",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ok-2026-sb1063",
   "jurisdiction": "OK",
   "session": "2026 Regular Session",
   "session_end": "2026-05-29",
   "bill": "SB 1063",
   "title": "Prescriptions; creating the Oklahoma Health Care Safety Net and Affordable Prescriptions Accessibility Act; prohibiting certain actions; providing for enforcement by Attorney General and Insurance Commissioner. Effective date.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination"
   ],
   "summary": "Would bar insurers and pharmacy benefit managers from paying 340B entities less or setting different terms for them than for other pharmacies, and would bar drug makers and distributors from blocking delivery of 340B drugs to contract pharmacies.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 42,
   "quote": "… in the Oklahoma Statutes as Section 5400 of Title 36, unless there is created a duplication in numbering, reads as follows: As used in this act: Req. No. 759 Page 1 1. “340B drug” means a drug that has been subject to any offer for reduced prices by a manufacturer pursuant to 42 U.S.C., Section 256b, and is purchased by a covered entity as …",
   "introduced_date": "2025-02-03",
   "sponsor": "Rosino",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-03",
   "failed_vote": "",
   "latest_action_date": "2025-02-04",
   "latest_action": "Second Reading referred to Health and Human Services",
   "law": "",
   "same_as": "",
   "bill_url": "http://www.oklegislature.gov/BillInfo.aspx?Bill=SB1063&session=2600",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://www.oklegislature.gov/cf_pdf/2025-26%20INT/SB/SB1063%20INT.PDF",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ok-2026-sb252",
   "jurisdiction": "OK",
   "session": "2026 Regular Session",
   "session_end": "2026-05-29",
   "bill": "SB 252",
   "title": "Medicaid; excluding prescription drug services from certain provisions; directing certain program delivery model. Effective date.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A Medicaid bill on how prescription drugs are delivered; its text on Medicaid managed care plans lists pharmacies contracted with 340B covered entities among the pharmacies those plans must give broad access to.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… by the Authority; and Req. No. 723 Page 12 2. Ensure broad access to pharmacies including, but not limited to, pharmacies contracted with covered entities under Section 340B of the Public Health Service Act. Such access shall, at a minimum, meet the requirements of the Patient’s Right to Pharmacy Choice Act, Section 6958 et seq. of Title 36 …",
   "introduced_date": "2025-02-03",
   "sponsor": "Standridge",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-03",
   "failed_vote": "",
   "latest_action_date": "2025-02-05",
   "latest_action": "Coauthored by Senator Bergstrom",
   "law": "",
   "same_as": "",
   "bill_url": "http://www.oklegislature.gov/BillInfo.aspx?Bill=SB252&session=2600",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://www.oklegislature.gov/cf_pdf/2025-26%20INT/SB/SB252%20INT.PDF",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "or-2025r1-hb2057",
   "jurisdiction": "OR",
   "session": "2025 Regular Session",
   "session_end": "2025-06-30",
   "bill": "HB 2057",
   "title": "Relating to prescription drugs; prescribing an effective date.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "Would bar insurers and pharmacy benefit managers from requiring a claim to carry a marker showing that the drug is a 340B drug, except for Medicaid claims or where the law requires the marker to prevent a duplicate discount.",
   "names_program_in": [
    "summary",
    "text"
   ],
   "text_mentions": 19,
   "quote": "… statement includes a measure digest written in compliance with applicable readability standards. Digest: Tells insurers and PBMs not to require that drugs be labeled as 340B drugs in a claim for repayment. (Flesch Readability Score: 62.8). Prohibits insurers offering policies or certificates of health insurance and pharmacy benefit managers …",
   "introduced_date": "2025-01-13",
   "sponsor": "Rob Nosse",
   "cosponsors": 2,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-13",
   "failed_vote": "",
   "latest_action_date": "2025-06-28",
   "latest_action": "In committee upon adjournment.",
   "law": "",
   "same_as": "",
   "bill_url": "https://olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/HB2057",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://olis.oregonlegislature.gov/liz/2025R1/Downloads/MeasureDocument/HB2057/Introduced",
   "status_updated": "2025-06-30",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "or-2025r1-hb2385",
   "jurisdiction": "OR",
   "session": "2025 Regular Session",
   "session_end": "2025-06-30",
   "bill": "HB 2385",
   "title": "Relating to restrictions on 340B covered entities; and prescribing an effective date.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Bars drug makers from denying or restricting delivery of 340B drugs to a pharmacy under contract with a covered entity, and from requiring claims or utilization review data as a condition. The state pharmacy board may fine a drug maker up to $5,000 a day for each violation.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 12,
   "quote": "… GAMBA, GOMBERG, JAVADI, PHAM H, Senator MANNING JR (Presession filed.) CHAPTER ................................................. AN ACT Relating to restrictions on 340B covered entities; and prescribing an effective date. Be It Enacted by the People of the State of Oregon: SECTION 1. (1) As used in this section: (a) “Covered entity” …",
   "introduced_date": "2025-01-13",
   "sponsor": "Rob Nosse; Deb Patterson",
   "cosponsors": 6,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-06-11",
   "failed_vote": "",
   "latest_action_date": "2025-06-24",
   "latest_action": "Chapter 297, (2025 Laws): effective on the 91st day following adjournment sine die.",
   "law": "",
   "same_as": "",
   "bill_url": "https://olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/HB2385",
   "text_version": "Enrolled",
   "text_date": "",
   "text_url": "https://olis.oregonlegislature.gov/liz/2025R1/Downloads/MeasureDocument/HB2385/Enrolled",
   "status_updated": "2025-09-25",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "or-2025r1-hb3212",
   "jurisdiction": "OR",
   "session": "2025 Regular Session",
   "session_end": "2025-06-30",
   "bill": "HB 3212",
   "title": "Relating to pharmacy benefits.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A bill adding rules for pharmacy benefit managers and drug coverage; it names 340B only in existing rules it restates, which bar paying 340B pharmacies differently or shutting them out of pharmacy networks.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 10,
   "quote": "… in paragraph (e) of this subsection. (g) Shall ensure that dispensing fees are not included in the calculation of maximum allowable cost. (h) May not reimburse a 340B pharmacy differently than any other network pharmacy based on its status as a 340B pharmacy. (i) Shall comply with the provisions of ORS 743A.062. (j) May not …",
   "introduced_date": "2025-01-13",
   "sponsor": "Rob Nosse; Nancy Nathanson; Ed Diehl; Bobby Levy; Kim Wallan; Sara Gelser Blouin; Jeff Golden; Gregory Smith",
   "cosponsors": 18,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-13",
   "failed_vote": "",
   "latest_action_date": "2025-06-28",
   "latest_action": "In committee upon adjournment.",
   "law": "",
   "same_as": "",
   "bill_url": "https://olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/HB3212",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://olis.oregonlegislature.gov/liz/2025R1/Downloads/MeasureDocument/HB3212/Introduced",
   "status_updated": "2025-09-25",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "or-2025r1-hb3226",
   "jurisdiction": "OR",
   "session": "2025 Regular Session",
   "session_end": "2025-06-30",
   "bill": "HB 3226",
   "title": "Relating to organizations that provide services related to obtaining prescription drugs; and prescribing an effective date.",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A law on organizations that provide services related to obtaining prescription drugs; it names 340B only in a definition of \"340B pharmacy\" in the pharmacy benefit manager statutes it amends.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… means a pharmacy capable of meeting the requirements applicable to specialty drugs. (15) “Third party administrator” means a person licensed under ORS 744.702. (16) “340B pharmacy” means a pharmacy that is authorized to purchase drugs at a discount under 42 U.S.C. 256b. SECTION 2. ORS 744.702 is amended to read: 744.702. (1) Subject to …",
   "introduced_date": "2025-01-13",
   "sponsor": "Nancy Nathanson; Rob Nosse; Bobby Levy",
   "cosponsors": 6,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-06-11",
   "failed_vote": "",
   "latest_action_date": "2025-06-24",
   "latest_action": "Chapter 303, (2025 Laws): effective on the 91st day following adjournment sine die.",
   "law": "",
   "same_as": "",
   "bill_url": "https://olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/HB3226",
   "text_version": "Enrolled",
   "text_date": "",
   "text_url": "https://olis.oregonlegislature.gov/liz/2025R1/Downloads/MeasureDocument/HB3226/Enrolled",
   "status_updated": "2025-06-24",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "or-2025r1-sb533",
   "jurisdiction": "OR",
   "session": "2025 Regular Session",
   "session_end": "2025-06-30",
   "bill": "SB 533",
   "title": "Relating to restrictions on 340B covered entities.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers from interfering with a contract pharmacy acquiring, receiving or dispensing 340B drugs for a covered entity, and from requiring claims or utilization review data as a condition. The pharmacy board could fine a drug maker up to $5,000 per day.",
   "names_program_in": [
    "title",
    "summary",
    "text"
   ],
   "text_mentions": 16,
   "quote": "… for violations. (Flesch Readability Score: 60.8). Creates a civil penalty for drug manufacturers that interfere directly or indirectly with certain entities acquiring 340B drugs, delivering 340B drugs to certain health care providers or dispensing 340B drugs. Creates a civil penalty for drug manufactures that require certain entities to …",
   "introduced_date": "2025-01-13",
   "sponsor": "Deb Patterson; Rob Nosse; James Manning Jr.",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-13",
   "failed_vote": "",
   "latest_action_date": "2025-06-27",
   "latest_action": "At President's desk upon adjournment.",
   "law": "",
   "same_as": "",
   "bill_url": "https://olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/SB533",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://olis.oregonlegislature.gov/liz/2025R1/Downloads/MeasureDocument/SB533/Introduced",
   "status_updated": "2025-06-30",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "pa-20252026-hb2797",
   "jurisdiction": "PA",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-11-30",
   "bill": "HB 2797",
   "title": "An Act providing for 340B drug reimbursement, for reimbursement claims methodology, for safety net reimbursement protection, for safety net prescription drug distribution and access protections and for enforcement; and imposing penalties.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination",
    "medicaid"
   ],
   "summary": "Would set a floor on what insurers and pharmacy benefit managers pay covered entities and contract pharmacies for 340B drugs, set rules for 340B drugs in Medicaid managed care, and bar drug makers from limiting delivery of 340B drugs or demanding claims data.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 23,
   "quote": "… HOUSE BILL No. 2797 Session of 2026 INTRODUCED BY ORTITAY AND KHAN, SEPTEMBER 24, 2026 REFERRED TO COMMITTEE ON HUMAN SERVICES, SEPTEMBER 29, 2026 AN ACT Providing for 340B drug reimbursement, for reimbursement claims methodology, for safety net reimbursement protection, for safety net prescription drug distribution and access protections …",
   "introduced_date": "2026-09-29",
   "sponsor": "Jason Ortitay",
   "cosponsors": 2,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-09-29",
   "failed_vote": "",
   "latest_action_date": "2026-09-29",
   "latest_action": "Referred to Human Services",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.palegis.us/legislation/bills/2025/hb2797",
   "text_version": "Printer's No. PN3953",
   "text_date": "",
   "text_url": "https://www.palegis.us/legislation/bills/text/HTM/2025/0/HB2797/PN3953",
   "status_updated": "2026-10-21",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "pa-20252026-sb1486",
   "jurisdiction": "PA",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-11-30",
   "bill": "SB 1486",
   "title": "An Act providing for prohibitions on discriminatory actions by manufacturers or distributors of certain drugs and for reimbursement claims methodology; providing for grants for sexually transmitted disease clinics; imposing duties on the Department of Human Services and Office of Attorney General; and imposing penalties.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "medicaid"
   ],
   "summary": "Would bar drug makers and distributors from limiting delivery of 340B drugs to places a covered entity names, or demanding claims data as a condition, with fines of $50,000 per violation. Would also require a billing modifier to mark 340B drugs on Medicaid claims.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 14,
   "quote": "… penalties. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. Short title. This act shall be known and may be cited as the 340B Contract Pharmacy Protection Act. Section 2. Definitions. The following words and phrases when used in this act shall have the meanings given to them in this section …",
   "introduced_date": "2026-10-13",
   "sponsor": "Michele Brooks",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-10-13",
   "failed_vote": "",
   "latest_action_date": "2026-10-13",
   "latest_action": "Referred to Health & Human Services",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.palegis.us/legislation/bills/2025/sb1486",
   "text_version": "Printer's No. PN2028",
   "text_date": "",
   "text_url": "https://www.palegis.us/legislation/bills/text/HTM/2025/0/SB1486/PN2028",
   "status_updated": "2026-10-14",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ri-2025-hb5116",
   "jurisdiction": "RI",
   "session": "2025 Regular Session",
   "session_end": "2025-06-30",
   "bill": "HB 5116",
   "title": "AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACEUTICAL COST TRANSPARENCY",
   "official_title": "",
   "role": "part",
   "kinds": [
    "medicaid",
    "study"
   ],
   "summary": "In a wider drug cost transparency bill, would have Medicaid use the same dispensing fee for 340B drugs as for other drugs, with leeway for health centers and family planning clinics, and would order a report on how 340B drugs are paid for and who benefits.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 20,
   "quote": "… is hereby amended by adding thereto the following chapter: CHAPTER 19.3 PHARMACEUTICAL COST TRANSPARENCY 5-19.3-1. Definitions. As used in this chapter: (1) \"340B\" means the federal drug pricing program established pursuant to 42 U.S.C.§ 256b. (2) \"340B prescription drug\" means a prescription drug that has been subject to any …",
   "introduced_date": "2025-01-22",
   "sponsor": "Lombardi; Hull; Potter; Stewart; Voas; Felix",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-22",
   "failed_vote": "",
   "latest_action_date": "2025-03-06",
   "latest_action": "03/06/2025 Committee recommended measure be held for further study",
   "law": "",
   "same_as": "",
   "bill_url": "http://webserver.rilegislature.gov/BillText/BillText25/HouseText25/H5116.pdf",
   "text_version": "5116",
   "text_date": "",
   "text_url": "http://webserver.rilegislature.gov/BillText/BillText25/HouseText25/H5116.pdf",
   "status_updated": "2025-03-07",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ri-2025-hb5634",
   "jurisdiction": "RI",
   "session": "2025 Regular Session",
   "session_end": "2025-06-30",
   "bill": "HB 5634",
   "title": "AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- DEFENDING AFFORDABLE PRESCRIPTION DRUG COSTS ACT",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination",
    "reporting"
   ],
   "summary": "Bars insurers and pharmacy benefit managers, but not Medicaid, from paying less or setting different terms for 340B drugs, and bars drug makers from blocking delivery to contract pharmacies. Each covered entity must file a yearly public report on its 340B costs, payments and use of savings.",
   "names_program_in": [
    "summary",
    "text"
   ],
   "text_mentions": 79,
   "quote": "… cited as the \"Defending Affordable Prescription Drug Costs Act\". 5-19.3-2. Definitions. As used in this chapter, the following terms have the following meanings: (1) \"340B drug\" means a drug that has been subject to any offer for reduced prices by a manufacturer pursuant to 42 U.S.C. § 256b and is purchased by a covered entity as defined …",
   "introduced_date": "2025-02-26",
   "sponsor": "Brien; Baginski; Cotter; Hopkins; Place",
   "cosponsors": 0,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-06-27",
   "failed_vote": "",
   "latest_action_date": "2025-06-27",
   "latest_action": "06/27/2025 Signed by Governor",
   "law": "",
   "same_as": "",
   "bill_url": "http://webserver.rilegislature.gov/BillText/BillText25/HouseText25/H5634Aaa.pdf",
   "text_version": "5634  SUB A as amended",
   "text_date": "",
   "text_url": "http://webserver.rilegislature.gov/BillText/BillText25/HouseText25/H5634Aaa.pdf",
   "status_updated": "2025-06-30",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ri-2025-sb114",
   "jurisdiction": "RI",
   "session": "2025 Regular Session",
   "session_end": "2025-06-30",
   "bill": "SB 114",
   "title": "AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- DEFENDING AFFORDABLE PRESCRIPTION DRUG COSTS ACT",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination",
    "reporting"
   ],
   "summary": "Bars insurers and pharmacy benefit managers, but not Medicaid, from paying less or setting different terms for 340B drugs, and bars drug makers from blocking delivery to contract pharmacies. Each covered entity must file a yearly public report on its 340B costs, payments and use of savings.",
   "names_program_in": [
    "summary",
    "text"
   ],
   "text_mentions": 79,
   "quote": "… cited as the \"Defending Affordable Prescription Drug Costs Act\". 5-19.3-2. Definitions. As used in this chapter, the following terms have the following meanings: (1) \"340B drug\" means a drug that has been subject to any offer for reduced prices by a manufacturer pursuant to 42 U.S.C. § 256b and is purchased by a covered entity as defined …",
   "introduced_date": "2025-01-31",
   "sponsor": "Valverde; DiMario; Ujifusa; Pearson; Murray; Bell; Euer; Lauria",
   "cosponsors": 0,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-06-27",
   "failed_vote": "",
   "latest_action_date": "2025-06-27",
   "latest_action": "06/27/2025 Signed by Governor",
   "law": "",
   "same_as": "",
   "bill_url": "http://webserver.rilegislature.gov/BillText/BillText25/SenateText25/S0114Aaa.pdf",
   "text_version": "114  SUB A as amended",
   "text_date": "",
   "text_url": "http://webserver.rilegislature.gov/BillText/BillText25/SenateText25/S0114Aaa.pdf",
   "status_updated": "2025-06-30",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "sc-20252026-s639",
   "jurisdiction": "SC",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-11-08",
   "bill": "S 639",
   "title": "Artie McKnight, Board of Pharmacy",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A Senate resolution honoring a retiring member of the state pharmacy board; it names 340B only in a list of hospital committees he serves on, one of which is the 340B Team.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… serves on multiple committees at McLeod Regional Medical Center, including the Pharmacy and Therapeutics Committee, the Cancer and Infusion Medication Committee, the 340B Team, and the Pharmacy Standardization Affinity Group. Prior to accepting his current position, he was Pharmacy Business Manager for McLeod Health; and W hereas, Artie …",
   "introduced_date": "2025-05-06",
   "sponsor": "Cromer",
   "cosponsors": 0,
   "committees": "",
   "stage": "Passed the Senate",
   "stage_date": "2025-05-06",
   "failed_vote": "",
   "latest_action_date": "2025-05-06",
   "latest_action": "Scrivener's error corrected",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.scstatehouse.gov/billsearch.php?billnumbers=639&session=126&summary=B",
   "text_version": "05/06/2025",
   "text_date": "",
   "text_url": "https://www.scstatehouse.gov/sess126_2025-2026/prever/639_20250506.htm",
   "status_updated": "2026-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "sd-2025-sb154",
   "jurisdiction": "SD",
   "session": "2025 Regular Session",
   "session_end": "2025-03-31",
   "bill": "SB 154",
   "title": "prohibit pharmaceutical manufacturers from interfering in contracts between 340B entities and pharmacies and to provide a penalty therefor.",
   "official_title": "",
   "role": "",
   "kinds": [],
   "summary": "",
   "names_program_in": [
    "title"
   ],
   "text_mentions": 0,
   "quote": "prohibit pharmaceutical manufacturers from interfering in contracts between 340B entities and pharmacies and to provide a penalty therefor.",
   "introduced_date": "2025-01-30",
   "sponsor": "Reed; Rehfeldt; Emery; Moore; Muckey; Perry; Roby; Sauder; Smith; Vilhauer; Wittman",
   "cosponsors": 0,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-03-13",
   "failed_vote": "",
   "latest_action_date": "2025-03-13",
   "latest_action": "Signed by the Governor on 2025-03-13 S.J. 528",
   "law": "",
   "same_as": "",
   "bill_url": "https://sdlegislature.gov/Session/Bill/25981",
   "text_version": "154A",
   "text_date": "",
   "text_url": "https://mylrc.sdlegislature.gov/api/Documents/282241.pdf",
   "status_updated": "2025-03-13",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "tn-114-hb1242",
   "jurisdiction": "TN",
   "session": "114th Regular Session (2025-2026)",
   "session_end": "2026-04-25",
   "bill": "HB 1242",
   "title": "Insurance, Health, Accident - As enacted, revises present law relative to 340B entities. - Amends TCA Title 47, Chapter 18 and Title 56.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "other"
   ],
   "summary": "Bars drug makers from limiting the purchase or delivery of 340B drugs to 340B entities and their contract pharmacies or requiring data as a condition, with penalties of $50,000 per violation. Also bars a 340B entity's contractors from restricting its other business relationships.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 43,
   "quote": "SENATE BILL 1414 By Briggs HOUSE BILL 1242 By Helton-Haynes AN ACT to amend Tennessee Code Annotated, Title 47, Chapter 18 and Title 56, relative to 340B entities. BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF TENNESSEE: SECTION 1. Tennessee Code Annotated, Section 56-7-3119, is amended by deleting subsection (d) …",
   "introduced_date": "2025-02-06",
   "sponsor": "Helton-Haynes",
   "cosponsors": 0,
   "committees": "",
   "stage": "Reported by committee",
   "stage_date": "2025-03-05",
   "failed_vote": "",
   "latest_action_date": "2025-05-13",
   "latest_action": "Comp. became Pub. Ch. 404",
   "law": "",
   "same_as": "",
   "bill_url": "https://wapp.capitol.tn.gov/apps/BillInfo/Default?BillNumber=HB1242&ga=114",
   "text_version": "Current Version",
   "text_date": "",
   "text_url": "https://capitol.tn.gov/Bills/114/Bill/HB1242.pdf",
   "status_updated": "2026-10-31",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "tn-114-hb1648",
   "jurisdiction": "TN",
   "session": "114th Regular Session (2025-2026)",
   "session_end": "2026-04-25",
   "bill": "HB 1648",
   "title": "Auditing - As enacted, clarifies that, as of November 1, 2026, a non-governmental entity receiving in-kind funding from the state or a political subdivision of the state pursuant to the federal Public Health Service Act is eligible to qualify as a 340B entity, only if the entity is also a recipient of one or more state or federal grant awards that are subject to audit, reporting, and oversight requirements under state and federal law; authorizes the comptroller of the treasury and any state agency or political subdivision providing in-kind funding to verify eligibility and enforce compliance. - Amends TCA Title 8, Chapter 4; Title 9; Title 47, Chapter 18; Title 56 and Title 63.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "other"
   ],
   "summary": "As of November 1, 2026, a non-governmental entity that gets in-kind funding from the state or a local government under the federal Public Health Service Act can qualify as a 340B entity only if it also receives a state or federal grant subject to audit. The comptroller may verify eligibility.",
   "names_program_in": [
    "title",
    "earlier text"
   ],
   "text_mentions": 1,
   "quote": "… the state or a political subdivision of the state pursuant to § 317 or § 318 of the Public Health Service Act (42 U.S.C. §§ 247b and 247c), is eligible to qualify as a 340B entity, as defined in § 56-7- 3119, only if the entity is also a recipient of one (1) or more state or federal grant awards that are subject to audit, reporting, and …",
   "introduced_date": "2026-01-14",
   "sponsor": "Helton-Haynes",
   "cosponsors": 0,
   "committees": "",
   "stage": "Reported by committee",
   "stage_date": "2026-03-24",
   "failed_vote": "",
   "latest_action_date": "2026-04-27",
   "latest_action": "Comp. became Pub. Ch. 790",
   "law": "",
   "same_as": "",
   "bill_url": "https://wapp.capitol.tn.gov/apps/BillInfo/Default?BillNumber=HB1648&ga=114",
   "text_version": "Amendment SA0748",
   "text_date": "",
   "text_url": "https://capitol.tn.gov/Bills/114/Amend/SA0748.pdf",
   "status_updated": "2026-10-31",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "tn-114-sb1414",
   "jurisdiction": "TN",
   "session": "114th Regular Session (2025-2026)",
   "session_end": "2026-04-25",
   "bill": "SB 1414",
   "title": "Insurance, Health, Accident - As enacted, revises present law relative to 340B entities. - Amends TCA Title 47, Chapter 18 and Title 56.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "other"
   ],
   "summary": "Bars drug makers from limiting the purchase or delivery of 340B drugs to 340B entities and their contract pharmacies or requiring data as a condition, with penalties of $50,000 per violation. Also bars a 340B entity's contractors from restricting its other business relationships.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 43,
   "quote": "HOUSE BILL 1242 By Helton-Haynes SENATE BILL 1414 By Briggs AN ACT to amend Tennessee Code Annotated, Title 47, Chapter 18 and Title 56, relative to 340B entities. BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF TENNESSEE: SECTION 1. Tennessee Code Annotated, Section 56-7-3119, is amended by deleting subsection (d) …",
   "introduced_date": "2025-02-06",
   "sponsor": "Briggs",
   "cosponsors": 0,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-05-05",
   "failed_vote": "",
   "latest_action_date": "2025-05-13",
   "latest_action": "Pub. Ch. 404",
   "law": "",
   "same_as": "",
   "bill_url": "https://wapp.capitol.tn.gov/apps/BillInfo/Default?BillNumber=SB1414&ga=114",
   "text_version": "Current Version",
   "text_date": "",
   "text_url": "https://capitol.tn.gov/Bills/114/Bill/SB1414.pdf",
   "status_updated": "2026-10-31",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "tn-114-sb1654",
   "jurisdiction": "TN",
   "session": "114th Regular Session (2025-2026)",
   "session_end": "2026-04-25",
   "bill": "SB 1654",
   "title": "Auditing - As enacted, clarifies that, as of November 1, 2026, a non-governmental entity receiving in-kind funding from the state or a political subdivision of the state pursuant to the federal Public Health Service Act is eligible to qualify as a 340B entity, only if the entity is also a recipient of one or more state or federal grant awards that are subject to audit, reporting, and oversight requirements under state and federal law; authorizes the comptroller of the treasury and any state agency or political subdivision providing in-kind funding to verify eligibility and enforce compliance. - Amends TCA Title 8, Chapter 4; Title 9; Title 47, Chapter 18; Title 56 and Title 63.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "other"
   ],
   "summary": "As of November 1, 2026, a non-governmental entity that gets in-kind funding from the state or a local government under the federal Public Health Service Act can qualify as a 340B entity only if it also receives a state or federal grant subject to audit. The comptroller may verify eligibility.",
   "names_program_in": [
    "title",
    "earlier text"
   ],
   "text_mentions": 1,
   "quote": "… the state or a political subdivision of the state pursuant to § 317 or § 318 of the Public Health Service Act (42 U.S.C. §§ 247b and 247c), is eligible to qualify as a 340B entity, as defined in § 56-7- 3119, only if the entity is also a recipient of one (1) or more state or federal grant awards that are subject to audit, reporting, and …",
   "introduced_date": "2026-01-14",
   "sponsor": "Gardenhire",
   "cosponsors": 0,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2026-04-23",
   "failed_vote": "",
   "latest_action_date": "2026-04-27",
   "latest_action": "Pub. Ch. 790",
   "law": "",
   "same_as": "",
   "bill_url": "https://wapp.capitol.tn.gov/apps/BillInfo/Default?BillNumber=SB1654&ga=114",
   "text_version": "Amendment HA0830",
   "text_date": "",
   "text_url": "https://capitol.tn.gov/Bills/114/Amend/HA0830.pdf",
   "status_updated": "2026-10-31",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "tx-89r-hb3265",
   "jurisdiction": "TX",
   "session": "89th Legislature (2025)",
   "session_end": "2025-06-02",
   "bill": "HB 3265",
   "title": "Relating to discriminatory practices by a health benefit plan issuer, pharmacy benefit manager, and third-party payor and certain prescription drug manufacturers, distributors, and related persons with respect to certain entities participating in a federal drug discount program; providing a civil penalty.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "payer-nondiscrimination"
   ],
   "summary": "Would bar drug makers and distributors from limiting delivery of 340B drugs to covered entities and their contract pharmacies or demanding claims data. Would also bar insurers and pharmacy benefit managers from paying covered entities less or setting different terms for them.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 18,
   "quote": "… 1. Subchapter N, Chapter 431, Health and Safety Code, is amended by adding Section 431.416 to read as follows: Sec. 431.416. DISCRIMINATION WITH RESPECT TO FEDERAL 340B DRUG DISCOUNT PROGRAM PROHIBITED. (a) In this section: (1) \"340B drug\" and \"covered entity\" have the meanings assigned by Section 1369.701, Insurance Code. (2) …",
   "introduced_date": "2025-02-25",
   "sponsor": "Darby; Craddick; Harris; Harless; Rose",
   "cosponsors": 12,
   "committees": "",
   "stage": "Reported by committee",
   "stage_date": "2025-04-24",
   "failed_vote": "",
   "latest_action_date": "2025-05-05",
   "latest_action": "Committee report sent to Calendars",
   "law": "",
   "same_as": "",
   "bill_url": "https://capitol.texas.gov/BillLookup/History.aspx?LegSess=89R&Bill=HB3265",
   "text_version": "House Committee Report",
   "text_date": "",
   "text_url": "http://capitol.texas.gov/tlodocs/89R/billtext/html/HB03265H.HTM",
   "status_updated": "2025-05-10",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "tx-89r-hb4422",
   "jurisdiction": "TX",
   "session": "89th Legislature (2025)",
   "session_end": "2025-06-02",
   "bill": "HB 4422",
   "title": "Relating to discriminatory practices by a health benefit plan issuer, pharmacy benefit manager, and third-party payor with respect to certain entities participating in a federal drug discount program.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "Would bar insurers, pharmacy benefit managers and other payers from discriminating against 340B covered entities.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 2,
   "quote": "… SECTION 1. Chapter 1369, Insurance Code, is amended by adding Subchapter O to read as follows: SUBCHAPTER O. PROHIBITION ON DISCRIMINATION WITH RESPECT TO FEDERAL 340B DRUG DISCOUNT PROGRAM Sec. 1369.701. DEFINITIONS. In this subchapter: (1) \"Covered entity\" has the meaning assigned by 42 U.S.C. Section 256b(a)(4). (2) \"Non-covered …",
   "introduced_date": "2025-03-11",
   "sponsor": "Rose",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-03-11",
   "failed_vote": "",
   "latest_action_date": "2025-04-02",
   "latest_action": "Referred to Insurance",
   "law": "",
   "same_as": "",
   "bill_url": "https://capitol.texas.gov/BillLookup/History.aspx?LegSess=89R&Bill=HB4422",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "http://capitol.texas.gov/tlodocs/89R/billtext/html/HB04422I.HTM",
   "status_updated": "2025-04-02",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "tx-90r-hb703",
   "jurisdiction": "TX",
   "session": "90th Legislature (2027)",
   "session_end": "2027-05-31",
   "bill": "HB 703",
   "title": "Relating to the 340B program and reporting requirements for the program; authorizing an administrative penalty.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting"
   ],
   "summary": "Would require hospital covered entities to report each year to the state health department on 340B drug costs, payments received, payments to contract pharmacies and use of savings. The department would post a combined report, and an entity that does not comply would face a $1,000 penalty.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 24,
   "quote": "90(R) HB 703 - Introduced version - Bill Text 90R1225 JG-D By: Oliverson H.B. No. 703 A BILL TO BE ENTITLED AN ACT relating to the 340B program and reporting requirements for the program; authorizing an administrative penalty. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Subtitle …",
   "introduced_date": "2026-11-09",
   "sponsor": "Oliverson",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-11-09",
   "failed_vote": "",
   "latest_action_date": "2026-11-09",
   "latest_action": "Filed",
   "law": "",
   "same_as": "",
   "bill_url": "https://capitol.texas.gov/BillLookup/History.aspx?LegSess=90R&Bill=HB703",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "http://capitol.texas.gov/tlodocs/90R/billtext/html/HB00703I.HTM",
   "status_updated": "2026-11-12",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ut-2025-hb257",
   "jurisdiction": "UT",
   "session": "2025 General Session",
   "session_end": "2025-03-17",
   "bill": "HB 257",
   "title": "Pharmacy Benefit Amendments",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A law on health insurance pharmacy benefits; the passage names 340B only in the definitions of 340B drug, 340B drug discount program and 340B entity in the pharmacy benefit manager chapter.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 11,
   "quote": "… benefit plan renewed or entered into on or after July 1, 2026. Section 3, Section 31A-46-102 is amended to read: 31A-46-102 . Definitions. As used in this chapter: (1) \"340B drug\" means a drug purchased through the 340B drug discount program by a 340B entity. (2) \"340B drug discount program\" means the 340B drug discount program described in …",
   "introduced_date": "2025-01-17",
   "sponsor": "Thurston, Norman K",
   "cosponsors": 1,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-03-27",
   "failed_vote": "",
   "latest_action_date": "2025-03-27",
   "latest_action": "Governor Signed",
   "law": "",
   "same_as": "",
   "bill_url": "https://le.utah.gov/~2025/bills/static/HB0257.html",
   "text_version": "Enrolled",
   "text_date": "",
   "text_url": "https://le.utah.gov/Session/2025/bills/enrolled/HB0257.xml",
   "status_updated": "2025-03-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ut-2025-hb519",
   "jurisdiction": "UT",
   "session": "2025 General Session",
   "session_end": "2025-03-17",
   "bill": "HB 519",
   "title": "Health Care Access Amendments",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers from restricting contracts between pharmacies and 340B entities, the delivery of 340B drugs to places an entity authorizes, or 340B pricing, and from requiring claims data as a condition of supply.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 26,
   "quote": "… Amendments 2025 GENERAL SESSION STATE OF UTAH Chief Sponsor: Steve Eliason Senate Sponsor: Evan J. Vickers LONG TITLE General Description: This bill addresses the 340B drug discount program. Highlighted Provisions: This bill: defines a term; prohibits a pharmaceutical manufacturer from restricting, prohibiting, or otherwise …",
   "introduced_date": "2025-02-18",
   "sponsor": "Eliason, Steve",
   "cosponsors": 1,
   "committees": "",
   "stage": "Passed the Senate",
   "stage_date": "2025-02-28",
   "failed_vote": "",
   "latest_action_date": "2025-03-08",
   "latest_action": "House/ filed",
   "law": "",
   "same_as": "",
   "bill_url": "https://le.utah.gov/~2025/bills/static/HB0519.html",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://le.utah.gov/Session/2025/bills/introduced/HB0519.xml",
   "status_updated": "2025-03-18",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ut-2025-sb69",
   "jurisdiction": "UT",
   "session": "2025 General Session",
   "session_end": "2025-03-17",
   "bill": "SB 69",
   "title": "Medication Amendments",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Bars drug makers from restricting contracts between pharmacies and 340B entities, limiting delivery of 340B drugs to places a 340B entity names, denying 340B pricing, or demanding claims data as a condition, unless federal law requires it.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 24,
   "quote": "… Amendments 2025 GENERAL SESSION STATE OF UTAH Chief Sponsor: Evan J. Vickers House Sponsor: Steve Eliason LONG TITLE General Description: This bill addresses the 340B drug discount program. Highlighted Provisions: This bill: defines a term; prohibits certain conduct by a pharmaceutical manufacturer with respect to the 340B drug …",
   "introduced_date": "2025-01-07",
   "sponsor": "Vickers, Evan J.",
   "cosponsors": 1,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-03-27",
   "failed_vote": "2025-02-28 Senate Comm - Motion to Recommend Failed",
   "latest_action_date": "2025-03-27",
   "latest_action": "Became Law w/o Governor Signature",
   "law": "",
   "same_as": "",
   "bill_url": "https://le.utah.gov/~2025/bills/static/SB0069.html",
   "text_version": "Enrolled",
   "text_date": "",
   "text_url": "https://le.utah.gov/Session/2025/bills/enrolled/SB0069.xml",
   "status_updated": "2025-03-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ut-2026-hb356",
   "jurisdiction": "UT",
   "session": "2026 General Session",
   "session_end": "2026-03-06",
   "bill": "HB 356",
   "title": "Drug Distribution Amendments",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Amends the state's ban on drug makers restricting 340B contract pharmacy arrangements: it defines covered entity, eligible drug and contracted pharmacy, and extends the bar on requiring claims data to cover contracted pharmacies.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 35,
   "quote": "… GENERAL SESSION STATE OF UTAH Chief Sponsor: Logan J. Monson Senate Sponsor: Evan J. Vickers LONG TITLE General Description: This bill amends provisions related to the 340B drug discount program. Highlighted Provisions: This bill: defines a 340B covered entity and a 340B eligible drug; clarifies prohibited actions under the 340B drug …",
   "introduced_date": "2026-01-23",
   "sponsor": "Monson, Logan",
   "cosponsors": 1,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2026-02-27",
   "failed_vote": "",
   "latest_action_date": "2026-02-27",
   "latest_action": "Governor Signed",
   "law": "",
   "same_as": "",
   "bill_url": "https://le.utah.gov/~2026/bills/static/HB0356.html",
   "text_version": "Enrolled",
   "text_date": "",
   "text_url": "https://le.utah.gov/Session/2026/bills/enrolled/HB0356.xml",
   "status_updated": "2026-10-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ut-2026-hb527",
   "jurisdiction": "UT",
   "session": "2026 General Session",
   "session_end": "2026-03-06",
   "bill": "HB 527",
   "title": "Pharmacy Pricing Amendments",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A law on pharmacy pricing and drug maximum allowable cost; the passage names 340B only in the definitions of 340B drug, 340B drug discount program and 340B entity in the pharmacy benefit manager chapter.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 11,
   "quote": "… 1953 Be it enacted by the Legislature of the state of Utah: Section 1. Section 31A-46-102 is amended to read: 31A-46-102 . Definitions. As used in this chapter: (1) \"340B drug\" means a drug purchased through the 340B drug discount program by a 340B entity. (2) \"340B drug discount program\" means the 340B drug discount program described in …",
   "introduced_date": "2026-02-09",
   "sponsor": "Hall, Katy",
   "cosponsors": 1,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2026-03-19",
   "failed_vote": "",
   "latest_action_date": "2026-03-19",
   "latest_action": "Governor Signed",
   "law": "",
   "same_as": "",
   "bill_url": "https://le.utah.gov/~2026/bills/static/HB0527.html",
   "text_version": "Enrolled",
   "text_date": "",
   "text_url": "https://le.utah.gov/Session/2026/bills/enrolled/HB0527.xml",
   "status_updated": "2026-10-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "ut-2026-sb300",
   "jurisdiction": "UT",
   "session": "2026 General Session",
   "session_end": "2026-03-06",
   "bill": "SB 300",
   "title": "Single Payer Health Insurance Amendments",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In a wider bill on a state operated health plan, would restate the section that bars drug makers from restricting 340B drugs and contract pharmacies, and would remove the line letting the public employees' insurance program adjust its practices in response.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 22,
   "quote": "… into the fund described in Section 26C-1-103 . Section 42. Section 31A-46-311 is amended to read: 31A-46-311 Effective 01/01/28 . Prohibited actions with respect to the 340B drug discount program. (1) As used in this section, \"manufacturer\" means a pharmaceutical manufacturer, including an agent or affiliate of a pharmaceutical …",
   "introduced_date": "2026-02-16",
   "sponsor": "Blouin, Nate",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-02-17",
   "failed_vote": "",
   "latest_action_date": "2026-03-07",
   "latest_action": "Senate/ filed",
   "law": "",
   "same_as": "",
   "bill_url": "https://le.utah.gov/~2026/bills/static/SB0300.html",
   "text_version": "Substitute #1",
   "text_date": "",
   "text_url": "https://le.utah.gov/Session/2026/bills/introduced/SB0300S01.xml",
   "status_updated": "2026-10-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "vt-20252026-h202",
   "jurisdiction": "VT",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-29",
   "bill": "H 202",
   "title": "An act relating to increasing the transparency of prescription drug costs and spending",
   "official_title": "",
   "role": "part",
   "kinds": [
    "reporting",
    "other"
   ],
   "summary": "In a wider drug cost transparency bill, would require hospitals to report each year to a state board on their 340B costs, payments, vendors and use of savings, and would require all covered entities to tell patients each year if their drugs were bought through 340B.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 23,
   "quote": "… Representative Cordes of Bristol Referred to Committee on Date: Subject: Health; health insurance; prescription drugs; pharmacy benefit managers; pharmacies; hospitals; 340B drug pricing program Statement of purpose of bill as introduced: This bill proposes to prohibit a pharmacy benefit manager from requiring a person covered by a health …",
   "introduced_date": "2025-02-12",
   "sponsor": "Mari Cordes",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-12",
   "failed_vote": "",
   "latest_action_date": "2025-02-12",
   "latest_action": "Read first time and referred to the Committee on Health Care",
   "law": "",
   "same_as": "",
   "bill_url": "http://legislature.vermont.gov/bill/loadBillsIntroduced/2026/",
   "text_version": "As IntroducedOpens in a new window",
   "text_date": "",
   "text_url": "http://legislature.vermont.gov/Documents/2026/Docs/BILLS/H-0202/H-0202%20As%20Introduced.pdf",
   "status_updated": "2026-07-02",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "vt-20252026-h266",
   "jurisdiction": "VT",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-29",
   "bill": "H 266",
   "title": "An act relating to the 340B prescription drug pricing program",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "reporting"
   ],
   "summary": "Bars drug makers from restricting delivery of 340B drugs to contract pharmacies, from requiring claims data as a condition, and from giving 340B pricing as a rebate instead of a discount at purchase. Requires hospitals in 340B to report yearly figures, which a state board posts online.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 49,
   "quote": "No. 55 Page 1 of 8 2025 No. 55. An act relating to the 340B prescription drug pricing program. (H.266) It is hereby enacted by the General Assembly of the State of Vermont: Sec. 1. 18 V.S.A. chapter 91, subchapter 6 is added to …",
   "introduced_date": "2025-02-19",
   "sponsor": "Alyssa Black",
   "cosponsors": 0,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-06-11",
   "failed_vote": "",
   "latest_action_date": "2025-06-13",
   "latest_action": "House message: Governor approved bill on June 11, 2025",
   "law": "",
   "same_as": "",
   "bill_url": "http://legislature.vermont.gov/bill/loadBillsIntroduced/2026/",
   "text_version": "As EnactedOpens in a new window",
   "text_date": "",
   "text_url": "http://legislature.vermont.gov/Documents/2026/Docs/ACTS/ACT055/ACT055%20As%20Enacted.pdf",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "vt-20252026-h611",
   "jurisdiction": "VT",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-29",
   "bill": "H 611",
   "title": "An act relating to miscellaneous provisions affecting the Department of Vermont Health Access",
   "official_title": "",
   "role": "part",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "In a wider law on the state's health access department, bars drug makers from requiring a covered entity's claims or other data as a condition of delivering 340B drugs to the entity or its contract pharmacy, and repeals the rule that 340B pricing be a discount at purchase, not a rebate.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 10,
   "quote": "… Access, to one or more health insurers, or both during the specified period of time; *** Sec. 2. 18 V.S.A. § 4682 is amended to read: § 4682. DISCRIMINATION AGAINST 340B ENTITIES PROHIBITED *** (b) A manufacturer or its agent shall not directly or indirectly require a 340B covered entity to submit any claims, utilization, encounter, …",
   "introduced_date": "2026-01-08",
   "sponsor": "Daisy Berbeco",
   "cosponsors": 0,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2026-05-29",
   "failed_vote": "",
   "latest_action_date": "2026-05-29",
   "latest_action": "House message: Governor approved bill on June 8, 2026",
   "law": "",
   "same_as": "",
   "bill_url": "http://legislature.vermont.gov/bill/loadBillsIntroduced/2026/",
   "text_version": "As EnactedOpens in a new window",
   "text_date": "",
   "text_url": "http://legislature.vermont.gov/Documents/2026/Docs/ACTS/ACT120/ACT120%20As%20Enacted.pdf",
   "status_updated": "2026-10-27",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wa-20252026-hb1197",
   "jurisdiction": "WA",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-03-06",
   "bill": "HB 1197",
   "title": "Making 2023-2025 fiscal biennium second supplemental operating appropriations.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "reporting",
    "medicaid"
   ],
   "summary": "In a wider state budget bill, a section funding fiscal years 2024 and 2025 would have the state Medicaid authority set a yearly reporting requirement for 340B covered entities that get Medicaid funds, and report by October 15, 2023 on the costs and benefits of its ways of providing drugs.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… cost and benefit of this service delivery method. The authority must establish an annual reporting requirement for all covered entities participating in the 340B drug pricing program that receive medicaid funds under this section; and the authority shall provide at an aggregate level, broken down by covered entities defined by …",
   "introduced_date": "2025-01-08",
   "sponsor": "Ormsby",
   "cosponsors": 3,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-08",
   "failed_vote": "",
   "latest_action_date": "2026-01-12",
   "latest_action": "By resolution, reintroduced and retained in present status.",
   "law": "",
   "same_as": "",
   "bill_url": "https://app.leg.wa.gov/billsummary/?BillNumber=1197&Year=2025&Initiative=false",
   "text_version": "Bill",
   "text_date": "",
   "text_url": "http://lawfilesext.leg.wa.gov/Biennium/2025-26/Htm/Bills/House%20Bills/1197.htm",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wa-20252026-hb1198",
   "jurisdiction": "WA",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-03-06",
   "bill": "HB 1198",
   "title": "Making 2025-2027 fiscal biennium operating appropriations.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "reporting",
    "medicaid"
   ],
   "summary": "In a wider state budget bill, a section funding fiscal years 2024 and 2025 would have the state Medicaid authority set a yearly reporting requirement for 340B covered entities that get Medicaid funds, and report by October 15, 2023 on the costs and benefits of its ways of providing drugs.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… cost and benefit of this service delivery method. The authority must establish an annual reporting requirement for all covered entities participating in the 340B drug pricing program that receive medicaid funds under this section; and the authority shall provide at an aggregate level, broken down by covered entities defined by …",
   "introduced_date": "2025-01-08",
   "sponsor": "Ormsby",
   "cosponsors": 2,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-08",
   "failed_vote": "",
   "latest_action_date": "2026-01-12",
   "latest_action": "House Rules \"X\" file.",
   "law": "",
   "same_as": "",
   "bill_url": "https://app.leg.wa.gov/billsummary/?BillNumber=1198&Year=2025&Initiative=false",
   "text_version": "Substitute Bill",
   "text_date": "",
   "text_url": "http://lawfilesext.leg.wa.gov/Biennium/2025-26/Htm/Bills/House%20Bills/1198-S.htm",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wa-20252026-hb2145",
   "jurisdiction": "WA",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-03-06",
   "bill": "HB 2145",
   "title": "Protecting patient access to discounted medications and health care services through Washington's health care safety net by preventing manufacturer limitations on the 340B drug pricing program.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy"
   ],
   "summary": "Would bar drug makers from denying or restricting delivery of 340B drugs to covered entities and their contract pharmacies, or from demanding claims data as a condition. Covered entities and the attorney general could sue, with civil penalties of up to $5,000 a day.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 38,
   "quote": "… protecting patient access to discounted medications and health care services through Washington's health care safety net by preventing manufacturer limitations on the 340B drug pricing program; adding a new chapter to Title 69 RCW; creating a new section; and prescribing penalties. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF …",
   "introduced_date": "2025-12-15",
   "sponsor": "Thai",
   "cosponsors": 40,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-12-15",
   "failed_vote": "",
   "latest_action_date": "2026-02-09",
   "latest_action": "Referred to Rules 2 Review.",
   "law": "",
   "same_as": "",
   "bill_url": "https://app.leg.wa.gov/billsummary/?BillNumber=2145&Year=2025&Initiative=false",
   "text_version": "Second Substitute Bill",
   "text_date": "",
   "text_url": "http://lawfilesext.leg.wa.gov/Biennium/2025-26/Htm/Bills/House%20Bills/2145-S2.htm",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wa-20252026-sb5166",
   "jurisdiction": "WA",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-03-06",
   "bill": "SB 5166",
   "title": "Making 2023-2025 fiscal biennium second supplemental operating appropriations.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "reporting",
    "medicaid"
   ],
   "summary": "In a wider state budget bill, a section funding fiscal years 2024 and 2025 would have the state Medicaid authority set a yearly reporting requirement for 340B covered entities that get Medicaid funds, and report by October 15, 2023 on the costs and benefits of its ways of providing drugs.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… cost and benefit of this service delivery method. The authority must establish an annual reporting requirement for all covered entities participating in the 340B drug pricing program that receive medicaid funds under this section; and the authority shall provide at an aggregate level, broken down by covered entities defined by …",
   "introduced_date": "2025-01-08",
   "sponsor": "Robinson",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-01-08",
   "failed_vote": "",
   "latest_action_date": "2026-01-12",
   "latest_action": "By resolution, reintroduced and retained in present status.",
   "law": "",
   "same_as": "",
   "bill_url": "https://app.leg.wa.gov/billsummary/?BillNumber=5166&Year=2025&Initiative=false",
   "text_version": "Bill",
   "text_date": "",
   "text_url": "http://lawfilesext.leg.wa.gov/Biennium/2025-26/Htm/Bills/Senate%20Bills/5166.htm",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wa-20252026-sb5167",
   "jurisdiction": "WA",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-03-06",
   "bill": "SB 5167",
   "title": "Making 2025-2027 fiscal biennium operating appropriations.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "reporting",
    "medicaid"
   ],
   "summary": "In a wider state budget law, a section funding fiscal years 2024 and 2025 has the state Medicaid authority set a yearly reporting requirement for 340B covered entities that get Medicaid funds, and report by October 15, 2023 on the costs and benefits of its ways of providing drugs.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… cost and benefit of this service delivery method. The authority must establish an annual reporting requirement for all covered entities participating in the 340B drug pricing program that receive medicaid funds under this section; and the authority shall provide at an aggregate level, broken down by covered entities defined by …",
   "introduced_date": "2025-01-08",
   "sponsor": "Robinson",
   "cosponsors": 5,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2025-05-20",
   "failed_vote": "",
   "latest_action_date": "2025-05-20",
   "latest_action": "Effective date 5/20/2025*.",
   "law": "",
   "same_as": "",
   "bill_url": "https://app.leg.wa.gov/billsummary/?BillNumber=5167&Year=2025&Initiative=false",
   "text_version": "Substitute Passed Legislature",
   "text_date": "",
   "text_url": "http://lawfilesext.leg.wa.gov/Biennium/2025-26/Htm/Bills/Senate%20Passed%20Legislature/5167-S.PL.htm",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wa-20252026-sb5810",
   "jurisdiction": "WA",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-03-06",
   "bill": "SB 5810",
   "title": "Making 2025-2027 fiscal biennium operating appropriations and 2023-2025 fiscal biennium second supplemental operating appropriations.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "reporting",
    "medicaid"
   ],
   "summary": "In a wider state budget bill, a section funding fiscal years 2024 and 2025 would have the state Medicaid authority set a yearly reporting requirement for 340B covered entities that get Medicaid funds, and report by October 15, 2023 on the costs and benefits of its ways of providing drugs.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 3,
   "quote": "… cost and benefit of this service delivery method. The authority must establish an annual reporting requirement for all covered entities participating in the 340B drug pricing program that receive medicaid funds under this section; and the authority shall provide at an aggregate level, broken down by covered entities defined by …",
   "introduced_date": "2025-04-15",
   "sponsor": "Gildon",
   "cosponsors": 11,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-04-15",
   "failed_vote": "",
   "latest_action_date": "2026-01-12",
   "latest_action": "By resolution, reintroduced and retained in present status.",
   "law": "",
   "same_as": "",
   "bill_url": "https://app.leg.wa.gov/billsummary/?BillNumber=5810&Year=2025&Initiative=false",
   "text_version": "Bill",
   "text_date": "",
   "text_url": "http://lawfilesext.leg.wa.gov/Biennium/2025-26/Htm/Bills/Senate%20Bills/5810.htm",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wa-20252026-sb5981",
   "jurisdiction": "WA",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-03-06",
   "bill": "SB 5981",
   "title": "Protecting patient access to discounted medications and health care services through Washington's health care safety net by preventing manufacturer limitations on the 340B drug pricing program.",
   "official_title": "",
   "role": "main",
   "kinds": [
    "contract-pharmacy",
    "reporting"
   ],
   "summary": "Bars drug makers from denying or restricting delivery of 340B drugs to covered entities and their contract pharmacies, or demanding claims data as a condition, with civil penalties of up to $5,000 a day. Also calls for 340B reporting by covered entities and drug makers, with a filing fee.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 71,
   "quote": "… Bateman, Alvarado, Chapman, Dhingra, Frame, Hasegawa, Liias, Pedersen, Saldaña, and Valdez) READ FIRST TIME 02/09/26. AN ACT Relating to protecting the integrity of the 340B drug pricing program; amending RCW 43.71C.010 , 43.71C.050 , 43.71C.090 , and 43.71C.100 ; adding new sections to chapter 43.71C RCW; adding a new chapter to Title 69 …",
   "introduced_date": "2026-01-05",
   "sponsor": "Cleveland",
   "cosponsors": 12,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2026-03-25",
   "failed_vote": "",
   "latest_action_date": "2026-03-25",
   "latest_action": "Effective date 6/11/2026.",
   "law": "",
   "same_as": "",
   "bill_url": "https://app.leg.wa.gov/billsummary/?BillNumber=5981&Year=2025&Initiative=false",
   "text_version": "Second Substitute Passed Legislature",
   "text_date": "",
   "text_url": "http://lawfilesext.leg.wa.gov/Biennium/2025-26/Htm/Bills/Senate%20Passed%20Legislature/5981-S2.PL.htm",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wa-20252026-sb5998",
   "jurisdiction": "WA",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-03-06",
   "bill": "SB 5998",
   "title": "Making 2025-2027 fiscal biennium supplemental operating appropriations.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "other"
   ],
   "summary": "In the supplemental state operating budget, provides $608,000 for fiscal year 2027 to carry out a separate 340B drug pricing bill. The money lapses if that bill is not enacted by June 30, 2026.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… (75) $608,000 of the general fund — state appropriation for fiscal year 2027 is provided solely for implementation of Engrossed Second Substitute Senate Bill No. 5981 (340b drug pricing program). If the bill is not enacted by June 30, 2026, the amount provided in this subsection shall lapse. (76) $51,000 of the general fund — state …",
   "introduced_date": "2026-01-06",
   "sponsor": "Robinson",
   "cosponsors": 1,
   "committees": "",
   "stage": "Became law",
   "stage_date": "2026-04-01",
   "failed_vote": "",
   "latest_action_date": "2026-04-01",
   "latest_action": "Effective date 4/1/2026.",
   "law": "",
   "same_as": "",
   "bill_url": "https://app.leg.wa.gov/billsummary/?BillNumber=5998&Year=2025&Initiative=false",
   "text_version": "Substitute Passed Legislature",
   "text_date": "",
   "text_url": "http://lawfilesext.leg.wa.gov/Biennium/2025-26/Htm/Bills/Senate%20Passed%20Legislature/5998-S.PL.htm",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wi-2025-ab173",
   "jurisdiction": "WI",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-25",
   "bill": "AB 173",
   "title": "Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)",
   "official_title": "",
   "role": "part",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "In a wider bill on pharmacy benefit managers, would bar them from paying 340B covered entities and their contract pharmacies less than other pharmacies for a 340B drug, refusing to pay for 340B drugs, adding fees after a claim is paid, or limiting network access because of 340B.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 33,
   "quote": "… service fees. 4. The amounts received from network pharmacies and pharmacists and the amount retained by the pharmacy benefit manager. Discriminatory reimbursement of 340B entities The bill prohibits a pharmacy benefit manager from taking certain actions with respect to 340B covered entities, pharmacies and pharmacists contracted with …",
   "introduced_date": "2025-04-09",
   "sponsor": "Novak; Tranel; Allen; Armstrong; Brooks; Callahan; Fitzgerald; B. Jacobson; Joers; Kirsch; Kitchens; Knodl; Kreibich; McCarville; Miresse; Mursau; O'Connor; Sortwell; Tittl; Wichgers; Tucker",
   "cosponsors": 18,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-04-09",
   "failed_vote": "2026-03-23 Failed to pass pursuant to Senate Joint Resolution 1",
   "latest_action_date": "2026-03-23",
   "latest_action": "Failed to pass pursuant to Senate Joint Resolution 1",
   "law": "",
   "same_as": "",
   "bill_url": "https://docs.legis.wisconsin.gov/2025/proposals/reg/asm/bill/ab173",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://docs.legis.wisconsin.gov/document/proposaltext/2025/REG/AB173",
   "status_updated": "2026-10-31",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wi-2025-ab62",
   "jurisdiction": "WI",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-25",
   "bill": "AB 62",
   "title": "Relating to: health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE)",
   "official_title": "",
   "role": "part",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "In a wider health care costs bill, would bar paying certain 340B entities (health centers, critical access hospitals, Ryan White grantees) and their pharmacies less for a 340B drug than similar-volume pharmacies, or charging them fees because they take part in 340B.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 4,
   "quote": "… claims or bona fide service fees. 4. The amounts received from network pharmacies and the amount retained by the pharmacy benefit manager. Reimbursements for certain 340B program entities The bill prohibits any person from reimbursing certain entities that participate in the federal drug pricing program, known as the 340B program, for a …",
   "introduced_date": "2025-02-24",
   "sponsor": "Subeck; Spaude; Johnson; Anderson; Andraca; Arney; Bare; Billings; Brown; Cruz; DeSanto; DeSmidt; Doyle; Emerson; Fitzgerald; Goodwin; Haywood; Hong; Hysell; J. Jacobson; Joers; Kirsch; Madison; Mayadev; McCarville; McGuire; Miresse; Moore Omokunde; Neubauer; Ortiz-Velez; Palmeri; Phelps; Prado; Rivera-Wagner; Roe; Sheehan; Sinicki; Snodgrass; Stroud; Stubbs; Taylor; Tenorio; Udell; Vining",
   "cosponsors": 14,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-24",
   "failed_vote": "2026-03-23 Failed to pass pursuant to Senate Joint Resolution 1",
   "latest_action_date": "2026-03-23",
   "latest_action": "Failed to pass pursuant to Senate Joint Resolution 1",
   "law": "",
   "same_as": "",
   "bill_url": "https://docs.legis.wisconsin.gov/2025/proposals/reg/asm/bill/ab62",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://docs.legis.wisconsin.gov/document/proposaltext/2025/REG/AB62",
   "status_updated": "2026-10-31",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wi-2025-sb203",
   "jurisdiction": "WI",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-25",
   "bill": "SB 203",
   "title": "Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)",
   "official_title": "",
   "role": "part",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "In a wider bill on pharmacy benefit managers, would bar them from paying 340B covered entities and their contract pharmacies less than other pharmacies for a 340B drug, refusing to pay for 340B drugs, adding fees after a claim is paid, or limiting network access because of 340B.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 33,
   "quote": "… service fees. 4. The amounts received from network pharmacies and pharmacists and the amount retained by the pharmacy benefit manager. Discriminatory reimbursement of 340B entities The bill prohibits a pharmacy benefit manager from taking certain actions with respect to 340B covered entities, pharmacies and pharmacists contracted with …",
   "introduced_date": "2025-04-16",
   "sponsor": "Felzkowski; Marklein; Cabral-Guevara; Dassler-Alfheim; Drake; Habush Sinykin; L. Johnson; Keyeski; Larson; Nass; Pfaff; Quinn; Ratcliff; Roys; Spreitzer; Wanggaard; Wimberger; James",
   "cosponsors": 22,
   "committees": "",
   "stage": "Reported by committee",
   "stage_date": "2025-08-21",
   "failed_vote": "2026-03-23 Failed to pass pursuant to Senate Joint Resolution 1",
   "latest_action_date": "2026-03-23",
   "latest_action": "Failed to pass pursuant to Senate Joint Resolution 1",
   "law": "",
   "same_as": "",
   "bill_url": "https://docs.legis.wisconsin.gov/2025/proposals/reg/sen/bill/sb203",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://docs.legis.wisconsin.gov/document/proposaltext/2025/REG/SB203",
   "status_updated": "2026-10-31",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wi-2025-sb50",
   "jurisdiction": "WI",
   "session": "2025-2026 Regular Session",
   "session_end": "2026-05-25",
   "bill": "SB 50",
   "title": "Relating to: health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE)",
   "official_title": "",
   "role": "part",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "In a wider health care costs bill, would bar paying certain 340B entities (health centers, critical access hospitals, Ryan White grantees) and their pharmacies less for a 340B drug than similar-volume pharmacies, or charging them fees because they take part in 340B.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 4,
   "quote": "… claims or bona fide service fees. 4. The amounts received from network pharmacies and the amount retained by the pharmacy benefit manager. Reimbursements for certain 340B program entities The bill prohibits any person from reimbursing certain entities that participate in the federal drug pricing program, known as the 340B program, for a …",
   "introduced_date": "2025-02-21",
   "sponsor": "Pfaff; Hesselbein; Drake; Carpenter; Dassler-Alfheim; Habush Sinykin; L. Johnson; Keyeski; Ratcliff; Roys; Smith; Spreitzer; Wall; Wirch",
   "cosponsors": 42,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-21",
   "failed_vote": "2026-03-23 Failed to pass pursuant to Senate Joint Resolution 1",
   "latest_action_date": "2026-03-23",
   "latest_action": "Failed to pass pursuant to Senate Joint Resolution 1",
   "law": "",
   "same_as": "",
   "bill_url": "https://docs.legis.wisconsin.gov/2025/proposals/reg/sen/bill/sb50",
   "text_version": "Bill Text",
   "text_date": "",
   "text_url": "https://docs.legis.wisconsin.gov/document/proposaltext/2025/REG/SB50",
   "status_updated": "2026-10-31",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wv-2025-hb2831",
   "jurisdiction": "WV",
   "session": "2025 Regular Session",
   "session_end": "2025-04-12",
   "bill": "HB 2831",
   "title": "Creating the Prescription Drug Affordability Board",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A bill creating a prescription drug affordability board; it names 340B only in requiring that at least one board member have expertise in it.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 1,
   "quote": "… of the Senate; and (C) One alternate member appointed by the Speaker of the House of Delegates. (3) At least one member of the board shall have expertise in: (A) The 340B Program under the federal Public Health Service Act; (B) The state's All-Payer Claims Database; (C) How the program and contract interact; and (D) How decisions made by …",
   "introduced_date": "2025-02-24",
   "sponsor": "Young",
   "cosponsors": 1,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-02-24",
   "failed_vote": "",
   "latest_action_date": "2025-02-24",
   "latest_action": "To House Health and Human Resources",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.wvlegislature.gov/Bill_Status/Bills_history.cfm?input=2831&year=2025&sessiontype=RS&btype=bill",
   "text_version": "Introduced Version",
   "text_date": "",
   "text_url": "https://www.wvlegislature.gov/Bill_Status/bills_text.cfm?billdoc=hb2831%20intr.htm&yr=2025&sesstype=RS&i=2831",
   "status_updated": "2025-02-24",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wv-2025-hb3068",
   "jurisdiction": "WV",
   "session": "2025 Regular Session",
   "session_end": "2025-04-12",
   "bill": "HB 3068",
   "title": "Update the regulation of pharmacy benefit managers",
   "official_title": "",
   "role": "mention",
   "kinds": [],
   "summary": "A bill on pharmacy benefit managers; it names 340B in two definitions, one defining a 340B entity and one leaving 340B discounts out of the meaning of a rebate.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 4,
   "quote": "… benefits management. Be it enacted by the Legislature of West Virginia: article 51. pharmacy audit integrity act. §33-51-3. Definitions. For purposes of this article: \"340B entity\" means an entity participating in the federal 340B drug discount program, as described in 42 U.S.C. § 256b, including its pharmacy or pharmacies, or any pharmacy …",
   "introduced_date": "2025-03-03",
   "sponsor": "Rohrbach",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-03-03",
   "failed_vote": "",
   "latest_action_date": "2025-03-03",
   "latest_action": "To House Health and Human Resources",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.wvlegislature.gov/Bill_Status/Bills_history.cfm?input=3068&year=2025&sessiontype=RS&btype=bill",
   "text_version": "Introduced Version",
   "text_date": "",
   "text_url": "https://www.wvlegislature.gov/Bill_Status/bills_text.cfm?billdoc=hb3068%20intr.htm&yr=2025&sesstype=RS&i=3068",
   "status_updated": "2025-03-03",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wv-2025-sb675",
   "jurisdiction": "WV",
   "session": "2025 Regular Session",
   "session_end": "2025-04-12",
   "bill": "SB 675",
   "title": "Requiring participant in federal 340B Drug Pricing Program to report certain data",
   "official_title": "",
   "role": "main",
   "kinds": [
    "reporting"
   ],
   "summary": "Would require 340B covered entities to report each year to the Board of Pharmacy their 340B drug costs, payments received, payments to contract pharmacies and how they use the savings, and require the board to publish a combined report.",
   "names_program_in": [
    "title",
    "text"
   ],
   "text_mentions": 18,
   "quote": "… A BILL to amend the Code of West Virginia, 1931, as amended, by adding a new section, designated §30-5-37, relating to requiring a participant in a federal 340B Drug Pricing Program to report certain data to the Board of Pharmacy. Be it enacted by the Legislature of West Virginia: ARTICLE 5. PHARMACISTS, PHARMACY TECHNICIANS, …",
   "introduced_date": "2025-03-04",
   "sponsor": "Rucker",
   "cosponsors": 6,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-03-04",
   "failed_vote": "",
   "latest_action_date": "2025-03-04",
   "latest_action": "To Government Organization",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.wvlegislature.gov/Bill_Status/Bills_history.cfm?input=675&year=2025&sessiontype=RS&btype=bill",
   "text_version": "Introduced Version",
   "text_date": "",
   "text_url": "https://www.wvlegislature.gov/Bill_Status/bills_text.cfm?billdoc=sb675%20intr.htm&yr=2025&sesstype=RS&i=675",
   "status_updated": "2025-03-29",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wv-2025-sb852",
   "jurisdiction": "WV",
   "session": "2025 Regular Session",
   "session_end": "2025-04-12",
   "bill": "SB 852",
   "title": "Relating to regulation of pharmacy benefit managers",
   "official_title": "",
   "role": "part",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "In a wider bill on pharmacy benefit managers, the amended section would bar them from paying a 340B entity less than similar pharmacies, adding fees or extra claim requirements, or excluding a pharmacy from their network because it dispenses 340B drugs.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 22,
   "quote": "… individual that exceeds the total submitted charges by the pharmacy or pharmacist to the pharmacy benefit manager. (c) A pharmacy benefit manager that reimburses a 340B entity for drugs that are subject to an agreement under 42 U.S.C. § 256b shall not reimburse the 340B entity for pharmacy-dispensed drugs at a rate lower than that paid …",
   "introduced_date": "2025-03-20",
   "sponsor": "Takubo",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2025-03-20",
   "failed_vote": "",
   "latest_action_date": "2025-03-20",
   "latest_action": "To Health and Human Resources",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.wvlegislature.gov/Bill_Status/Bills_history.cfm?input=852&year=2025&sessiontype=RS&btype=bill",
   "text_version": "Introduced Version",
   "text_date": "",
   "text_url": "https://www.wvlegislature.gov/Bill_Status/bills_text.cfm?billdoc=sb852%20intr.htm&yr=2025&sesstype=RS&i=852",
   "status_updated": "2025-03-20",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wv-2026-sb907",
   "jurisdiction": "WV",
   "session": "2026 Regular Session",
   "session_end": "2026-03-14",
   "bill": "SB 907",
   "title": "Relating to pharmacy benefit managers and state pharmacy purchasing",
   "official_title": "",
   "role": "part",
   "kinds": [
    "payer-nondiscrimination"
   ],
   "summary": "In a wider bill on pharmacy benefit managers, the amended section would bar them from paying a 340B entity less than similar pharmacies, adding fees or extra claim requirements, or excluding a pharmacy from their network because it dispenses 340B drugs.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 22,
   "quote": "… individual that exceeds the total submitted charges by the pharmacy or pharmacist to the pharmacy benefit manager. (c) A pharmacy benefit manager that reimburses a 340B entity for drugs that are subject to an agreement under 42 U.S.C. § 256b shall not reimburse the 340B entity for pharmacy-dispensed drugs at a rate lower than that paid …",
   "introduced_date": "2026-02-10",
   "sponsor": "Helton",
   "cosponsors": 0,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-02-10",
   "failed_vote": "",
   "latest_action_date": "2026-02-10",
   "latest_action": "To Health and Human Resources",
   "law": "",
   "same_as": "",
   "bill_url": "https://www.wvlegislature.gov/Bill_Status/Bills_history.cfm?input=907&year=2026&sessiontype=RS&btype=bill",
   "text_version": "Introduced Version",
   "text_date": "",
   "text_url": "https://www.wvlegislature.gov/Bill_Status/bills_text.cfm?billdoc=sb907%20intr.htm&yr=2026&sesstype=RS&i=907",
   "status_updated": "2026-10-28",
   "retrieved": "2026-11-15"
  },
  {
   "bill_id": "wy-2026-hb179",
   "jurisdiction": "WY",
   "session": "2026 Regular Session",
   "session_end": "2026-03-06",
   "bill": "HB 179",
   "title": "Hospital pricing transparency.",
   "official_title": "",
   "role": "part",
   "kinds": [
    "reporting"
   ],
   "summary": "In a wider hospital price transparency bill, would require 340B hospitals to report each year their 340B drug costs, payments received, payments to contract pharmacies and use of savings, and to show on their public price lists the 340B discounts they receive.",
   "names_program_in": [
    "text"
   ],
   "text_mentions": 34,
   "quote": "… and services, to provide civil penalties and to prohibit debt collection by hospitals in violation of this act. 35-2-1502. Definitions. (a) As used in this act: (i) \"340B covered facility\" means a facility described in 42 U.S.C. § 256b(a)(4)(L) through 42 U.S.C. § 256b(a)(4)(O) that: 2 HB0179 2026 STATE OF WYOMING 26LSO-0305 (A) Is …",
   "introduced_date": "2026-02-11",
   "sponsor": "Singh",
   "cosponsors": 3,
   "committees": "",
   "stage": "Introduced",
   "stage_date": "2026-02-12",
   "failed_vote": "",
   "latest_action_date": "2026-02-14",
   "latest_action": "H Failed Introduction 31-29-2-0-0",
   "law": "",
   "same_as": "",
   "bill_url": "https://wyoleg.gov/Legislation/2026/HB0179",
   "text_version": "Introduced",
   "text_date": "",
   "text_url": "https://wyoleg.gov/2026/Introduced/HB0179.pdf",
   "status_updated": "2026-07-15",
   "retrieved": "2026-11-15"
  }
 ]
}
